<!DOCTYPE html>
 <!--[if lt IE 7]> <html dir="ltr" lang="en-US" class="aui ltr no-js lt-ie9 lt-ie8 lt-ie7"> <![endif]--> <!--[if IE 7]> <html dir="ltr" lang="en-US" class="aui ltr no-js lt-ie9 lt-ie8"> <![endif]--> <!--[if IE 8]> <html dir="ltr" lang="en-US" class="aui ltr no-js lt-ie9"> <![endif]--> <!--[if gt IE 8]><!--> <html class="aui ltr" dir="ltr" lang="en-US" prefix="og: http://ogp.me/ns#"> <!--<![endif]--> <head> <title>Normobaric and hyperbaric oxygen therapy for the treatment and prevention of migraine and cluster headache - Bennett, MH - 2015 | Cochrane Library</title> <meta content="Normobaric and hyperbaric oxygen therapy for the treatment and prevention of migraine and cluster headache - Bennett, MH - 2015 | Cochrane Library" property="og:title"/> <meta content="https://www.cochranelibrary.com/cdsr/doi/10.1002/14651858.CD005219.pub3/full" property="og:url"/> <meta content="article" property="og:type"/> <meta content="https://www.cochranelibrary.com/cochrane-theme/images/cochrane_circulargraphic.png" property="og:image"/> <meta content="summary_large_image" name="twitter:card"/> <meta content="Normobaric and hyperbaric oxygen therapy for the treatment and prevention of migraine and cluster headache - Bennett, MH - 2015 | Cochrane Library" name="twitter:title"/> <meta content="https://www.cochranelibrary.com/cdsr/doi/10.1002/14651858.CD005219.pub3/full" name="twitter:url"/> <meta content="https://www.cochranelibrary.com/cochrane-theme/images/cochrane_circulargraphic.png" name="twitter:image"/> <meta content="initial-scale=1.0, width=device-width" name="viewport"/> <meta content="10.1002/14651858.CD005219.pub3" name="dc.identifier" scheme="DOI"/> <meta content="Normobaric and hyperbaric oxygen therapy for the treatment and prevention of migraine and cluster headache" name="citation_title"/> <meta content="Michael H Bennett" name="citation_author"/> <meta content="Prince of Wales Clinical School, University of NSW" name="citation_author_institution"/> <meta content="m.bennett@unsw.edu.au" name="citation_author_email"/> <meta content="Christopher French" name="citation_author"/> <meta content="University of Melbourne" name="citation_author_institution"/> <meta content="Alexander Schnabel" name="citation_author"/> <meta content="University of Würzburg" name="citation_author_institution"/> <meta content="Jason Wasiak" name="citation_author"/> <meta content="The Epworth Hospital" name="citation_author_institution"/> <meta content="Peter Kranke" name="citation_author"/> <meta content="University of Würzburg" name="citation_author_institution"/> <meta content="Stephanie Weibel" name="citation_author"/> <meta content="University of Würzburg" name="citation_author_institution"/> <meta content="Cochrane Database of Systematic Reviews" name="citation_journal_title"/> <meta content="John Wiley &amp; Sons, Ltd" name="citation_publisher"/> <meta content="12" name="citation_issue"/> <meta content="10.1002/14651858.CD005219.pub3" name="citation_doi"/> <meta content="2015" name="citation_date"/> <meta content="2016/12/28" name="citation_online_date"/> <meta content="https://www.cochranelibrary.com/cdsr/doi/10.1002/14651858.CD005219.pub3/abstract" name="citation_abstract_html_url"/> <meta content="https://www.cochranelibrary.com/cdsr/doi/10.1002/14651858.CD005219.pub3/full" name="citation_fulltext_html_url"/> <meta content="https://www.cochranelibrary.com/cdsr/doi/10.1002/14651858.CD005219.pub3/pdf/full" name="citation_pdf_url"/> <meta content="1465-1858" name="citation_issn"/> <meta content="en" name="citation_language"/> <meta content="*Hyperbaric Oxygenation; *Oxygen Inhalation Therapy; Cluster Headache [*therapy]; Migraine Disorders [*therapy]; Randomized Controlled Trials as Topic" name="citation_keywords"/> <link href="https://fonts.googleapis.com/css?family=Source+Sans+Pro:400,700,600,900" rel="stylesheet"/> <script src="https://cmp.osano.com/AzZdRbSORDOOzF9W/d594efc1-9663-477d-9528-6576640e64fd/osano.js"></script> <style> .osano-cm-widget{display: none;} </style> <script src="https://static.addtoany.com/menu/page.js"></script> <script async="" charset="utf-8" src="https://platform.twitter.com/widgets.js"></script> <script async="async" src="//script.crazyegg.com/pages/scripts/0056/6375.js" type="text/javascript"></script> <script type="text/javascript">window.dataLayer={};var xtend=function(){var a={};var b=false;var c=0;var d=arguments.length;if(Object.prototype.toString.call(arguments[0])==="[object Boolean]"){b=arguments[0];c++}var f=function(g){for(var h in g){if(Object.prototype.hasOwnProperty.call(g,h)){if(b&&Object.prototype.toString.call(g[h])==="[object Object]"){a[h]=xtend(true,a[h],g[h])}else{a[h]=g[h]}}}};for(;c<d;c++){var e=arguments[c];f(e)}return a};</script> <!-- Global site tag (gtag.js) - Google Analytics --> <script src="https://www.googletagmanager.com/gtag/js?id=UA-189672-63&amp;l=gDataLayer"></script> <script>window.gDataLayer=window.gDataLayer||[];function gtag(){gDataLayer.push(arguments)}gtag("js",new Date());gtag("config","UA-189672-63");</script> <script type="text/javascript">var o={auth:{customerIds:[],individualId:null,brandedCustomer:null,roles:["Guest"]}};window.dataLayer=xtend(true,window.dataLayer,o);</script> <script type="text/javascript">var o={page:{siteSection:"Content",languageCode:"en",cms:{pageTitle:"Content"}}};window.dataLayer=xtend(true,window.dataLayer,o);</script> <meta content="text/html; charset=utf-8" http-equiv="content-type"/> <link href="https://www.cochranelibrary.com/cochrane-theme/images/favicon.ico" rel="Shortcut Icon"/> <link href="https://www.cochranelibrary.com/web/cochrane/content?templateType=full&amp;urlTitle=/cdsr/doi/10.1002/14651858.CD005219.pub3&amp;doi=10.1002/14651858.CD005219.pub3&amp;type=cdsr&amp;contentLanguage=" rel="canonical"/> <link href="https://www.cochranelibrary.com/zh/web/cochrane/content?templateType=full&amp;urlTitle=/cdsr/doi/10.1002/14651858.CD005219.pub3&amp;doi=10.1002/14651858.CD005219.pub3&amp;type=cdsr&amp;contentLanguage=" hreflang="zh-HANS" rel="alternate"/> <link href="https://www.cochranelibrary.com/zh_HANT/web/cochrane/content?templateType=full&amp;urlTitle=/cdsr/doi/10.1002/14651858.CD005219.pub3&amp;doi=10.1002/14651858.CD005219.pub3&amp;type=cdsr&amp;contentLanguage=" hreflang="zh-HANT" rel="alternate"/> <link href="https://www.cochranelibrary.com/hr/web/cochrane/content?templateType=full&amp;urlTitle=/cdsr/doi/10.1002/14651858.CD005219.pub3&amp;doi=10.1002/14651858.CD005219.pub3&amp;type=cdsr&amp;contentLanguage=" hreflang="hr-HR" rel="alternate"/> <link href="https://www.cochranelibrary.com/nl/web/cochrane/content?templateType=full&amp;urlTitle=/cdsr/doi/10.1002/14651858.CD005219.pub3&amp;doi=10.1002/14651858.CD005219.pub3&amp;type=cdsr&amp;contentLanguage=" hreflang="nl-NL" rel="alternate"/> <link href="https://www.cochranelibrary.com/web/cochrane/content?templateType=full&amp;urlTitle=/cdsr/doi/10.1002/14651858.CD005219.pub3&amp;doi=10.1002/14651858.CD005219.pub3&amp;type=cdsr&amp;contentLanguage=" hreflang="x-default" rel="alternate"/> <link href="https://www.cochranelibrary.com/web/cochrane/content?templateType=full&amp;urlTitle=/cdsr/doi/10.1002/14651858.CD005219.pub3&amp;doi=10.1002/14651858.CD005219.pub3&amp;type=cdsr&amp;contentLanguage=" hreflang="en-US" rel="alternate"/> <link href="https://www.cochranelibrary.com/fr/web/cochrane/content?templateType=full&amp;urlTitle=/cdsr/doi/10.1002/14651858.CD005219.pub3&amp;doi=10.1002/14651858.CD005219.pub3&amp;type=cdsr&amp;contentLanguage=" hreflang="fr-FR" rel="alternate"/> <link href="https://www.cochranelibrary.com/de/web/cochrane/content?templateType=full&amp;urlTitle=/cdsr/doi/10.1002/14651858.CD005219.pub3&amp;doi=10.1002/14651858.CD005219.pub3&amp;type=cdsr&amp;contentLanguage=" hreflang="de-DE" rel="alternate"/> <link href="https://www.cochranelibrary.com/hi/web/cochrane/content?templateType=full&amp;urlTitle=/cdsr/doi/10.1002/14651858.CD005219.pub3&amp;doi=10.1002/14651858.CD005219.pub3&amp;type=cdsr&amp;contentLanguage=" hreflang="hi-HI" rel="alternate"/> <link href="https://www.cochranelibrary.com/hu/web/cochrane/content?templateType=full&amp;urlTitle=/cdsr/doi/10.1002/14651858.CD005219.pub3&amp;doi=10.1002/14651858.CD005219.pub3&amp;type=cdsr&amp;contentLanguage=" hreflang="hu-HU" rel="alternate"/> <link href="https://www.cochranelibrary.com/in/web/cochrane/content?templateType=full&amp;urlTitle=/cdsr/doi/10.1002/14651858.CD005219.pub3&amp;doi=10.1002/14651858.CD005219.pub3&amp;type=cdsr&amp;contentLanguage=" hreflang="in-ID" rel="alternate"/> <link href="https://www.cochranelibrary.com/ja/web/cochrane/content?templateType=full&amp;urlTitle=/cdsr/doi/10.1002/14651858.CD005219.pub3&amp;doi=10.1002/14651858.CD005219.pub3&amp;type=cdsr&amp;contentLanguage=" hreflang="ja-JP" rel="alternate"/> <link href="https://www.cochranelibrary.com/ko/web/cochrane/content?templateType=full&amp;urlTitle=/cdsr/doi/10.1002/14651858.CD005219.pub3&amp;doi=10.1002/14651858.CD005219.pub3&amp;type=cdsr&amp;contentLanguage=" hreflang="ko-KR" rel="alternate"/> <link href="https://www.cochranelibrary.com/ms/web/cochrane/content?templateType=full&amp;urlTitle=/cdsr/doi/10.1002/14651858.CD005219.pub3&amp;doi=10.1002/14651858.CD005219.pub3&amp;type=cdsr&amp;contentLanguage=" hreflang="ms-MY" rel="alternate"/> <link href="https://www.cochranelibrary.com/fa/web/cochrane/content?templateType=full&amp;urlTitle=/cdsr/doi/10.1002/14651858.CD005219.pub3&amp;doi=10.1002/14651858.CD005219.pub3&amp;type=cdsr&amp;contentLanguage=" hreflang="fa-IR" rel="alternate"/> <link href="https://www.cochranelibrary.com/pl/web/cochrane/content?templateType=full&amp;urlTitle=/cdsr/doi/10.1002/14651858.CD005219.pub3&amp;doi=10.1002/14651858.CD005219.pub3&amp;type=cdsr&amp;contentLanguage=" hreflang="pl-PL" rel="alternate"/> <link href="https://www.cochranelibrary.com/pt/web/cochrane/content?templateType=full&amp;urlTitle=/cdsr/doi/10.1002/14651858.CD005219.pub3&amp;doi=10.1002/14651858.CD005219.pub3&amp;type=cdsr&amp;contentLanguage=" hreflang="pt-PT" rel="alternate"/> <link href="https://www.cochranelibrary.com/ro/web/cochrane/content?templateType=full&amp;urlTitle=/cdsr/doi/10.1002/14651858.CD005219.pub3&amp;doi=10.1002/14651858.CD005219.pub3&amp;type=cdsr&amp;contentLanguage=" hreflang="ro-RO" rel="alternate"/> <link href="https://www.cochranelibrary.com/ru/web/cochrane/content?templateType=full&amp;urlTitle=/cdsr/doi/10.1002/14651858.CD005219.pub3&amp;doi=10.1002/14651858.CD005219.pub3&amp;type=cdsr&amp;contentLanguage=" hreflang="ru-RU" rel="alternate"/> <link href="https://www.cochranelibrary.com/es/web/cochrane/content?templateType=full&amp;urlTitle=/cdsr/doi/10.1002/14651858.CD005219.pub3&amp;doi=10.1002/14651858.CD005219.pub3&amp;type=cdsr&amp;contentLanguage=" hreflang="es-ES" rel="alternate"/> <link href="https://www.cochranelibrary.com/ta/web/cochrane/content?templateType=full&amp;urlTitle=/cdsr/doi/10.1002/14651858.CD005219.pub3&amp;doi=10.1002/14651858.CD005219.pub3&amp;type=cdsr&amp;contentLanguage=" hreflang="ta-IN" rel="alternate"/> <link href="https://www.cochranelibrary.com/th/web/cochrane/content?templateType=full&amp;urlTitle=/cdsr/doi/10.1002/14651858.CD005219.pub3&amp;doi=10.1002/14651858.CD005219.pub3&amp;type=cdsr&amp;contentLanguage=" hreflang="th-TH" rel="alternate"/> <link class="lfr-css-file" href="https://www.cochranelibrary.com/cochrane-theme/css/main.css?browserId=other&amp;themeId=cochrane_WAR_cochranetheme&amp;minifierType=css&amp;languageId=en_US&amp;b=6210&amp;t=1738735355000" rel="stylesheet" type="text/css"/> <link class="lfr-css-file" href="https://www.cochranelibrary.com/cochrane-theme/css/aui.css?browserId=other&amp;themeId=cochrane_WAR_cochranetheme&amp;minifierType=css&amp;languageId=en_US&amp;b=6210&amp;t=1738735355000" rel="stylesheet" type="text/css"/> <link href="/html/css/main.css?browserId=other&amp;themeId=cochrane_WAR_cochranetheme&amp;minifierType=css&amp;languageId=en_US&amp;b=6210&amp;t=1739774054000" rel="stylesheet" type="text/css"/> <link href="https://www.cochranelibrary.com/scolaris-content-display/css/main.css?browserId=other&amp;themeId=cochrane_WAR_cochranetheme&amp;minifierType=css&amp;languageId=en_US&amp;b=6210&amp;t=1739773978000" rel="stylesheet" type="text/css"/> <link href="https://www.cochranelibrary.com/notifications-portlet/notifications/css/main.css?browserId=other&amp;themeId=cochrane_WAR_cochranetheme&amp;minifierType=css&amp;languageId=en_US&amp;b=6210&amp;t=1739774000000" rel="stylesheet" type="text/css"/> <link href="https://www.cochranelibrary.com/html/portlet/login/css/main.css?browserId=other&amp;themeId=cochrane_WAR_cochranetheme&amp;minifierType=css&amp;languageId=en_US&amp;b=6210&amp;t=1739774081000" rel="stylesheet" type="text/css"/> <script type="text/javascript">var Liferay={Browser:{acceptsGzip:function(){return false},getMajorVersion:function(){return 80},getRevision:function(){return"537.36"},getVersion:function(){return"80.0"},isAir:function(){return false},isChrome:function(){return true},isFirefox:function(){return false},isGecko:function(){return true},isIe:function(){return false},isIphone:function(){return false},isLinux:function(){return true},isMac:function(){return false},isMobile:function(){return false},isMozilla:function(){return false},isOpera:function(){return false},isRtf:function(){return true},isSafari:function(){return true},isSun:function(){return false},isWap:function(){return false},isWapXhtml:function(){return false},isWebKit:function(){return true},isWindows:function(){return false},isWml:function(){return false}},Data:{NAV_SELECTOR:"#navigation",isCustomizationView:function(){return false},notices:[null]},ThemeDisplay:{getLayoutId:function(){return"7"},getLayoutURL:function(){return"https://www.cochranelibrary.com/en/content"},getParentLayoutId:function(){return"0"},isPrivateLayout:function(){return"false"},isVirtualLayout:function(){return false},getBCP47LanguageId:function(){return"en-US"},getCDNBaseURL:function(){return"https://www.cochranelibrary.com"},getCDNDynamicResourcesHost:function(){return""},getCDNHost:function(){return""},getCompanyId:function(){return"20155"},getCompanyGroupId:function(){return"20195"},getDefaultLanguageId:function(){return"en_US"},getDoAsUserIdEncoded:function(){return""},getLanguageId:function(){return"en_US"},getParentGroupId:function(){return"20182"},getPathContext:function(){return""},getPathImage:function(){return"/image"},getPathJavaScript:function(){return"/html/js"},getPathMain:function(){return"/en/c"},getPathThemeImages:function(){return"https://www.cochranelibrary.com/cochrane-theme/images"},getPathThemeRoot:function(){return"/cochrane-theme"},getPlid:function(){return"20757"},getPortalURL:function(){return"https://www.cochranelibrary.com"},getPortletSetupShowBordersDefault:function(){return true},getScopeGroupId:function(){return"20182"},getScopeGroupIdOrLiveGroupId:function(){return"20182"},getSessionId:function(){return""},getSiteGroupId:function(){return"20182"},getURLControlPanel:function(){return"/group/control_panel?refererPlid=20757"},getURLHome:function(){return"https\x3a\x2f\x2fwww\x2ecochranelibrary\x2ecom\x2fweb\x2fcochrane"},getUserId:function(){return"20159"},getUserName:function(){return""},isAddSessionIdToURL:function(){return false},isFreeformLayout:function(){return false},isImpersonated:function(){return false},isSignedIn:function(){return false},isStateExclusive:function(){return false},isStateMaximized:function(){return false},isStatePopUp:function(){return false}},PropsValues:{NTLM_AUTH_ENABLED:false}};var themeDisplay=Liferay.ThemeDisplay;Liferay.AUI={getAvailableLangPath:function(){return"available_languages.jsp?browserId=other&themeId=cochrane_WAR_cochranetheme&colorSchemeId=01&minifierType=js&languageId=en_US&b=6210&t=1559916434000"},getCombine:function(){return true},getComboPath:function(){return"/combo/?browserId=other&minifierType=&languageId=en_US&b=6210&t=1559916434000&"},getFilter:function(){return"min"},getJavaScriptRootPath:function(){return"/html/js"},getLangPath:function(){return"aui_lang.jsp?browserId=other&themeId=cochrane_WAR_cochranetheme&colorSchemeId=01&minifierType=js&languageId=en_US&b=6210&t=1559916434000"},getStaticResourceURLParams:function(){return"?browserId=other&minifierType=&languageId=en_US&b=6210&t=1559916434000"}};Liferay.authToken="jU9oKp1Y";Liferay.currentURL="\x2fweb\x2fcochrane\x2fcontent\x3ftemplateType\x3dfull\x26urlTitle\x3d\x2fcdsr\x2fdoi\x2f10\x2e1002\x2f14651858\x2eCD005219\x2epub3\x26doi\x3d10\x2e1002\x2f14651858\x2eCD005219\x2epub3\x26type\x3dcdsr\x26contentLanguage\x3d";Liferay.currentURLEncoded="\x252Fweb\x252Fcochrane\x252Fcontent\x253FtemplateType\x253Dfull\x2526urlTitle\x253D\x252Fcdsr\x252Fdoi\x252F10\x2e1002\x252F14651858\x2eCD005219\x2epub3\x2526doi\x253D10\x2e1002\x252F14651858\x2eCD005219\x2epub3\x2526type\x253Dcdsr\x2526contentLanguage\x253D";</script> <script src="/html/js/barebone.jsp?browserId=other&amp;themeId=cochrane_WAR_cochranetheme&amp;colorSchemeId=01&amp;minifierType=js&amp;minifierBundleId=javascript.barebone.files&amp;languageId=en_US&amp;b=6210&amp;t=1559916434000" type="text/javascript"></script> <script type="text/javascript"></script> <script type="text/javascript">var o={database:"CDSR",page:{pageType:"Article Full Text HTML"},article:{availableLanguage:["en","es","de","ru","ko","ja","hr","fa"],languageCode:"en",accessStatus:"delayed-free",doi:"10.1002/14651858.CD005219.pub3",title:"Normobaric and hyperbaric oxygen therapy for the treatment and prevention of migraine and cluster headache",firstPublishedDate:"Dec 28, 2015 12:00:00 AM",isCurrentVersion:true,editorialGroup:"Cochrane Pain, Palliative and Supportive Care Group",availableParts:["PDF Full","PDF Standard","PDF Abstract","HTML","Comments","Information","References","Stats","Related Content"]}};window.dataLayer=xtend(true,window.dataLayer,o);</script> <link class="lfr-css-file" href="https://www.cochranelibrary.com/cochrane-theme/css/custom.css?browserId=other&amp;themeId=cochrane_WAR_cochranetheme&amp;minifierType=css&amp;languageId=en_US&amp;b=6210&amp;t=1738735355000" rel="stylesheet" type="text/css"/> <style type="text/css"></style> <script async="" src="https://assets.adobedtm.com/59640f9fa510/7cad07cf7779/launch-a215d9c51521.min.js"></script> <!--[if lt IE 9]> <script src="/cochrane-theme/vendor/respond/dest/respond.min.js?t=1738735355000" type="text/javascript"></script> <![endif]--> </head> <body class="yui3-skin-sam controls-visible guest-site signed-out public-page site"> <div class="site-container"> <a href="#main-content" id="skip-to-content">Skip to Content</a> <div class="cookie-message cookie-message--hidden system-message-container" id="js-cookie-message"> <div class="container"> <a aria-label="Close cookies message" class="fa fa-times js-cookie-close pull-right" href="#"></a> <div class="system-message-wrapper container"> <i aria-hidden="true" class="fa fa-exclamation-triangle"></i> <div class="system-message-title">Cookies</div> <div class="system-message-description"> <p> Our site uses cookies to improve your experience. You can find out more about our use of cookies in About Cookies, including instructions on how to turn off cookies if you wish to do so. By continuing to browse this site you agree to us using cookies as described in <a href="http://olabout.wiley.com/WileyCDA/Section/id-813473.html">About Cookies</a>. </p> <a class="btn secondary js-cookie-close js-cookie-accept" href="#">I accept</a> </div> </div> </div> </div> <script>document.body.className=document.body.className+" js_enabled";</script><header> <div class="container"> <div class="branding"> <h1 class="brand-container"> <a href="https://www.cochranelibrary.com/en/"> <span class="brand-name">The Cochrane Library</span> <img alt="Cochrane Library logo" class="brand-logo" src="https://www.cochranelibrary.com/cochrane-theme/images/en-US_logo.png" title="Cochrane Library"/> </a> </h1> <span class="additional-branding"> <p class="brand-message"> <em>Trusted evidence.</em> <em>Informed decisions.</em> <em>Better health.</em> </p> </span> </div> <div class="desktop-search basic-search-container"> <div class="desktop-search-form"> <div class="portlet-boundary portlet-boundary_scolarissearchportlet_WAR_scolarissearch_ portlet-static portlet-static-end" id="p_p_id_scolarissearchportlet_WAR_scolarissearch_"> <span id="p_scolarissearchportlet_WAR_scolarissearch"></span> <section class="portlet" id="portlet_scolarissearchportlet_WAR_scolarissearch"> <header class="portlet-topper"> <h1 class="portlet-title"> <span class="" onmouseover="Liferay.Portal.ToolTip.show(this, 'Scolaris\x20Search\x20Portlet')"> <img alt="" id="owel__null__null" src="/scolaris-search/icon.png"/> <span class="taglib-text hide-accessible">Scolaris Search Portlet</span> </span> <span class="portlet-title-text">Scolaris Search Portlet</span> </h1> <menu class="portlet-topper-toolbar" id="portlet-topper-toolbar_scolarissearchportlet_WAR_scolarissearch" type="toolbar"> </menu> </header> <div class="portlet-content"> <div class="portlet-content-container"> <div class="portlet-body"> <div class="header-search"> <form action="https://www.cochranelibrary.com/en/content?p_auth=jU9oKp1Y&amp;p_p_id=scolarissearchportlet_WAR_scolarissearch&amp;p_p_lifecycle=1&amp;p_p_state=normal&amp;p_p_mode=view&amp;_scolarissearchportlet_WAR_scolarissearch_scolarisAction=redirectSearchResult" method="post"> <input name="searchType" type="hidden" value="basic"/> <input name="facetDisplayName" type="hidden" value=""/> <input name="facetQueryTerm" type="hidden" value=""/> <input name="facetQueryField" type="hidden" value=""/> <input name="facetCategory" type="hidden" value=""/> <fieldset class="fieldset"> <legend class="sr-only">Basic Search</legend> <div class="select search-by"> <select aria-label="Search by options" class="custom-select-enabled search-type" name="searchBy" title="Search by options"> <option value="1">Title Abstract Keyword</option> <option value="2">Record Title</option> <option value="3">Abstract</option> <option value="4">Author</option> <option value="5">Keyword</option> <option value="6">All Text</option> <option value="7">Publication Type</option> <option value="8">Source</option> <option value="9">DOI</option> <option value="14">Language</option> <option value="10">Accession Number</option> <option value="11">Trial Registry Number</option> <option value="12">Cochrane Group</option> <option value="13">Cochrane Topic</option> </select> </div> <div class="search-select-crg-container select" style="display: none;"> <select class="search-select-crg-list"></select> </div> <div class="search-select-topic-container select" data-topic-list-url="https://www.cochranelibrary.com/en/content?p_p_id=scolaristopics_WAR_scolaristopics&amp;p_p_lifecycle=2&amp;p_p_state=normal&amp;p_p_mode=view&amp;p_p_resource_id=topics-list&amp;p_p_cacheability=cacheLevelPage" style="display: none;"> <select class="search-select-topic-list"></select> </div> <div class="search-select-cl-container select" style="display: none;"> <select class="search-select-cl-list"></select> </div> <div class="search-text-container"> <div class="control-group control-group-inline search-input-wrapper"> <input aria-label="Enter search term" class="field browser-search search-text ui-autocomplete-input" id="searchText" name="searchText" placeholder="Search" size="30" type="text" value=""/>
<div id="autocomplete-results"></div>
</div>
<div class="control-group control-group-inline search-button-wrapper">
<button aria-label="Search" class="searchByBtn" type="submit">
<i aria-hidden="true" class="fa fa-search"></i>
</button>
</div>
</div>
</fieldset>
</form>
</div>
<script>
    window.displayResultURL = 'https://www.cochranelibrary.com/en/content?p_p_id=scolarissearchportlet_WAR_scolarissearch&p_p_lifecycle=2&p_p_state=normal&p_p_mode=view&p_p_resource_id=getSuggestions&p_p_cacheability=cacheLevelPage&_scolarissearchportlet_WAR_scolarissearch_templateType=full&_scolarissearchportlet_WAR_scolarissearch_urlTitle=%2Fcdsr%2Fdoi%2F10.1002%2F14651858.CD005219.pub3&_scolarissearchportlet_WAR_scolarissearch_contentLanguage=&_scolarissearchportlet_WAR_scolarissearch_type=cdsr&_scolarissearchportlet_WAR_scolarissearch_doi=10.1002%2F14651858.CD005219.pub3';
    window.searchByOption = '';
</script>
</div>
</div>
</div>
<div style="display:none">
<input id="freelabel" name="freelabel" type="hidden" value="Free access"/>
<input id="openlabel" name="openlabel" type="hidden" value="Open access"/>
</div>
</section>
</div>
</div>
<div class="search-tools-nav">
<a class="btn secondary" href="/en/browse-by-topic">Browse</a>
<a class="btn primary advanced-search-button" href="/en/advanced-search">Advanced search</a>
</div>
</div>
<a class="toggle-menu-switch" href="#"><i aria-hidden="true" class="fa fa-bars"></i> <div class="toggle-menu-text">Open menu</div></a>
</div>
<div class="auxiliary-container">
<div class="container">
<div class="header-auxiliary-menu">
<div class="auxiliary-menu-item language-selector">
<div class="portlet-boundary portlet-boundary_scolarislanguageselector_WAR_scolarislanguageportlet_ portlet-static portlet-static-end" id="p_p_id_scolarislanguageselector_WAR_scolarislanguageportlet_INSTANCE_header_">
<span id="p_scolarislanguageselector_WAR_scolarislanguageportlet_INSTANCE_header"></span>
<section class="portlet" id="portlet_scolarislanguageselector_WAR_scolarislanguageportlet_INSTANCE_header">
<header class="portlet-topper">
<h1 class="portlet-title">
<span class="" onmouseover="Liferay.Portal.ToolTip.show(this, 'Scolaris\x20Language\x20Selector')">
<img alt="" id="bvrs__null__null" src="/scolaris-language-portlet/icon.png"/> <span class="taglib-text hide-accessible">Scolaris Language Selector</span> </span> <span class="portlet-title-text">Scolaris Language Selector</span> </h1> <menu class="portlet-topper-toolbar" id="portlet-topper-toolbar_scolarislanguageselector_WAR_scolarislanguageportlet_INSTANCE_header" type="toolbar"> </menu> </header> <div class="portlet-content"> <div class="portlet-content-container"> <div class="portlet-body"> <div class="language-display" data-content-languages="[de, en, es, fa, fr, hi, hr, id, ja, ko, hu, ms, nl, pl, pt, ru, ro, ta, th, zh_HANT, zh_HANS]"> <a class="open-language-modal" href="#" title="Select your preferred language"> <i class="fa fa-file-text"></i> Review language : English </a> <a class="open-language-modal" href="#" title="Select your preferred language"> <i class="fa fa-globe"></i> Website language : English </a> </div> <div class="language-selector-modal-content" data-modal-title="Language selection" data-size="large" style="display: none;"> <div class="form-content language-selector-modal"> <div class="row-fluid"> <div> <table class="mytable" style="border: 1px solid #f0f0f0" width="90%"> <tbody> <tr class="row-box"> <td><i class="fa fa-file-text icon-size"></i></td> <td><h3>Cochrane review language</h3> <p>Select your preferred language for Cochrane reviews and other content. Sections without translation will be in English.</p> </td> <td> <div> <select id="contentLanguageSelector" onchange="updateLang(this.value)"> <option class="content-language-option" data-languagecode="de" value="de"> Deutsch </option> <option class="content-language-option" data-languagecode="en" selected="" value="en"> English </option> <option class="content-language-option" data-languagecode="es" value="es"> Español </option> <option class="content-language-option" data-languagecode="fa" value="fa"> فارسی </option> <option class="content-language-option" data-languagecode="fr" value="fr"> Français </option> <option class="content-language-option" data-languagecode="hi" value="hi"> हिन्दी </option> <option class="content-language-option" data-languagecode="hr" value="hr"> Hrvatski </option> <option class="content-language-option" data-languagecode="id" value="id"> Bahasa Indonesia </option> <option class="content-language-option" data-languagecode="ja" value="ja"> 日本語 </option> <option class="content-language-option" data-languagecode="ko" value="ko"> 한국어 </option> <option class="content-language-option" data-languagecode="hu" value="hu"> Magyar </option> <option class="content-language-option" data-languagecode="ms" value="ms"> Bahasa Malaysia </option> <option class="content-language-option" data-languagecode="nl" value="nl"> Nederlands </option> <option class="content-language-option" data-languagecode="pl" value="pl"> Polski </option> <option class="content-language-option" data-languagecode="pt" value="pt"> Português </option> <option class="content-language-option" data-languagecode="ru" value="ru"> Русский </option> <option class="content-language-option" data-languagecode="ro" value="ro"> Română </option> <option class="content-language-option" data-languagecode="ta" value="ta"> தமிழ் </option> <option class="content-language-option" data-languagecode="th" value="th"> ภาษาไทย </option> <option class="content-language-option" data-languagecode="zh_HANT" value="zh_HANT"> 繁體中文 </option> <option class="content-language-option" data-languagecode="zh_HANS" value="zh_HANS"> 简体中文 </option> </select> </div> </td> </tr> <tr> <td colspan="1" style="height: 10px"></td> </tr> <tr class="row-box"> <td><i class="fa fa-globe icon-size"></i></td> <td> <div class="language-info"> <h3>Website language</h3> <p>Select your preferred language for the Cochrane Library website.</p> </div> </td> <td> <div class="language-dropdown"> <select id="portalLanguageSelector"> <option class="portal-language-selector" data-portallanguage="en" selected="" value="/en/cdsr/doi/10.1002/14651858.CD005219.pub3/full/en"> English </option> <option class="portal-language-selector" data-portallanguage="es" value="/es/cdsr/doi/10.1002/14651858.CD005219.pub3/full/es"> Español </option> </select> </div> </td> </tr> <tr> <td colspan="1" style="height: 10px"></td> </tr> </tbody> </table> </div> </div> <div style="text-align: right;"> <button class="btn primary btn-cancel" style="margin-left: 10px;" type="button">Cancel</button> <a class="btn secondary ok-btn" href="https://www.cochranelibrary.com/en/content?p_p_id=scolariscontentlanguagebanner_WAR_scolarislanguageportlet&amp;p_p_lifecycle=2&amp;p_p_state=normal&amp;p_p_mode=view&amp;p_p_resource_id=set-content-language&amp;p_p_cacheability=cacheLevelPage">Save</a> </div> </div> </div> </div> </div> </div> <div style="display:none"> <input id="freelabel" name="freelabel" type="hidden" value="Free access"/>
<input id="openlabel" name="openlabel" type="hidden" value="Open access"/>
</div>
</section>
</div>
</div>
<a class="auxiliary-menu-item signin last" href="https://www.cochranelibrary.com/c/portal/login?p_l_id=20757&amp;redirect=%2Fcdsr%2Fdoi%2F10.1002%2F14651858.CD005219.pub3%2Ffull" rel="nofollow">
<i class="icon fa fa-user"></i> Sign In
    </a>
<span class="auxiliary-container-extended"></span>
</div>
</div>
</div>
</header>
<div class="main-nav-wrapper">
<span class="main-nav-left-extended"></span>
<nav class="main container">
<ul>
<li class="nav-root-item parent">
<a href="#">Cochrane reviews<span class="icon fa fa-caret-down"></span></a>
<ul class="child">
<li class="child-nav-item" id="layout_nav_child_attr_14" role="presentation">
<a aria-labelledby="layout_14" href="https://www.cochranelibrary.com/en/cdsr/reviews" role="menuitem">
            Search reviews (CDSR)
        </a>
</li>
<li class="child-nav-item" id="layout_nav_child_attr_15" role="presentation">
<a aria-labelledby="layout_15" href="https://www.cochranelibrary.com/en/cdsr/reviews/topics" role="menuitem">
            Browse reviews
        </a>
</li>
<li class="child-nav-item" id="layout_nav_child_attr_18" role="presentation">
<a aria-labelledby="layout_18" href="https://www.cochranelibrary.com/en/cdsr/table-of-contents" role="menuitem">
            Issues
        </a>
</li>
<li class="child-nav-item" id="layout_nav_child_attr_17" role="presentation">
<a aria-labelledby="layout_17" href="https://www.cochranelibrary.com/en/cdsr/editorials" role="menuitem">
            Editorials
        </a>
</li>
<li class="child-nav-item" id="layout_nav_child_attr_19" role="presentation">
<a aria-labelledby="layout_19" href="https://www.cochranelibrary.com/en/special-collections" role="menuitem">
            Special Collections
        </a>
</li>
<li class="child-nav-item" id="layout_nav_child_attr_20" role="presentation">
<a aria-labelledby="layout_20" href="https://www.cochranelibrary.com/en/cdsr/supplements" role="menuitem">
            Supplements
        </a>
</li>
<li class="child-nav-item" id="layout_nav_child_attr_121" role="presentation">
<a aria-labelledby="layout_121" href="https://www.cochranelibrary.com/en/about/about-cochrane-reviews" role="menuitem">
            About Cochrane reviews
        </a>
</li>
</ul>
</li>
<li class="nav-root-item parent">
<a href="#">Searching for trials<span class="icon fa fa-caret-down"></span></a>
<ul class="child">
<li class="child-nav-item" id="layout_nav_child_attr_254" role="presentation">
<a aria-labelledby="layout_254" href="https://www.cochranelibrary.com/en/search/releases" role="menuitem">
            What's new (search and CENTRAL)
        </a>
</li>
<li class="child-nav-item" id="layout_nav_child_attr_266" role="presentation">
<a aria-labelledby="layout_266" href="https://www.cochranelibrary.com/en/search-help" role="menuitem">
            Search help
        </a>
</li>
<li class="child-nav-item" id="layout_nav_child_attr_252" role="presentation">
<a aria-labelledby="layout_252" href="https://www.cochranelibrary.com/en/search-help-quick-guides" role="menuitem">
            Search help quick guides
        </a>
</li>
<li class="child-nav-item" id="layout_nav_child_attr_251" role="presentation">
<a aria-labelledby="layout_251" href="https://www.cochranelibrary.com/en/search-faqs" role="menuitem">
            Search FAQs
        </a>
</li>
<li class="child-nav-item" id="layout_nav_child_attr_114" role="presentation">
<a aria-labelledby="layout_114" href="https://www.cochranelibrary.com/en/central/about-central" role="menuitem">
            About CENTRAL
        </a>
</li>
<li class="child-nav-item" id="layout_nav_child_attr_115" role="presentation">
<a aria-labelledby="layout_115" href="https://www.cochranelibrary.com/en/central/central-creation" role="menuitem">
            How CENTRAL is created
        </a>
</li>
<li class="child-nav-item" id="layout_nav_child_attr_241" role="presentation">
<a aria-labelledby="layout_241" href="https://www.cochranelibrary.com/en/retracted-trials" role="menuitem">
            Retracted publications in CENTRAL
        </a>
</li>
</ul>
</li>
<li class="nav-root-item parent">
<a href="#">Clinical Answers<span class="icon fa fa-caret-down"></span></a>
<ul class="child">
<li class="child-nav-item" id="layout_nav_child_attr_29" role="presentation">
<a aria-labelledby="layout_29" href="https://www.cochranelibrary.com/en/cca" role="menuitem">
            Browse Clinical Answers
        </a>
</li>
<li class="child-nav-item" id="layout_nav_child_attr_91" role="presentation">
<a aria-labelledby="layout_91" href="https://www.cochranelibrary.com/en/cca/about" role="menuitem">
            About Clinical Answers
        </a>
</li>
</ul>
</li>
<li class="nav-root-item parent">
<a href="#">About<span class="icon fa fa-caret-down"></span></a>
<ul class="child">
<li class="child-nav-item" id="layout_nav_child_attr_116" role="presentation">
<a aria-labelledby="layout_116" href="https://www.cochranelibrary.com/en/about/about-cochrane-library" role="menuitem">
            About the Cochrane Library
        </a>
</li>
<li class="child-nav-item" id="layout_nav_child_attr_13" role="presentation">
<a aria-labelledby="layout_13" href="https://www.cochranelibrary.com/en/cdsr/about-cdsr" role="menuitem">
            Cochrane Database of Systematic reviews
        </a>
</li>
<li class="child-nav-item" id="layout_nav_child_attr_198" role="presentation">
<a aria-labelledby="layout_198" href="https://www.cochranelibrary.com/en/cdsr/editorial-policies" role="menuitem">
            Editorial policies
        </a>
</li>
<li class="child-nav-item" id="layout_nav_child_attr_92" role="presentation">
<a aria-labelledby="layout_92" href="https://www.cochranelibrary.com/en/about/author-information" role="menuitem">
            Information for authors
        </a>
</li>
<li class="child-nav-item" id="layout_nav_child_attr_212" role="presentation">
<a aria-labelledby="layout_212" href="https://www.cochranelibrary.com/en/about-pico" role="menuitem">
            About PICO
        </a>
</li>
<li class="child-nav-item" id="layout_nav_child_attr_207" role="presentation">
<a aria-labelledby="layout_207" href="https://www.cochranelibrary.com/en/about/about-translations" role="menuitem">
            About translations
        </a>
</li>
<li class="child-nav-item" id="layout_nav_child_attr_188" role="presentation">
<a aria-labelledby="layout_188" href="https://www.cochranelibrary.com/en/about/releases" role="menuitem">
            What's new
        </a>
</li>
<li class="child-nav-item" id="layout_nav_child_attr_216" role="presentation">
<a aria-labelledby="layout_216" href="https://www.cochranelibrary.com/en/data" role="menuitem">
            Data reuse
        </a>
</li>
<li class="child-nav-item" id="layout_nav_child_attr_235" role="presentation">
<a aria-labelledby="layout_235" href="https://www.cochranelibrary.com/en/about/about-cochrane-library/editorial-board" role="menuitem">
            Cochrane Library Editorial Board
        </a>
</li>
</ul>
</li>
<li class="nav-root-item parent">
<a href="#">Help<span class="icon fa fa-caret-down"></span></a>
<ul class="child">
<li class="child-nav-item" id="layout_nav_child_attr_259" role="presentation">
<a aria-labelledby="layout_259" href="https://m.info.wiley.com/webApp/cochranenewsletter?id=0" role="menuitem">
            Newsletter
        </a>
</li>
<li class="child-nav-item" id="layout_nav_child_attr_177" role="presentation">
<a aria-labelledby="layout_177" href="https://www.wiley.com/en-us/customer-success/cochrane-library-training-hub" role="menuitem">
            Cochrane Library Training
        </a>
</li>
<li class="child-nav-item" id="layout_nav_child_attr_44" role="presentation">
<a aria-labelledby="layout_44" href="https://www.cochranelibrary.com/en/help/access" role="menuitem">
            Access
        </a>
</li>
<li class="child-nav-item" id="layout_nav_child_attr_150" role="presentation">
<a aria-labelledby="layout_150" href="https://www.cochranelibrary.com/en/help/permissions" role="menuitem">
            Permissions and reprints
        </a>
</li>
<li class="child-nav-item" id="layout_nav_child_attr_93" role="presentation">
<a aria-labelledby="layout_93" href="https://www.cochranelibrary.com/en/help/media" role="menuitem">
            Media information
        </a>
</li>
<li class="child-nav-item" id="layout_nav_child_attr_97" role="presentation">
<a aria-labelledby="layout_97" href="https://www.cochranelibrary.com/en/help/contact-us" role="menuitem">
            Contact us
        </a>
</li>
<li class="child-nav-item" id="layout_nav_child_attr_125" role="presentation">
<a aria-labelledby="layout_125" href="https://www.cochranelibrary.com/en/about/terms-and-conditions" role="menuitem">
            Terms and conditions
        </a>
</li>
<li class="child-nav-item" id="layout_nav_child_attr_176" role="presentation">
<a aria-labelledby="layout_176" href="https://cochranesupport.wiley.com/s/article/cochrane-library-known-issues" role="menuitem">
            Known issues
        </a>
</li>
<li class="child-nav-item" id="layout_nav_child_attr_270" role="presentation">
<a aria-labelledby="layout_270" href="https://www.cochranelibrary.com/search-help" role="menuitem">
            Search help
        </a>
</li>
</ul>
</li>
<li class="about-link"><a href="https://www.cochrane.org/about-us" target="_blank"><span>About Cochrane</span><i class="fa fa-caret-right"></i></a></li>
</ul>
</nav>
</div>
<div class="portlet-boundary portlet-boundary_scolariscontentlanguagebanner_WAR_scolarislanguageportlet_ portlet-static portlet-static-end" id="p_p_id_scolariscontentlanguagebanner_WAR_scolarislanguageportlet_">
<span id="p_scolariscontentlanguagebanner_WAR_scolarislanguageportlet"></span>
<section class="portlet" id="portlet_scolariscontentlanguagebanner_WAR_scolarislanguageportlet">
<header class="portlet-topper">
<h1 class="portlet-title">
<span class="" onmouseover="Liferay.Portal.ToolTip.show(this, 'Scolaris\x20Content\x20Language\x20Banner\x20Portlet')">
<img alt="" id="etlj__null__null" src="/scolaris-language-portlet/icon.png"/> <span class="taglib-text hide-accessible">Scolaris Content Language Banner Portlet</span> </span> <span class="portlet-title-text">Scolaris Content Language Banner Portlet</span> </h1> <menu class="portlet-topper-toolbar" id="portlet-topper-toolbar_scolariscontentlanguagebanner_WAR_scolarislanguageportlet" type="toolbar"> </menu> </header> <div class="portlet-content"> <div class="portlet-content-container"> <div class="portlet-body"> </div> </div> </div> <div style="display:none"> <input id="freelabel" name="freelabel" type="hidden" value="Free access"/>
<input id="openlabel" name="openlabel" type="hidden" value="Open access"/>
</div>
</section>
</div>
<div class="" id="content">
<div class="columns-1" id="main-content" role="main">
<div class="portlet-layout row-fluid">
<div class="portlet-column portlet-column-only span12" id="column-1">
<div class="portlet-dropzone portlet-column-content portlet-column-content-only" id="layout-column_column-1">
<div class="portlet-boundary portlet-boundary_scolariscontentdisplay_WAR_scolariscontentdisplay_ portlet-static portlet-static-end scolaris-content-display-portlet" id="p_p_id_scolariscontentdisplay_WAR_scolariscontentdisplay_">
<span id="p_scolariscontentdisplay_WAR_scolariscontentdisplay"></span>
<section class="portlet" id="portlet_scolariscontentdisplay_WAR_scolariscontentdisplay">
<header class="portlet-topper">
<h1 class="portlet-title">
<span class="" onmouseover="Liferay.Portal.ToolTip.show(this, 'Scolaris\x20Content\x20Display')">
<img alt="" id="rjus__column1__0" src="/scolaris-content-display/icon.png"/> <span class="taglib-text hide-accessible">Scolaris Content Display</span> </span> <span class="portlet-title-text">Scolaris Content Display</span> </h1> <menu class="portlet-topper-toolbar" id="portlet-topper-toolbar_scolariscontentdisplay_WAR_scolariscontentdisplay" type="toolbar"> </menu> </header> <div class="portlet-content"> <div class="portlet-content-container"> <div class="portlet-body"> <div class="publication cdsr container"> <div class="article-navigation-container" id="cdsr-nav"> <nav class="article-navigation"> <ul class="tools-row"> <li> <li class="tools pdf pulldown-menu readcube-menu closed en_US"> <a class="pulldown-menu-trigger" href="#0"> <span class="pdf-icon"> <i class="icon fa fa-file-pdf-o"></i> <span>Download PDF</span> </span> <i aria-hidden="true" class="fa fa-caret-down"></i> </a> <ul class="pulldown-menu-items"> <li class=""> <a class="download media pdf-link-full pdf-link" href="/cdsr/doi/10.1002/14651858.CD005219.pub3/pdf/full/en" title="Article in PDF format"> <span class="readcube-label"> Full </span> <span class="readcube-description"> All content </span> </a> <a class="download media pdf-link-full readcube-epdf-link" href="/cdsr/doi/10.1002/14651858.CD005219.pub3/epdf/full/en" title="Article in PDF format"> <span class="readcube-label"> Full </span> <span class="readcube-description"> All content </span> </a> </li> <li class=""> <a class="download media pdf-link-abstract pdf-link" href="/cdsr/doi/10.1002/14651858.CD005219.pub3/pdf/abstract/en" title="Article in PDF format"> <span class="readcube-label"> Summary </span> <span class="readcube-description"> Abstract and plain language summary only </span> </a> <a class="download media pdf-link-abstract readcube-epdf-link" href="/cdsr/doi/10.1002/14651858.CD005219.pub3/epdf/abstract/en" title="Article in PDF format"> <span class="readcube-label"> Summary </span> <span class="readcube-description"> Abstract and plain language summary only </span> </a> </li> </ul> </li> <li class="tools cite cite-article-link" data-article-id="CD005219.PUB3" data-modal-title="Cite this review"> <span><i aria-hidden="true" class="icon fa fa-share"></i></span> <span>Cite this review</span> </li> </li> </ul> <ul class="tools-row tools-secondary"> <li> <li class="tools print print-cdsr-link" data-content-language="en" data-indicator-tooltip="scolaris.print.modal.language.tooltip.en" data-print-options="[{&quot;param&quot;: &quot;abstract&quot;,&quot;titles&quot;:[{&quot;language&quot;:&quot;en&quot;,&quot;title&quot;:&quot;Abstract&quot;},{&quot;language&quot;:&quot;es&quot;,&quot;title&quot;:&quot;Resumen&quot;},{&quot;language&quot;:&quot;fa&quot;,&quot;title&quot;:&quot;چکیده&quot;},{&quot;language&quot;:&quot;ko&quot;,&quot;title&quot;:&quot;초록&quot;}]},{&quot;param&quot;: &quot;pls&quot;,&quot;titles&quot;:[{&quot;language&quot;:&quot;en&quot;,&quot;title&quot;:&quot;Plain language summary&quot;},{&quot;language&quot;:&quot;de&quot;,&quot;title&quot;:&quot;Laienverständliche Zusammenfassung&quot;},{&quot;language&quot;:&quot;es&quot;,&quot;title&quot;:&quot;Resumen en términos sencillos&quot;},{&quot;language&quot;:&quot;fa&quot;,&quot;title&quot;:&quot;خلاصه به زبان ساده&quot;},{&quot;language&quot;:&quot;hr&quot;,&quot;title&quot;:&quot;Laički sažetak&quot;},{&quot;language&quot;:&quot;ja&quot;,&quot;title&quot;:&quot;一般語訳&quot;},{&quot;language&quot;:&quot;ko&quot;,&quot;title&quot;:&quot;쉬운 말 요약&quot;},{&quot;language&quot;:&quot;ru&quot;,&quot;title&quot;:&quot;Резюме на простом языке&quot;}]},{&quot;param&quot;: &quot;conclusions&quot;,&quot;titles&quot;:[{&quot;language&quot;:&quot;en&quot;,&quot;title&quot;:&quot;Authors' conclusions&quot;}]},{&quot;param&quot;: &quot;summaryOfFindings&quot;,&quot;titles&quot;:[{&quot;language&quot;:&quot;en&quot;,&quot;title&quot;:&quot;Summary of findings&quot;}]},{&quot;param&quot;: &quot;background&quot;,&quot;titles&quot;:[{&quot;language&quot;:&quot;en&quot;,&quot;title&quot;:&quot;Background&quot;}]},{&quot;param&quot;: &quot;objectives&quot;,&quot;titles&quot;:[{&quot;language&quot;:&quot;en&quot;,&quot;title&quot;:&quot;Objectives&quot;}]},{&quot;param&quot;: &quot;methods&quot;,&quot;titles&quot;:[{&quot;language&quot;:&quot;en&quot;,&quot;title&quot;:&quot;Methods&quot;}]},{&quot;param&quot;: &quot;results&quot;,&quot;titles&quot;:[{&quot;language&quot;:&quot;en&quot;,&quot;title&quot;:&quot;Results&quot;}]},{&quot;param&quot;: &quot;discussion&quot;,&quot;titles&quot;:[{&quot;language&quot;:&quot;en&quot;,&quot;title&quot;:&quot;Discussion&quot;}]},{&quot;param&quot;: &quot;references&quot;,&quot;titles&quot;:[{&quot;language&quot;:&quot;en&quot;,&quot;title&quot;:&quot;References&quot;}]},{&quot;param&quot;: &quot;appendices&quot;,&quot;titles&quot;:[{&quot;language&quot;:&quot;en&quot;,&quot;title&quot;:&quot;Appendices&quot;},{&quot;language&quot;:&quot;en&quot;,&quot;title&quot;:&quot;Search strategies&quot;}]},{&quot;param&quot;: &quot;characteristics&quot;,&quot;titles&quot;:[{&quot;language&quot;:&quot;en&quot;,&quot;title&quot;:&quot;Characteristics of studies&quot;}]},{&quot;param&quot;: &quot;data&quot;,&quot;titles&quot;:[{&quot;language&quot;:&quot;en&quot;,&quot;title&quot;:&quot;Analyses&quot;}]},{&quot;param&quot;: &quot;information&quot;,&quot;titles&quot;:[{&quot;language&quot;:&quot;en&quot;,&quot;title&quot;:&quot;Information&quot;}]},{&quot;param&quot;: &quot;authors&quot;,&quot;titles&quot;:[{&quot;language&quot;:&quot;en&quot;,&quot;title&quot;:&quot;Authors&quot;}]},{&quot;param&quot;: &quot;history&quot;,&quot;titles&quot;:[{&quot;language&quot;:&quot;en&quot;,&quot;title&quot;:&quot;History&quot;},{&quot;language&quot;:&quot;en&quot;,&quot;title&quot;:&quot;History&quot;}]},{&quot;param&quot;: &quot;comments&quot;,&quot;titles&quot;:[{&quot;language&quot;:&quot;en&quot;,&quot;title&quot;:&quot;Comments&quot;}]}]" data-print-urlbase="/cdsr/doi/10.1002/14651858.CD005219.pub3/print"> <span><i class="icon fa fa-print"></i></span> <span>Print</span> </li> <li class="js-old-version-modal-trigger tools comments comment-on-review" data-article-id="CD005219.PUB3" data-english-only-message="Please note, that commenting is available in English only. Apologies for any inconvenience." data-href="/cdsr/doi/10.1002/14651858.CD005219.pub3/read-comments" data-new-version="" id="comment-on-review"> <span class="comment-icon"><i class="icon fa fa-comment"></i></span> <span class="comments-count">0</span> <span>Comment</span> </li> <li class="tools share-cdsr-link" data-share-url="/cdsr/doi/10.1002/14651858.CD005219.pub3/full"> <span><i class="icon fa fa-share-alt"></i></span> <span>Share</span> </li> <li class="tools follow"> <span class="article-not-followed cochrane-link signin follow-wrapper"> <span> <i class="icon fa fa-plus"></i> </span> <span> Follow </span> </span> </li> </li> </ul> <div class="metrics-wrapper"> <div class="metrics-count"> <span>Full text views: </span> <span>11364 <i class="icon fa fa-info-circle custom-tooltip" style="padding-left: 2px;color: #962d91;" title="Usage represents full text views on Cochrane Library since January 2022 or 2023. For articles published after this date, the usage represents views since the article was first published on Cochrane Library."> </i> </span> </div> </div> <div class="metrics-wrapper nav-link-section"> <div class="altmetric-embed" data-badge-type="1" data-condensed="true" data-doi="10.1002/14651858.CD005219.pub3" data-link-target="_blank"></div> <div class="inline-status-wrapper guidelines-count" data-count-plural="Cited in $1 guidelines" data-count-single="Cited in 1 guideline"> <a href="related-content#guidelines_data" title="Guidelines"></a> </div> </div> <ul class="nav-section-header"> <li> <h3>Contents</h3> </li> </ul> <ul class="nav-long-form nav-link-section"> <li class="cdsr-nav-link bold-nav-link" lang="en"> <a href="/cdsr/doi/10.1002/14651858.CD005219.pub3/full"> Abstract </a> </li> <li class="cdsr-nav-link bold-nav-link" lang="en"> <a href="/cdsr/doi/10.1002/14651858.CD005219.pub3/full#pico"> PICOs </a> </li> <li class="cdsr-nav-link bold-nav-link" lang="en"> <a href="/cdsr/doi/10.1002/14651858.CD005219.pub3/full#CD005219-abs-0003"> Plain language summary </a> </li> <li class="cdsr-nav-link bold-nav-link" lang="en"> <a href="/cdsr/doi/10.1002/14651858.CD005219.pub3/full#CD005219-sec-0156"> Authors' conclusions </a> </li> <li class="cdsr-nav-link bold-nav-link" lang="en"> <a href="/cdsr/doi/10.1002/14651858.CD005219.pub3/full#CD005219-sec-0022"> Summary of findings </a> </li> <li class="cdsr-nav-link" lang="en"> <a href="/cdsr/doi/10.1002/14651858.CD005219.pub3/full#CD005219-sec-0023"> Background </a> </li> <li class="cdsr-nav-link" lang="en"> <a href="/cdsr/doi/10.1002/14651858.CD005219.pub3/full#CD005219-sec-0028"> Objectives </a> </li> <li class="cdsr-nav-link" lang="en"> <a href="/cdsr/doi/10.1002/14651858.CD005219.pub3/full#CD005219-sec-0029"> Methods </a> </li> <li class="cdsr-nav-link" lang="en"> <a href="/cdsr/doi/10.1002/14651858.CD005219.pub3/full#CD005219-sec-0056"> Results </a> </li> <li class="cdsr-nav-link" lang="en"> <a href="/cdsr/doi/10.1002/14651858.CD005219.pub3/full#CD005219-sec-0150"> Discussion </a> </li> <li class="cdsr-nav-link"> <a class="figures-and-tables-link" href="/cdsr/doi/10.1002/14651858.CD005219.pub3/#"> Figures and tables </a> </li> <li class="cdsr-nav-link" lang="en"> <a href="/cdsr/doi/10.1002/14651858.CD005219.pub3/references"> References </a> </li> </ul> <div class="nav-section-header"> <h3>Supplementary materials</h3> </div> <ul class="nav-long-form nav-link-section"> <li class="cdsr-nav-link" lang="en"> <a href="/cdsr/doi/10.1002/14651858.CD005219.pub3/appendices#CD005219-sec-0161"> Search strategies </a> </li> <li class="cdsr-nav-link" lang="en"> <a href="/cdsr/doi/10.1002/14651858.CD005219.pub3/references#characteristicStudies"> Characteristics of studies </a> </li> <li class="cdsr-nav-link" lang="en"> <a href="/cdsr/doi/10.1002/14651858.CD005219.pub3/references#dataAndAnalyses"> Analyses </a> </li> <li class="cdsr-nav-link download-stats-data-link" data-download-href="/cdsr/doi/10.1002/14651858.CD005219.pub3/media/CDSR/CD005219/table_n/CD005219StatsDataOnly.rm5?content-disposition=attachment&amp;mime-type=application/octet-stream"> <a href="/cdsr/doi/10.1002/14651858.CD005219.pub3/media/CDSR/CD005219/table_n/CD005219StatsDataOnly.rm5?content-disposition=attachment&amp;mime-type=application/octet-stream"> Download data </a> </li> </ul> <ul class="tools-row"> <li> </li> </ul> <ul class="nav-section-header"> <li><h3>Related</h3></li> </ul> <ul class="linked-content linked-content-dropdown" id="linked-content-articles" tabindex="0"> <li class="linked-cca" data-type="cca"> <div class="linked-content-section"> <span class="linked-type">Cochrane Clinical Answers<span class="count"></span></span> <i aria-hidden="true" class="fa fa-caret-down"></i> </div> <div class="articles"></div> </li> <li class="linked-editorials" data-type="editorial"> <div class="linked-content-section"> <span class="linked-type">Editorials<span class="count"></span></span> <i aria-hidden="true" class="fa fa-caret-down"></i> </div> <div class="articles"></div> </li> <li class="linked-podcasts" data-type="podcast"> <div class="linked-content-section"> <span class="linked-type">Podcasts<span class="count"></span></span> <i aria-hidden="true" class="fa fa-caret-down"></i> </div> <div class="articles"></div> </li> <li class="linked-sc" data-type="sc"> <div class="linked-content-section"> <span class="linked-type">Special Collections<span class="count"></span></span> <i aria-hidden="true" class="fa fa-caret-down"></i> </div> <div class="articles"></div> </li> </ul> <div class="nav-section-header"> <h3>About this review</h3> </div> <ul class="nav-long-form nav-info nav-link-section"> <li class="cdsr-nav-link" lang="en"> <a href="/cdsr/doi/10.1002/14651858.CD005219.pub3/information"> <i> <svg viewbox="0 0 24 24"> <path d="M11,9H13V7H11M12,20C7.59,20 4,16.41 4,12C4,7.59 7.59,4 12,4C16.41,4 20,7.59 20,12C20,16.41 16.41,20 12,20M12,2A10,10 0 0,0 2,12A10,10 0 0,0 12,22A10,10 0 0,0 22,12A10,10 0 0,0 12,2M11,17H13V11H11V17Z"></path> </svg> </i> Information </a> </li> <li class="cdsr-nav-link" lang="en"> <a href="/cdsr/doi/10.1002/14651858.CD005219.pub3/information#authors"> <i> <svg viewbox="0 0 24 24"> <path d="M12,5.5A3.5,3.5 0 0,1 15.5,9A3.5,3.5 0 0,1 12,12.5A3.5,3.5 0 0,1 8.5,9A3.5,3.5 0 0,1 12,5.5M5,8C5.56,8 6.08,8.15 6.53,8.42C6.38,9.85 6.8,11.27 7.66,12.38C7.16,13.34 6.16,14 5,14A3,3 0 0,1 2,11A3,3 0 0,1 5,8M19,8A3,3 0 0,1 22,11A3,3 0 0,1 19,14C17.84,14 16.84,13.34 16.34,12.38C17.2,11.27 17.62,9.85 17.47,8.42C17.92,8.15 18.44,8 19,8M5.5,18.25C5.5,16.18 8.41,14.5 12,14.5C15.59,14.5 18.5,16.18 18.5,18.25V20H5.5V18.25M0,20V18.5C0,17.11 1.89,15.94 4.45,15.6C3.86,16.28 3.5,17.22 3.5,18.25V20H0M24,20H20.5V18.25C20.5,17.22 20.14,16.28 19.55,15.6C22.11,15.94 24,17.11 24,18.5V20Z"></path> </svg> </i> Authors </a> </li> <li class="cdsr-nav-link" lang="en"> <a href="/cdsr/doi/10.1002/14651858.CD005219.pub3/information#history"> <i> <svg viewbox="0 0 24 24"> <path d="M13.5,8H12V13L16.28,15.54L17,14.33L13.5,12.25V8M13,3A9,9 0 0,0 4,12H1L4.96,16.03L9,12H6A7,7 0 0,1 13,5A7,7 0 0,1 20,12A7,7 0 0,1 13,19C11.07,19 9.32,18.21 8.06,16.94L6.64,18.36C8.27,20 10.5,21 13,21A9,9 0 0,0 22,12A9,9 0 0,0 13,3"></path> </svg> </i> Version history </a> </li> <li class="cdsr-nav-link"> <a href="/cdsr/doi/10.1002/14651858.CD005219.pub3/information#keywords"> <i> <svg viewbox="0 0 24 24"> <path d="M11 3C10.18 3 9.44 3.5 9.14 4.27L3.64 18.27C3.12 19.58 4.09 21 5.5 21H7.75C8.59 21 9.33 20.5 9.62 19.7L10.26 18H13.74L14.38 19.7C14.67 20.5 15.42 21 16.25 21H18.5C19.91 21 20.88 19.58 20.36 18.27L14.86 4.27C14.56 3.5 13.82 3 13 3M11 5H13L18.5 19H16.25L15.12 16H8.87L7.75 19H5.5M12 7.67L9.62 14H14.37Z"></path> </svg> </i> Keywords (MeSH, PICOs) </a> </li> <li class="cdsr-nav-link"> <a href="/cdsr/doi/10.1002/14651858.CD005219.pub3/related-content"> <i class="icon fa fa-sitemap fa-rotate-270"></i> Related content </a> </li> <li class="cdsr-nav-link translation-notes-link"> <a href="/cdsr/doi/10.1002/14651858.CD005219.pub3/#"> <i> <svg viewbox="0 0 24 24"> <path d="M12.87,15.07L10.33,12.56L10.36,12.53C12.1,10.59 13.34,8.36 14.07,6H17V4H10V2H8V4H1V6H12.17C11.5,7.92 10.44,9.75 9,11.35C8.07,10.32 7.3,9.19 6.69,8H4.69C5.42,9.63 6.42,11.17 7.67,12.56L2.58,17.58L4,19L9,14L12.11,17.11L12.87,15.07M18.5,10H16.5L12,22H14L15.12,19H19.87L21,22H23L18.5,10M15.88,17L17.5,12.67L19.12,17H15.88Z"></path> </svg> </i> Translation notes </a> </li> <li class="cdsr-nav-link"> <a class="request-permissions" data-copyright="Copyright © 2016 The Cochrane Collaboration. Published by John Wiley &amp; Sons, Ltd." data-creative-commons="false" href="/cdsr/doi/10.1002/14651858.CD005219.pub3/#"> <span class="request-permissions-icon"></span> Request permissions </a> </li> <li class="cdsr-nav-link"> <a href="/data"> <i class="icon fa fa-database"></i> Request data reuse </a> </li> </ul> </nav> </div> <article> <div class="cdsr-header-top"> <div class="cdsr-header-left"> <a class="publish-database" href="/">Cochrane Database of Systematic reviews</a> <span class="publish-type">Review - Intervention</span> </div> <div class="cdsr-header-right"> </div> </div> <header class="publication-header"> <h1 class="publication-title" lang="en">Normobaric and hyperbaric oxygen therapy for the treatment and prevention of migraine and cluster headache </h1> <div class="publication-metadata-block"> <div class="publication-authors"> <div class="publish-meta-wrapper"> <ul class="authors"> <li class="author"><a href="/cdsr/doi/10.1002/14651858.CD005219.pub3/information#CD005219-cr-0002"><i class="icon corresponding-author fa fa-envelope"></i>Michael H Bennett</a></li> <li class="author"><a href="/cdsr/doi/10.1002/14651858.CD005219.pub3/information#CD005219-cr-0003">Christopher French</a></li> <li class="author"><a href="/cdsr/doi/10.1002/14651858.CD005219.pub3/information#CD005219-cr-0004">Alexander Schnabel</a></li> <li class="author"><a href="/cdsr/doi/10.1002/14651858.CD005219.pub3/information#CD005219-cr-0005">Jason Wasiak</a></li> <li class="author"><a href="/cdsr/doi/10.1002/14651858.CD005219.pub3/information#CD005219-cr-0006">Peter Kranke</a></li> <li class="author"><a href="/cdsr/doi/10.1002/14651858.CD005219.pub3/information#CD005219-cr-0007">Stephanie Weibel</a></li> </ul> <span class="author declaration"> <a class="declarationsOfInterestLink" href="/cdsr/doi/10.1002/14651858.CD005219.pub3/information/en#CD005219-sec-0176">Authors' declarations of interest</a> </span> </div> </div> </div> <div class="publication-metadata-block"> <p> <span class="publish-date">Version published: 28 December 2015 </span> <a class="whatsNewLink" href="/cdsr/doi/10.1002/14651858.CD005219.pub3/information/en#versionTable">Version history</a> </p> <div class="doi-header"> <a href="https://doi.org/10.1002/14651858.CD005219.pub3">https://doi.org/10.1002/14651858.CD005219.pub3</a> </div> </div> </header> <div class="publication-control-bar"> <span class="publication-control-button publication-control-collapse"> Collapse all </span> <span class="publication-control-button publication-control-expand"> Expand all </span> </div> <section class="abstract"> <div class="section-header section-collapse-header" id="CD005219-abs-0001" lang="en"> <h2 class="title section-collapse-title"> Abstract <i aria-hidden="true" class="fa fa-caret-up section-collapse-icon"></i> </h2> <div class="section-language-toggles"> <span class="section-languages-legend">available in</span> <nav class="section-languages"> <li class="section-language"> <a class="is-active" href="full/en#CD005219-abs-0001">English</a> </li> <li class="section-language"> <a class="" href="full/es#CD005219-abs-0011">Español</a> </li> <li class="section-language"> <a class="" href="full/fa#CD005219-abs-0009">فارسی</a> </li> <li class="section-language"> <a class="" href="full/ko#CD005219-abs-0002">한국어</a> </li> </nav> </div> </div> <div class="abstract full_abstract" id="CD005219-abs-0001" lang="en"> <section id="CD005219-sec-0001"> <h3 class="title" id="CD005219-sec-0001">Background</h3> <p>Migraine and cluster headaches are severe and disabling. Migraine affects up to 18% of women, while cluster headaches are much less common (0.2% of the population). A number of acute and prophylactic therapies are available. Hyperbaric oxygen therapy (HBOT) is the therapeutic administration of 100% oxygen at environmental pressures greater than one atmosphere, while normobaric oxygen therapy (NBOT) is oxygen administered at one atmosphere. This is an updated version of the original Cochrane review published in Issue 3, 2008 under the title 'Normobaric and hyperbaric oxygen for migraine and cluster headache'. </p> </section> <section id="CD005219-sec-0002"> <h3 class="title" id="CD005219-sec-0002">Objectives</h3> <p>To examine the efficacy and safety of normobaric oxygen therapy (NBOT) and hyperbaric oxygen therapy (HBOT) in the treatment and prevention of migraine and cluster headache. </p> </section> <section id="CD005219-sec-0003"> <h3 class="title" id="CD005219-sec-0003">Search methods</h3> <p>We updated searches of the following databases up to 15 June 2015: CENTRAL (the Cochrane Library), MEDLINE, EMBASE, and CINAHL. For the original review we searched the following databases up to May 2008: CENTRAL, MEDLINE, EMBASE, CINAHL, DORCTIHM, and reference lists from relevant articles. We handsearched relevant journals and contacted researchers to identify trials. </p> </section> <section id="CD005219-sec-0004"> <h3 class="title" id="CD005219-sec-0004">Selection criteria</h3> <p>Randomised controlled trials comparing HBOT or NBOT with one another, other active therapies, placebo (sham) interventions, or no treatment in participants with migraine or cluster headache. </p> </section> <section id="CD005219-sec-0005"> <h3 class="title" id="CD005219-sec-0005">Data collection and analysis</h3> <p>Three review authors independently extracted data and assessed the quality of the evidence using the GRADE approach. </p> </section> <section id="CD005219-sec-0006"> <h3 class="title" id="CD005219-sec-0006">Main results</h3> <p>In this update, we included 11 trials with 209 participants. Five trials (103 participants) compared HBOT versus sham therapy for acute migraine, three trials compared NBOT to sham therapy or ergotamine tartrate for cluster headache (145 participants), two trials evaluated HBOT for cluster headache (29 participants), and one trial (56 participants) compared NBOT to sham for a mixed group of headache. The risk of bias varied considerably across these trials but in general trial quality was poor to moderate. One trial may not have been truly randomised and two included studies were reported as abstracts only. Seven trials did not indicate allocation concealment or randomisation method. Notably, 10 of the 11 trials used a sham comparator therapy and masked the outcome assessor to allocation. </p> <p>We pooled data from three trials, which suggested that HBOT was effective in relieving migraine headaches compared to sham therapy (risk ratio (RR) 6.21, 95% CI 2.41 to 16.00; 58 participants, three trials). The quality of evidence was low, having been downgraded for small crossover studies with incomplete reporting. There was no evidence that HBOT could prevent migraine episodes, reduce the incidence of nausea and vomiting, or reduce the requirement for rescue medication. There was no evidence that HBOT was effective for the termination of cluster headache (RR 11.38, 95% CI 0.77 to 167.85; P = 0.08) (one trial), but this trial had low power. </p> <p>NBOT was effective in terminating cluster headache compared to sham in a single small study (RR 7.88, 95% CI 1.13 to 54.66), but not superior to ergotamine administration in another small trial (RR 1.17, 95% CI 0.94 to 1.46; P = 0.16). A third trial reported a statistically significant difference in the proportion of attacks successfully treated with oxygen (117 of 150 attacks were successfully treated with NBOT (78%) versus 30 of 148 attacks treated with NBOT (20%)). The proportion of responders was consistent across these three trials, and suggested more than 75% of headaches were likely to respond to NBOT. </p> <p>No serious adverse events during HBOT or NBOT were reported.</p> </section> <section id="CD005219-sec-0007"> <h3 class="title" id="CD005219-sec-0007">Authors' conclusions</h3> <p>Since the last version of this review, two new included studies have provided additional information to change the conclusions. There was some evidence that HBOT was effective for the termination of acute migraine in an unselected population, and some evidence that NBOT was similarly effective in cluster headache. Given the cost and poor availability of HBOT, more research should be done on patients unresponsive to standard therapy. NBOT is cheap, safe, and easy to apply, so will probably continue to be used despite the limited evidence in this review. </p> </section> </div> </section> <section class="pico-section" id="pico"> <h2 class="title section-collapse-title">PICOs <i class="icon fa fa-info-circle" title="The PICO model is widely used and taught in evidence-based health care as a strategy for formulating questions and search strategies and for characterizing clinical studies or meta-analyses. PICO stands for four different potential components of a clinical question: Patient, Population or Problem; Intervention; Comparison; Outcome."></i> <i aria-hidden="true" class="fa fa-caret-up section-collapse-icon"></i> </h2> <div class="section-content" style="display: block;"> <h3 class="keyword-heading">PICOs</h3> <div class="pico-table"> <div class="pico-column Population"> <h6>Population<span class="pico-count"></span></h6> <ul class="pico-terms"> </ul> </div> <div class="pico-column Intervention"> <h6>Intervention<span class="pico-count"></span></h6> <ul class="pico-terms"> </ul> </div> <div class="pico-column Comparison"> <h6>Comparison<span class="pico-count"></span></h6> <ul class="pico-terms"> </ul> </div> <div class="pico-column Outcome"> <h6>Outcome<span class="pico-count"></span></h6> <ul class="pico-terms"> </ul> </div> </div> <div class="pico-information"> <p><i class="icon fa fa-info-circle"></i> The PICO model is widely used and taught in evidence-based health care as a strategy for formulating questions and search strategies and for characterizing clinical studies or meta-analyses. PICO stands for four different potential components of a clinical question: Patient, Population or Problem; Intervention; Comparison; Outcome.</p> <p>See more on using PICO in the <a href="https://training.cochrane.org/handbook/current/chapter-02#section-2-3">Cochrane Handbook</a>.</p> </div> </div> </section> <section class="pls"> <div class="section-header section-collapse-header" id="CD005219-abs-0003" lang="en"> <h2 class="title section-collapse-title"> Plain language summary <i aria-hidden="true" class="fa fa-caret-up section-collapse-icon"></i> </h2> <div class="section-language-toggles"> <span class="section-languages-legend">available in</span> <nav class="section-languages"> <li class="section-language"> <a class="is-active" href="full/en#CD005219-abs-0003">English</a> </li> <li class="section-language"> <a class="" href="full/de#CD005219-abs-0004">Deutsch</a> </li> <li class="section-language"> <a class="" href="full/es#CD005219-abs-0012">Español</a> </li> <li class="section-language"> <a class="" href="full/fa#CD005219-abs-0010">فارسی</a> </li> <li class="section-language"> <a class="" href="full/hr#CD005219-abs-0008">Hrvatski</a> </li> <li class="section-language"> <a class="" href="full/ja#CD005219-abs-0007">日本語</a> </li> <li class="section-language"> <a class="" href="full/ko#CD005219-abs-0006">한국어</a> </li> <li class="section-language"> <a class="" href="full/ru#CD005219-abs-0005">Русский</a> </li> </nav> </div> </div> <div class="abstract abstract_plainLanguageSummary" id="CD005219-abs-0003" lang="en"> <h3>Normal pressure oxygen therapy and hyperbaric oxygen therapy for migraine and cluster headaches </h3> <p><b>Background</b> </p> <p>Migraine and cluster headaches are severe and disabling. Hyperbaric oxygen therapy (HBOT, that is the breathing of pure oxygen at pressures greater than one atmosphere in a pressurised chamber) and normal pressure oxygen therapy (NBOT) can be delivered via a mask at home or in a clinic. These treatments may help to end acute attacks and prevent future attacks. </p> <p><b>Results</b> </p> <p>We originally searched the literature widely in May 2008, and most recently in June 2015. We looked for high quality trials that would help define whether or not there was good evidence for or against the use of oxygen for migraine or cluster headache. We included 11 trials in this review. </p> <p><b>Quality of the evidence</b> </p> <p>We found some low quality evidence to suggest that HBOT relieves pain with acute migraine headaches and possibly cluster headaches, and that NBOT may relieve pain with cluster headache. We found no evidence that either treatment can prevent future attacks. Many migraines can be treated simply with appropriate drug therapy, so further research is needed to help choose the most appropriate patients (if any) to receive HBOT. </p> </div> </section> <section id="vls" style="display: none"> <div class="section-header section-collapse-header"> <h2 class="title section-collapse-title">Visual summary<i aria-hidden="true" class="fa fa-caret-up section-collapse-icon"></i></h2> </div> <a href="" target="_blank"><img alt="visual summary" src=""/></a> </section> <section class="conclusions"> <div class="section-header section-collapse-header" id="CD005219-sec-0156" lang="en"> <h2 class="title section-collapse-title"> Authors' conclusions <i aria-hidden="true" class="fa fa-caret-up section-collapse-icon"></i> </h2> </div> <section class="authorsConclusions" lang="en"> <div class="section-header" id="CD005219-sec-0156"></div> <h3 class="title" id="CD005219-sec-0157">Implications for practice</h3> <section id="CD005219-sec-0157"> <p>While there is some evidence that HBOT may effectively terminate migraine headache in a general population of migraineurs, the practical problems involved in delivery of therapy suggest that HBOT should be reserved for those migraineurs resistant to standard pharmacological therapies. There is, however, insufficient evidence of the efficacy of HBOT in this subgroup of patients to support the use of HBOT for this purpose. The use of HBOT as a prophylactic therapy for migraine is not supported by the evidence. While one small trial supports the practice of administering NBOT to patients with acute migrainous headache, further evidence is required to support the use of NBOT for this purpose. </p> <p>There is insufficient evidence from good quality RCTs to establish the effects of HBOT on cluster headache as a treatment for an acute episode or as a prophylaxis against future clusters. Three RCTs suggest that the administration of NBOT to treat acute cluster headache is likely to be effective in more than 70% of cases, and given the safety and ease of administration of NBOT, NBOT use is likely to continue. There is no evidence to support NBOT use as a prophylactic measure. </p> </section> <h3 class="title" id="CD005219-sec-0158">Implications for research</h3> <section id="CD005219-sec-0158"> <p>Given the findings of this review update, there is a case for further investigation of HBOT as a possible therapy for acute migraine and cluster headache resistant to standard therapies. There is also a case for confirming the apparent effectiveness of NBOT for cluster headache in a study with sufficient power to produce valid conclusions. Any further investigations would need to be carefully justified. The effect of differing oxygen dosage and of other therapies administered simultaneously is not known. Any future trials would need to consider in particular: </p> <p> <ul id="CD005219-list-0009"> <li> <p>Appropriate sample sizes with power to detect expected differences;</p> </li> <li> <p>Careful definition and selection of target patients;</p> </li> <li> <p>Appropriate range of oxygen doses per treatment session (pressure and time);</p> </li> <li> <p>Appropriate and carefully defined comparator therapy;</p> </li> <li> <p>Use of an effective sham therapy;</p> </li> <li> <p>Effective and explicit blinding of outcome assessors;</p> </li> <li> <p>Appropriate outcome measures including all those listed in this review;</p> </li> <li> <p>Careful elucidation of any adverse events;</p> </li> <li> <p>The cost‐utility of the therapy;</p> </li> <li> <p>Appropriate and full reporting.</p> </li> </ul> </p> </section> </section> </section> <section class="summaryOfFindings"> <div class="section-header section-collapse-header" id="CD005219-sec-0022" lang="en"> <h2 class="title section-collapse-title"> Summary of findings <i aria-hidden="true" class="fa fa-caret-up section-collapse-icon"></i> </h2> </div> <section class="summaryOfFindings" lang="en"> <div class="section-header" id="CD005219-sec-0022"></div> <div class="table" id="CD005219-tbl-0001"> <table class="summary-of-findings framed"><a class="open-table-viewer open-in-figure-viewer" href="#0">Open in table viewer</a><div class="table-heading"><span class="table-label">Summary of findings for the main comparison.</span> <span class="table-title">Hyperbaric oxygen therapy for acute migraine</span></div> <tbody> <tr class="separated"> <td align="left" bgcolor="#ffffff" colspan="7" rowspan="1" valign="top"> <p><b>Hyperbaric oxygen therapy for the relief of acute migraine</b> </p> </td> </tr> <tr class="separated"> <td align="left" bgcolor="#ffffff" colspan="7" rowspan="1" valign="top"> <p><b>Patient or population:</b> Acute migraine<br/> <b>Setting:</b> Hospital care<br/> <b>Intervention:</b> HBOT (2.0 to 2.4 ATA for 40 to 45 minutes)<br/> <b>Comparison:</b> Sham therapy (air at pressure or 100% oxygen at 1 ATA) </p> </td> </tr> <tr class="table-header separated"> <td align="left" class="table-header" colspan="1" rowspan="2" valign="top"> <p><b>Outcomes</b> </p> </td> <td align="left" class="table-tint table-highlight" colspan="2" rowspan="1" valign="top"> <p><b>Anticipated absolute effects<sup>*</sup> (95% CI)</b> </p> </td> <td align="left" class="table-header" colspan="1" rowspan="2" valign="top"> <p><b>Relative effect<br/> (95% CI)</b> </p> </td> <td align="left" class="table-header" colspan="1" rowspan="2" valign="top"> <p><b>Number of participants<br/> (trials)</b> </p> </td> <td align="left" class="table-header" colspan="1" rowspan="2" valign="top"> <p><b>Quality of the evidence<br/> (GRADE)</b> </p> </td> <td align="left" class="table-header" colspan="1" rowspan="2" valign="top"> <p><b>Comments</b> </p> </td> </tr> <tr class="table-header separated"> <td align="left" class="table-tint table-highlight" colspan="1" rowspan="1" valign="top"> <p><b>Risk with sham therapy</b> </p> </td> <td align="left" class="table-tint table-highlight" colspan="1" rowspan="1" valign="top"> <p><b>Risk with HBOT</b> </p> </td> </tr> <tr class="separated"> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="2" valign="top"> <p>Chance of obtaining substantial headache relief (Relief).<br/> Assessed with: Patient self‐assessment </p> </td> <td align="left" class="table-tint table-highlight" colspan="2" rowspan="1" valign="top"> <p>Study population</p> </td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="2" valign="top"> <p>RR 6.21<br/> (2.41 to 16.00) </p> </td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="2" valign="top"> <p>58<br/> (3 RCTs) </p> </td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="2" valign="top"> <p>Low¹</p> </td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="2" valign="top"> <p>We included 3 small RCTs but all showed large effect size with HBOT compared to either air or 100% oxygen sham. </p> </td> </tr> <tr class="separated"> <td align="left" class="table-tint table-highlight" colspan="1" rowspan="1" valign="top"> <p>111 per 1000</p> </td> <td align="left" class="table-tint table-highlight" colspan="1" rowspan="1" valign="top"> <p>663 per 1000<br/> (162 to 1000) </p> </td> </tr> <tr class="separated"> <td align="" bgcolor="#ffffff" colspan="7" rowspan="1" valign=""> <p>*<b>The risk in the intervention group</b> (and its 95% CI) is based on the assumed risk in the comparison group and the <b>relative effect</b> of the intervention (and its 95% CI).<br/> <b>Abbreviations: CI:</b> confidence interval; <b>RR:</b> risk ratio; <b>OR:</b> odds ratio; <b>ATA:</b> atmospheres absolute; <b>HBOT:</b> hyperbaric oxygen therapy. </p> </td> </tr> <tr class="separated"> <td align="" bgcolor="#ffffff" colspan="7" rowspan="1" valign=""> <p><b>GRADE Working Group grades of evidence</b> <br/> <b>High quality:</b> We are very confident that the true effect lies close to that of the estimate of the effect.<br/> <b>Moderate quality:</b> We are moderately confident in the effect estimate: The true effect is likely to be close to the estimate of the effect, but there is a possibility that it is substantially different.<br/> <b>Low quality:</b> Our confidence in the effect estimate is limited: The true effect may be substantially different from the estimate of the effect.<br/> <b>Very low quality:</b> We have very little confidence in the effect estimate: The true effect is likely to be substantially different from the estimate of effect. </p> </td> </tr> </tbody> <tfoot> <tr> <td colspan="7"> <div class="table-footnote"> <p>¹The evidence has been downgraded from moderate to low due to two of these trials being incompletely reported crossover trials reported only in abstract. [Two of the three included studies were planned as crossover trials. In those two, many patients obtained relief during the first treatment period and were not crossed to the second period. For <a href="./references#CD005219-bbs2-0006" title="HillRK . A blinded, crossover controlled study of the use of hyperbaric oxygen in the treatment of migraine headache. Undersea Biomedical Research1992;19(S):106. ">Hill 1992</a>, where all patients are not clearly accounted for we have included the results only from the first treatment period.] </p> </div> </td> </tr> </tfoot> </table> </div> </section> </section> <section class="background"> <div class="section-header section-collapse-header" id="CD005219-sec-0023" lang="en"> <h2 class="title section-collapse-title"> Background <i aria-hidden="true" class="fa fa-caret-up section-collapse-icon"></i> </h2> </div> <section class="background" lang="en"> <div class="section-header" id="CD005219-sec-0023"></div> <p>This is an updated version of the original Cochrane review published in Issue 3, 2008 under the title 'Normobaric and hyperbaric oxygen for migraine and cluster headache' (<a href="./references#CD005219-bbs2-0080" title="BennettMH , FrenchC , SchnabelA , WasiakJ , KrankeP . Normobaric and hyperbaric oxygen therapy for migraine and cluster headache. Cochrane Database of Systematic Reviews2008, Issue 7. [DOI: 10.1002/14651858.CD005219.pub2] ">Bennett 2008</a>). </p> <section id="CD005219-sec-0024"> <h3 class="title" id="CD005219-sec-0024">Description of the condition</h3> <p>Migraine and cluster headache are disabling health problems among adults and migraine has been identified as a leading contributor to years lived with disability in an analysis for the Global Burden of Disease Study 2010 (<a href="./references#CD005219-bbs2-0075" title="VosT , FlaxmanAD , NaghaviM , LozanoR , MichaudC , EzzatiM , et al. Years lived with disability (YLDs) for 1160 sequelae of 289 diseases and injuries 1990–2010: a systematic analysis for the Global Burden of Disease Study 2010. The Lancet2013;380(9859):2163‐96. ">Vos 2013</a>). Both types of headache are frequently severe and associated with features other than pain (<a href="./references#CD005219-bbs2-0051" title="Headache Classification Subcommittee of the International Headache Society. IHS Classification ICHD‐II. http://ihs‐classification.org/en/. International Headache Society, (accessed dd Month yyyy). [0022‐3050 0022‐3050] ">IHS 2014</a>). While the diagnosis and classification of headaches can be difficult and complex, migraine and cluster headaches are generally distinguished by the nature of associated symptoms (nausea, vomiting, and photophobia occur commonly with migraine, while cluster headaches are typically accompanied by tearing and nasal congestion), the pattern in which they occur (cluster headaches typically occur daily for up to several weeks before resolving, often for lengthy periods) and their location and character (cluster headaches are periorbital and unilateral, while migraines can be bilateral and are often described as throbbing). Migraine may be preceded by an aura—most often a visual disturbance—in some people. </p> <p>Severe headache is common; in a review of studies on the prevalence of severe headache, <a href="./references#CD005219-bbs2-0071" title="SmithermanTA , BurchR , SheikhH , LoderE . The Prevalence, impact, and treatment of migraine and severe headaches in the United States: a review of statistics from national surveillance studies. Headache2013;53(3):427‐36. ">Smitherman 2013</a> suggests about 16% of the adult population in the USA will complain of at least one severe headache over a three‐month period, most of which are labelled as 'migraine' or 'probable migraine'. Surveys from the USA and elsewhere suggest that 6% to 7% of men and 15% to 18% of women experience migraine headaches, while about 0.1 to 0.2% of the population suffer with cluster headache (<a href="./references#CD005219-bbs2-0061" title="MathewNT . Pathophysiology, epidemiology, and impact of migraine. Clinical Cornerstone2001;4(3):1‐17. ">Mathew 2001</a>; <a href="./references#CD005219-bbs2-0065" title="NesbittAD , GoadsbyPJ . Cluster headache. BMJ2012;344:e2407. ">Nesbitt 2012</a>; <a href="./references#CD005219-bbs2-0069" title="RussellMB . Epidemiology and genetics of cluster headache. Lancet Neurology2004;3(5):279‐83. ">Russell 2004</a>). First‐degree relatives of those with cluster headaches are five to 18 times more likely to have such headaches than individuals in the general population. The mechanisms involved in both types of headache remain incompletely understood and are active areas of research (<a href="./references#CD005219-bbs2-0065" title="NesbittAD , GoadsbyPJ . Cluster headache. BMJ2012;344:e2407. ">Nesbitt 2012</a>). Migraine is generally seen as a vascular headache that seems to result from a mixture of environmental and genetic factors (<a href="./references#CD005219-bbs2-0067" title="PianeM , LulliP , FarinelliI , SimeoniS , DeFilippisS , PatacchioliFR , et al. Genetics of migraine and pharmacogenomics: some considerations. The Journal of Headache and Pain 2007;8(6):334‐9. ">Piane 2007</a>), while cluster headache is classified among the trigeminal autonomic cephalalgias and probably involves the hypothalamus (<a href="./references#CD005219-bbs2-0065" title="NesbittAD , GoadsbyPJ . Cluster headache. BMJ2012;344:e2407. ">Nesbitt 2012</a>). Migraine results in significant disability, work loss, and costs to the individual (<a href="./references#CD005219-bbs2-0034" title="BurtonWN , ContiDJ , ChenCY , SchultzAB , EdingtonDW . The economic burden of lost productivity due to migraine headache: a specific worksite analysis. Journal of Occupational and Environmental Medicine2002;44(6):523‐9. [1076‐2752] ">Burton 2002</a>; <a href="./references#CD005219-bbs2-0049" title="HuXH , MarksonLE , LiptonRB , StewartWF , BergerML . Burden of migraine in the United States: disability and economic costs. Archives of Internal Medicine1999;159(8):813‐8. [MEDLINE: 10219926] ">Hu 1999</a>; <a href="./references#CD005219-bbs2-0064" title="MunakataJ , HazardE , SerranoD , KlingmanD , RupnowMF , TierceJ , et al. Economic burden of transformed migraine: results from the American Migraine Prevalence and Prevention (AMPP) Study. Headache: The Journal of Headache and Face Pain2009;49(4):498‐508. ">Munakata 2009</a>; <a href="./references#CD005219-bbs2-0072" title="StokesM , BeckerWJ , LiptonRB , SullivanSD , WilcoxTK , WellsL , et al. Cost of health care among patients with chronic and episodic migraine in Canada and the USA: results from the International Burden of Migraine Study (IBMS). Headache: The Journal of Head and Face Pain2011;51(7):1058‐77. ">Stokes 2011</a>); estimated aggregate indirect costs to employers in the USA for reduced productivity due to migraine range from USD 5.6 billion to USD 17.2 billion annually (<a href="./references#CD005219-bbs2-0064" title="MunakataJ , HazardE , SerranoD , KlingmanD , RupnowMF , TierceJ , et al. Economic burden of transformed migraine: results from the American Migraine Prevalence and Prevention (AMPP) Study. Headache: The Journal of Headache and Face Pain2009;49(4):498‐508. ">Munakata 2009</a>; <a href="./references#CD005219-bbs2-0066" title="OsterhausJT , GuttermanDL , PlachetkaJR . Healthcare resource and lost labour costs of migraine headache in the US. Pharmacoeconomics1992;2(1):67‐76. ">Osterhaus 1992</a>). The social and economic impact of cluster headache is less clear, but data from Germany suggest time lost to work and healthcare costs are substantial (<a href="./references#CD005219-bbs2-0040" title="GaulC , FinkenJ , Biermann , J , MostardtS , DienerHC , MüllerO , et al. Treatment costs and indirect costs of cluster headache: A health economics analysis. Cephalalgia2011;31(16):1664‐72. ">Gaul 2011</a>). </p> <p>The traditional view has been that migraine is primarily a vascular event. This view focuses on explaining the pain involved, but more recently migraine is seen as a sensory processing disturbance, primarily of the sub‐cortical aminergic sensory modulatory systems. Such a brain‐centered explanation helps to explain the symptomatology of migraine beyond the headache and has implications for treatment (<a href="./references#CD005219-bbs2-0042" title="GoadsbyPJ . Pathophysiology of migraine. Annals of Indian Academy of Neurology2012;15(Suppl 1):S15. ">Goadsby 2012</a>). </p> <p>Therapy for headache falls into two categories: acute and preventive. Acute therapy aims at the symptomatic treatment of the head pain and other symptoms associated with an acute attack or cluster. The goal of preventive therapy is to reduce the frequency or intensity of attacks, or both, and thereby improve patient functioning and quality of life. Preventive therapy is especially well‐suited to patients with very frequent or severe attacks, significant headache‐related disability, or resistance to acute therapy. </p> <p>There are many accepted drug therapies for acute migraine, including non‐specific analgesics such as non‐steroidal anti‐inflammatory drugs, and specific agents such as sumatriptan, ergotamine, and dihydroergotamine (DHE) (<a href="./references#CD005219-bbs2-0056" title="LawS , DerryS , MooreRA . Naproxen with or without an antiemetic for acute migraine headaches in adults. Cochrane Database of Systematic Reviews2013, Issue 10. [DOI: 10.1002/14651858.CD009455.pub2] ">Law 2013a</a>; <a href="./references#CD005219-bbs2-0057" title="LawS , DerryS , MooreRA . Sumatriptan plus naproxen for acute migraine attacks in adults. Cochrane Database of Systematic Reviews2013, Issue 10. [DOI: 10.1002/14651858.CD008541.pub2] ">Law 2013b</a>; <a href="./references#CD005219-bbs2-0045" title="GéraudG , Lanteri‐MinetM , LucasC , ValadeD , French Society for the Study of Migraine Headache (SFEMC). French guidelines for the diagnosis and management of migraine in adults and children. Clinical Therapeutics2004;26(8):1305‐18. [MEDLINE: 15476911] ">Géraud 2004</a>). Epidemiological studies suggest that 80% of all analgesic prescriptions for migraine are triptans, mainly sumatriptan (<a href="./references#CD005219-bbs2-0071" title="SmithermanTA , BurchR , SheikhH , LoderE . The Prevalence, impact, and treatment of migraine and severe headaches in the United States: a review of statistics from national surveillance studies. Headache2013;53(3):427‐36. ">Smitherman 2013</a>). These drugs are effective in most cases, although headache may recur within 48 hours (<a href="./references#CD005219-bbs2-0032" title="BatemanDN . Sumatriptan. Lancet1993;341(8839):221‐4. [MEDLINE: 8093509] ">Bateman 1993</a>). Most people with migraine are able to manage even these recurrent headaches successfully at home with self‐administered medication. Thus, while migraine is a common problem, the number of cases unresponsive to accepted therapeutic approaches may be quite small. It is these patients who may benefit from a therapy delivered at a health facility, such as intravenous DHE, parenteral analgesics or antinauseants or, potentially, hyperbaric oxygen therapy (HBOT). </p> <p>Pharmacological and non‐pharmacological therapies used for the prevention of migraine include various beta‐blockers, amitriptyline, topiramate; sodium valproate, gabapentin, relaxation, biofeedback, feverfew, and cognitive‐behavioural therapy (<a href="./references#CD005219-bbs2-0045" title="GéraudG , Lanteri‐MinetM , LucasC , ValadeD , French Society for the Study of Migraine Headache (SFEMC). French guidelines for the diagnosis and management of migraine in adults and children. Clinical Therapeutics2004;26(8):1305‐18. [MEDLINE: 15476911] ">Géraud 2004</a>; <a href="./references#CD005219-bbs2-0059" title="LindeM , MullenersWM , ChronicleEP , McCroryDC . Gabapentin or pregabalin for the prophylaxis of episodic migraine in adults. Cochrane Database of Systematic Reviews2013, Issue 6. [DOI: 10.1002/14651858.CD010609] ">Linde 2013a</a>; <a href="./references#CD005219-bbs2-0060" title="LindeM , MullenersWM , ChronicleEP , McCroryDC . Topiramate for the prophylaxis of episodic migraine in adults. Cochrane Database of Systematic Reviews2013, Issue 6. [DOI: 10.1002/14651858.CD010610] ">Linde 2013b</a>; <a href="./references#CD005219-bbs2-0077" title="WiderB , PittlerMH , ErnstE . Feverfew for preventing migraine. Cochrane Database of Systematic Reviews2015, Issue 4. [DOI: 10.1002/14651858.CD002286] ">Wider 2015</a>). Again, while most patients respond to such therapies, they are not always effective. Refractory patients may be offered preventive drug treatments with potentially serious toxicities, such as methysergide; these patients may also be candidates for other resource‐intensive treatments, such as HBOT. </p> <p>The standard acute treatment for cluster headache is sumatriptan and inhalation of 100% oxygen, while steroids are commonly used both as treatment and prophylaxis (<a href="./references#CD005219-bbs2-0058" title="LawS , DerryS , MooreRA . Triptans for acute cluster headache. Cochrane Database of Systematic Reviews2013, Issue 7. [DOI: 10.1002/14651858.CD008042.pub3] ">Law 2013c</a>). Secondary agents include methysergide, lithium, and topiramate. A number of agents have been used for prophylaxis, including verapamil, ergotamine, lithium, and steroids (<a href="./references#CD005219-bbs2-0063" title="MayA , LeoneM , AfraJ , LindeM , SándorPS , EversS , et al. EFNS guidelines on the treatment of cluster headache and other trigeminal‐autonomic cephalalgias. European Journal of Neurology2006;13(10):1066‐77. ">May 2006</a>). Again, most patients respond well to the administration of specific acute therapy. For example, in one randomised study, 74% of attacks responded to subcutaneous sumatriptan within 15 minutes (<a href="./references#CD005219-bbs2-0038" title="EkbomK , MonstadI , PrusinskiA , ColeJA , PilgrimAJ , NoronhaD . Subcutaneous sumatriptan in the acute treatment of cluster headache: a dose comparison study. The Sumatriptan Cluster Headache Study Group. Acta Neurologica Scandinavica1993;88(1):63‐9. [MEDLINE: 8396833] ">Ekbom 1993</a>). Only a subset of cluster headache patients would therefore be candidates for the administration of therapies such as hyperbaric oxygen where hospital attendance is required. Most recently, there have been promising advances in the search for a more permanent cure, particularly with deep hypothalamic stimulation techniques and subsequent surgical procedures (<a href="./references#CD005219-bbs2-0063" title="MayA , LeoneM , AfraJ , LindeM , SándorPS , EversS , et al. EFNS guidelines on the treatment of cluster headache and other trigeminal‐autonomic cephalalgias. European Journal of Neurology2006;13(10):1066‐77. ">May 2006</a>). </p> </section> <section id="CD005219-sec-0025"> <h3 class="title" id="CD005219-sec-0025">Description of the intervention</h3> <p>This review considers the evidence for the effectiveness and safety of oxygen administration for migraine or cluster headache. It includes both the use of oxygen at high percentage of normal atmospheric pressure (normobaric oxygen therapy (NBOT)) and the use of 100% oxygen at pressures above one atmosphere (HBOT). NBOT is delivered by a mask connected to an oxygen cylinder and may be administered in a hospital, general practice, or home setting. HBOT requires the patient to be subjected to a higher than atmospheric pressure in a specialised vessel designed for the purpose. For the treatment of headache, each session of therapy typically involves exposure to pressure for 30 minutes to one hour at between 2.0 and 2.4 atmospheres absolute (ATA, equivalent to 101.3 kPa of 760 mmHg), although some workers cease treatment on the resolution of headache. Treatment therefore takes place at 2.0 to 2.4 times the normal air pressure at sea level (1 ATA). While at pressure, the patient breathes 100% oxygen via a hood tent or a tight‐fitting mask designed for the purpose. We will consider oxygen both as an acute therapy for terminating individual attacks and as a preventive therapy for reducing the frequency of headache episodes. </p> <p>Precautions against fire are required and standard practice in areas where oxygen is in use. Prolonged administration to premature neonates may be implicated in the development of retinopathy of prematurity, and oxygen has produced respiratory arrest in chronically hypercarbic patients relying on an hypoxic drive for respiration. Neither of these groups of individuals is likely to be relevant in this review. Regardless of the particular pathology being treated, HBOT is associated with some risk of adverse events, including damage to the ears, sinuses, and lungs from the effects of pressure; temporary worsening of shortsightedness; claustrophobia; and oxygen poisoning. Although serious adverse events are rare, HBOT cannot be regarded as an entirely benign intervention. </p> </section> <section id="CD005219-sec-0026"> <h3 class="title" id="CD005219-sec-0026">How the intervention might work</h3> <p>NBOT has been used with some success to treat both migraine and cluster headaches for many years (<a href="./references#CD005219-bbs2-0031" title="AlvarezWC . The new oxygen treatment for migraine. American Journal of Digestive Diseases1939;6:728. ">Alvarez 1939</a>; <a href="./references#CD005219-bbs2-0007" title="KudrowL . Response of cluster headache attacks to oxygen inhalation. Headache1981;21(1):1‐4. ">Kudrow 1981</a>), presumably through the ability of oxygen to constrict distal cerebral resistance vessels (<a href="./references#CD005219-bbs2-0016" title="DrummondPD , AnthonyM . Extracranial vascular responses to sublingual nitroglycerine and oxygen inhalation in cluster headache patients. Headache1985;25(2):70‐4. ">Drummond 1985</a>; <a href="./references#CD005219-bbs2-0052" title="IversenHK , NielsenTH , OlesenJ , Tfelt‐HansenP . Arterial responses during migraine headache. Lancet1990;336(8719):837‐9. ">Iversen 1990</a>). The observation that oxygen administered at higher pressures produced even further vasoconstriction (with preservation of tissue oxygenation) led directly to the suggestion that HBOT might favourably influence vascular headache resistant to conventional drug therapy (<a href="./references#CD005219-bbs2-0039" title="FifeCE , PowellMG , SuttonTE , MeyerJS . Transcranial doppler evaluation of the middle cerebral artery from 1ATA to 3ATA PO2. Undersea and Hyperbaric Medicine1994;21 Suppl:77. [10662936] ">Fife 1994</a>). It has been suggested that HBOT may also exert therapeutic effects through the action of oxygen as a serotonergic agonist and an immunomodulator of response to substance P (a short chain neuropeptide involved in pain signal transmission) (<a href="./references#CD005219-bbs2-0014" title="DiSabatoF , GiacovazzoM , CristalliG , RoccoM , FuscoBM . Effect of hyperbaric oxygen on the immunoreactivity to substance P in the nasal mucosa of cluster headache patients. Headache1996;36(4):221‐3. ">Di Sabato 1996</a>; <a href="./references#CD005219-bbs2-0015" title="DiSabatoF , RoccoM , MartellettiP , GiacovazzoM . Hyperbaric oxygen in chronic cluster headaches: influence on serotonergic pathways. Undersea &amp; Hyperbaric Medicine1997;24(2):117‐22. ">Di Sabato 1997</a>). Indeed, while acknowledging that vascular mechanisms are involved, it has been suggested that inflammation plays a critical role in the genesis of a migraine episode (<a href="./references#CD005219-bbs2-0041" title="GoadsbyPJ . Current concepts of the pathophysiology of migraine. Neurologic Clinics1997;15(1):27‐42. [MEDLINE: 97211397] ">Goadsby 1997</a>). If this is correct, then the well‐described moderation of inflammatory pathways by HBOT may both influence acute attacks and provide useful prophylaxis (<a href="./references#CD005219-bbs2-0070" title="SlotmanGJ . Hyperbaric oxygen in systemic inflammation ... HBO is not just a movie channel anymore. Critical Care Medicine1998;26(12):1932‐3. [MEDLINE: 9875888] ">Slotman 1998</a>; <a href="./references#CD005219-bbs2-0073" title="SümenG , CimşitM , ErogluL . Hyperbaric oxygen treatment reduces carrageenan‐induced acute inflammation in rats. European Journal of Pharmacology2001;431(2):265‐8. [MEDLINE: 11728435] ">Sümen 2001</a>). </p> </section> <section id="CD005219-sec-0027"> <h3 class="title" id="CD005219-sec-0027">Why it is important to do this review</h3> <p>While the use of NBOT is relatively common for cluster headache, the evidence for this practice is less well known. For this reason we felt an assessment of the strength of the evidence was appropriate. NBOT is rarely used for the treatment of migraine. Clinically, HBOT has been reported as a successful treatment for headache since at least 1989 (<a href="./references#CD005219-bbs2-0019" title="FifeWP , FifeCE . Treatment of migraine with hyperbaric oxygen. Journal of Hyperbaric Medicine1989;4:7‐15. ">Fife 1989</a>; <a href="./references#CD005219-bbs2-0076" title="WeissLD , RamasastrySS , EidelmanBH . Treatment of a cluster headache patient in a hyperbaric chamber. Headache1989;29(2):109‐10. [MEDLINE: 2708039] ">Weiss 1989</a>), and sporadic reports have followed since that time, including some comparative trials. On the other hand, oxygen in high doses may increase oxidative stress through oxygen free radical species and is potentially toxic (<a href="./references#CD005219-bbs2-0078" title="YusaT , BeckmanJS , CrapoJD , FreemanBA . Hyperoxia increases H2O2 production by brain in vivo. Journal of Applied Physiology1987;63(1):353‐8. ">Yusa 1987</a>). Indeed, the brain is particularly at risk (<a href="./references#CD005219-bbs2-0035" title="ClarkJM , ThomSR . Oxygen under pressure. In: BrubakkAO , NeumanTS editor(s). Bennett and Elliott's Physiology and Medicine of Diving. 5th Edition. London: Saunders, 2003:358‐418. ">Clark 2003</a>). For this reason, it is appropriate to postulate that in some migraine or cluster headache patients, HBOT may do more harm than good. </p> </section> </section> </section> <section class="objectives"> <div class="section-header section-collapse-header" id="CD005219-sec-0028" lang="en"> <h2 class="title section-collapse-title"> Objectives <i aria-hidden="true" class="fa fa-caret-up section-collapse-icon"></i> </h2> </div> <section class="objectives" lang="en"> <div class="section-header" id="CD005219-sec-0028"></div> <p>To examine the efficacy and safety of normobaric oxygen therapy (NBOT) and hyperbaric oxygen therapy (HBOT) in the treatment and prevention of migraine and cluster headache. </p> </section> </section> <section class="methods"> <div class="section-header section-collapse-header" id="CD005219-sec-0029" lang="en"> <h2 class="title section-collapse-title"> Methods <i aria-hidden="true" class="fa fa-caret-up section-collapse-icon"></i> </h2> </div> <section class="methods" lang="en"> <div class="section-header" id="CD005219-sec-0029"></div> <section id="CD005219-sec-0030"> <h3 class="title">Criteria for considering studies for this review</h3> <section id="CD005219-sec-0031"> <h4 class="title">Types of studies</h4> <p>All randomised controlled trials (RCTs) that evaluate the effectiveness of NBOT or HBOT for the prevention or treatment of migraine or cluster headache were included. We accepted any comparator including drug or sham interventions. </p> </section> <section id="CD005219-sec-0032"> <h4 class="title">Types of participants</h4> <p>We sought to identify trials that included patients of any age and either sex with migraine (with or without aura) or cluster headache. Headache classification followed the guidelines of the International Headache Society where possible (<a href="./references#CD005219-bbs2-0051" title="Headache Classification Subcommittee of the International Headache Society. IHS Classification ICHD‐II. http://ihs‐classification.org/en/. International Headache Society, (accessed dd Month yyyy). [0022‐3050 0022‐3050] ">IHS 2014</a>). </p> </section> <section id="CD005219-sec-0033"> <h4 class="title">Types of interventions</h4> <p>We considered interventions that included NBOT at any concentration above ambient air (whether administered in a health facility or at home) or HBOT administered in a compression chamber. We included trials where NBOT was compared to HBOT, or where either was compared to a standard therapy or no treatment. The comparator groups included any standard treatment regimen designed to prevent or terminate headache or prevent recurrence, including combined therapies, as well as placebo (sham) interventions and no treatment. We included regimens where adjunctive NBOT or HBOT was compared against similar regimens excluding NBOT or HBOT. Where regimens differed significantly between studies, we have stated this clearly and discussed the implications. </p> </section> <section id="CD005219-sec-0034"> <h4 class="title">Types of outcome measures</h4> <p>We anticipated that short‐term response would be of greatest clinical importance. Primary outcome assessments were generally made during or immediately following therapy. </p> <p>For outcomes relating to headache intensity, we preferred those that measured headache relief or change in headache intensity, since these are more comparable among participants with different baseline scores. The outcomes we considered eligible for inclusion in this review were: </p> <section id="CD005219-sec-0035"> <h5 class="title">Primary outcomes</h5> <section id="CD005219-sec-0036"> <h6 class="title">Treatment of acute attack</h6> <p> <ol id="CD005219-list-0001"> <li> <p>Proportion of participant with pain‐free response (complete resolution of headache pain). Assessment times preferred were one and two hours for migraine, and 15 and 30 minutes for cluster headache. </p> </li> <li> <p>Proportion of participants with headache pain reduction from moderate/severe to mild or none (timing as for 1, above). </p> </li> <li> <p>Proportion of participants with sustained relief for 24 hours.</p> </li> </ol> </p> </section> <section id="CD005219-sec-0037"> <h6 class="title">Prevention</h6> <p> <ol id="CD005219-list-0002"> <li> <p>Frequency of attacks.</p> </li> <li> <p>Number of days with headache in the week after therapy.</p> </li> <li> <p>Days lost to work.</p> </li> </ol> </p> </section> </section> <section id="CD005219-sec-0038"> <h5 class="title">Secondary outcomes</h5> <section id="CD005219-sec-0039"> <h6 class="title">Treatment of acute attack</h6> <p> <ol id="CD005219-list-0003"> <li> <p>Degree of headache relief or headache intensity.</p> </li> <li> <p>Functional status or disability.</p> </li> <li> <p>Pain‐free response at four hours for migraine and two hours for cluster headache.</p> </li> <li> <p>Proportion of participants requiring rescue medication.</p> </li> <li> <p>Proportion of participants with sustained relief for 48 hours.</p> </li> <li> <p>Proportion of participants with photophobia or phonophobia (migraine only).</p> </li> <li> <p>Proportion of participants with nausea and/or vomiting, after therapy (migraine only).</p> </li> </ol> </p> </section> <section id="CD005219-sec-0040"> <h6 class="title">Prevention</h6> <p> <ol id="CD005219-list-0004"> <li> <p>Self‐reported assessment of treatment success.</p> </li> <li> <p>Frequency of attacks rated by participant as 'severe'.</p> </li> <li> <p>Quality of life.</p> </li> <li> <p>Functional status or disability.</p> </li> <li> <p>Headache index (nature and calculation discussed).</p> </li> <li> <p>Proportion of participants requiring rescue medication.</p> </li> <li> <p>Proportion of participants with nausea and/or vomiting, or both (migraine only).</p> </li> </ol> </p> </section> <section id="CD005219-sec-0041"> <h6 class="title">Adverse events/safety</h6> <p> <ol id="CD005219-list-0005"> <li> <p>Adverse events during HBOT, such as the proportion of participants with visual disturbance (short‐ and long‐term), barotrauma (aural, sinus, pulmonary in the short‐ and long‐ term) and oxygen toxicity (short‐term). </p> </li> <li> <p>Any other recorded adverse events were reported and discussed.</p> </li> </ol> </p> </section> </section> </section> </section> <section id="CD005219-sec-0042"> <h3 class="title">Search methods for identification of studies</h3> <p>We intended to capture both published and unpublished trials. We did not impose language restrictions. </p> <section id="CD005219-sec-0043"> <h4 class="title">Electronic searches</h4> <p>We searched the following databases up to 15 June 2015:</p> <p> <ul id="CD005219-list-0006"> <li> <p>Cochrane Central Register of Controlled Trials (CENTRAL; the Cochrane Library), Issue 6 2015; </p> </li> <li> <p>MEDLINE &amp; MEDLINE in Process (OVID) (1966 to 15 June 2015);</p> </li> <li> <p>EMBASE (OVID) (1980 to 15 June 2015);</p> </li> <li> <p>CINAHL (EBSCO) (1982 to June 2015);</p> </li> <li> <p>An additional database developed in our hyperbaric facility (the Database of Randomised Trials in Hyperbaric Medicine (<a href="./references#CD005219-bbs2-0033" title="BennettM , ConnorD . The Database of Randomised Controlled Trials in Hyperbaric Medicine (updated monthly). http://hboevidence.unsw.wikispaces.net/ (accessed 4th December 2015). ">Bennett 2004</a>) was searched for the original review in 2005 and for subsequent updates). </p> </li> </ul> </p> </section> <section id="CD005219-sec-0044"> <h4 class="title">Searching other resources</h4> <p>In addition we made a systematic search for relevant RCTs by other means available. For the initial review in 2005 we contacted experts in the field of headache and leading hyperbaric therapy centres and asked authors of relevant studies for details of any unpublished or ongoing investigations. </p> <p>Both <a href="./references#CD005219-bbs2-0079" title="BennettMH , FrenchC , KrankeP , SchnabelA , WasiakJ . Normobaric and hyperbaric oxygen therapy for the treatment and prevention of migraine and cluster headache. Cochrane Database of Systematic Reviews2005, Issue 4. [DOI: 10.1002/14651858.CD005219] ">Bennett 2005</a> and all subsequent updates, we handsearched relevant hyperbaric textbooks (latest editions for this update: <a href="./references#CD005219-bbs2-0053" title="JainKK . Textbook of Hyperbaric Medicine. 5th Edition. Seattle: Hogrefe &amp; Huber, 2009. [0‐88937‐203‐9] ">Jain 2009</a>; <a href="./references#CD005219-bbs2-0055" title="KindwallEP , WhelanHT . Hyperbaric Medicine Practice. 3rd Edition. Flagstaff, AZ: Best Publishing Company, 2008. [0‐941332‐78‐0] ">Kindwall 2008</a>; <a href="./references#CD005219-bbs2-0062" title="MathieuD . Handbook on Hyperbaric Medicine. 2nd Edition. Milan: Springer, 2006. [3‐540‐75016‐9] ">Mathieu 2006</a>), relevant journals up to 15 June 2015 (<i>Undersea and Hyperbaric Medicine</i> ; <i>Hyperbaric Medicine Review</i> ; <i>Diving and Hyperbaric Medicine</i> ; and <i>Aviation, Space and Environmental Medicine Journal</i> ) and conference proceedings (<i>Undersea and Hyperbaric Medical Society</i> , <i>South Pacific Underwater Medicine Society</i> , <i>European Undersea and Baromedical Society</i> , <i>International Congress of Hyperbaric Medicine</i>) from first editions to 15 June 2015. We also searched the USA NIH database of registered trials at <a href="https://clinicaltrials.gov/" target="_blank">https://clinicaltrials.gov/</a>. Finally, we checked the reference lists of the trials and reviews identified by the above strategies. </p> </section> </section> <section id="CD005219-sec-0045"> <h3 class="title" id="CD005219-sec-0045">Data collection and analysis</h3> <p>We analysed data from trials enrolling patients with migraine separately from those enrolling patients with cluster headache. </p> <section id="CD005219-sec-0046"> <h4 class="title">Selection of studies</h4> <p>Two review authors (MB and JW) scanned the records retrieved by the initial search and the updated searches and excluded obviously irrelevant studies by title. Subsequently, MB and AS read the abstracts of the citations remaining in order to identify trials that may have met the inclusion criteria. We retrieved the full‐text articles and these were assessed by three review authors (MB, AS, and CF) independently and a decision made on inclusion/exclusion. We resolved any differences of opinion by discussion among the review authors. </p> </section> <section id="CD005219-sec-0047"> <h4 class="title">Data extraction and management</h4> <p>Two review authors (MB and AS) independently extracted data from the included trials using standardised forms we developed for this review. We collected data on trial methodology, numbers of participants enrolled, number reaching analysis and all outcomes reported. We contacted primary study investigators to provide further information when we encountered missing data. We resolved any differences in opinion by discussion among the review authors. All included trials were available in English. </p> </section> <section id="CD005219-sec-0048"> <h4 class="title">Assessment of risk of bias in included studies</h4> <p>Two review authors (MB and SW) independently undertook assessment of the risk of bias of the included trials with the following taken into consideration, as guided by the<i>Cochrane Handbook for Systematic Reviews of Interventions</i> (<a href="./references#CD005219-bbs2-0046" title="HigginsJPT , GreenS (editors) . Cochrane Handbook for Systematic Reviews of Interventions. 5.1.0 [updated March 2011]. The Cochrane Collaboration, 2011. ">Higgins 2009</a>): </p> <p> <ul id="CD005219-list-0007"> <li> <p>Sequence generation;</p> </li> <li> <p>Allocation concealment;</p> </li> <li> <p>Blinding;</p> </li> <li> <p>Incomplete outcome data;</p> </li> <li> <p>Selective outcome reporting; and</p> </li> <li> <p>Other sources of bias.</p> </li> </ul> </p> <p>We used the Cochrane ‘Risk of bias’ assessment tool in RevMan 5.3 (<a href="./references#CD005219-bbs2-0068" title="The Nordic Cochrane Centre, The Cochrane Collaboration. Review Manager. Version 5.3. Copenhagen: The Nordic Cochrane Centre, The Cochrane Collaboration, 2014. ">RevMan 2014</a>,) in which each of these domains is described as reported in the trial and then a judgement assigned about the adequacy of each entry: either 'low', 'high', or 'unclear' (or unknown) risk of bias. </p> </section> <section id="CD005219-sec-0049"> <h4 class="title">Measures of treatment effect</h4> <p>For proportions (dichotomous outcomes), we used relative risk (RR).</p> <p>We converted continuous data to the mean difference (MD) using the inverse variance method, and calculated an overall MD. </p> </section> <section id="CD005219-sec-0050"> <h4 class="title">Unit of analysis issues</h4> <p>We intended to include cluster randomised trials but did not find any.</p> <p>When data from cross‐over trials contributed to an analysis, we intended to use the Peto method for taking joint conditional probabilities into account, as described in <a href="./references#CD005219-bbs2-0036" title="CurtinF , ElbourneD , AltmanDG . Meta‐analysis combining parallel and cross‐over clinical trials. Statistics in Medicine2002;21(15):2145‐59. ">Curtin 2002</a>. However this was not possible with the data available and we have analysed these trials as if they were parallel‐group in design. This is a generally conservative approach that ignores the reduction in inter‐participant variability in cross‐over studies. </p> </section> <section id="CD005219-sec-0051"> <h4 class="title">Dealing with missing data</h4> <p>All analyses were made on an intention‐to‐treat (ITT) basis where possible. In the case of missing data, we employed different approaches to imputing missing data. The best‐case scenario assumed that none of the originally enrolled patients missing from the primary analysis in the treatment group had the negative outcome of interest while all those missing from the control group did. The worst‐case scenario was the reverse. </p> </section> <section id="CD005219-sec-0052"> <h4 class="title">Assessment of heterogeneity</h4> <p>We assessed statistical heterogeneity using the I² statistic, and gave consideration to the appropriateness of pooling and meta‐analysis by interpretation of both statistical and clinical heterogeneity. </p> </section> <section id="CD005219-sec-0053"> <h4 class="title">Assessment of reporting biases</h4> <p>If 10 or more trials contributed data to a meta‐analysis, we intended to investigate the possibility of publication bias through the use of funnel plots, however this was inappropriate. </p> </section> <section id="CD005219-sec-0054"> <h4 class="title">Subgroup analysis and investigation of heterogeneity</h4> <p>Tests of interaction were calculated to determine if the results for subgroups were significantly different. We used a fixed‐effect model where there was no evidence of significant heterogeneity between studies, and a random‐effects model when such heterogeneity was likely (<a href="./references#CD005219-bbs2-0037" title="DerSimonianR , LairdN . Meta‐analysis in clinical trials. Controlled Clinical Trials1986;7(3):177‐88. ">DerSimonian 1986</a>). </p> <p>We performed subgroup analyses where appropriate by calculation of RR or MD in each subgroup and examination of the 95% confidence intervals (CIs). Non‐overlap in intervals was taken to indicate a statistically significant difference between subgroups. </p> <p>We considered subgroup analyses based on the following factors, but such analyses were inappropriate: </p> <p> <ul id="CD005219-list-0008"> <li> <p>Dose of oxygen received: NBOT versus HBOT;</p> </li> <li> <p>Dose of oxygen received during HBOT: variables to be considered: pressure (&lt; 2.0 atmospheres absolute [ATA] versus ≥ 2.0 ATA), time (&lt; 60 min versus ≥ 60 min), and length of treatment course (&lt; five sessions versus ≥ five sessions); </p> </li> <li> <p>Migraine with aura versus without aura;</p> </li> <li> <p>Comparator treatment (where oxygen has been compared to different alternative treatments).</p> </li> </ul> </p> <p>We assumed statistical heterogeneity to be significant if the I² statistic analysis suggested more than 30% of the variability in an analysis was due to differences between trials. Consideration was then given to the appropriateness of pooling and meta‐analysis; when analysis was undertaken in the face of statistical or clinical heterogeneity, we used a random‐effects model. </p> </section> <section id="CD005219-sec-0055"> <h4 class="title">Sensitivity analysis</h4> <p>We performed sensitivity analyses for missing data where appropriate, but sensitivity analysis for study quality was inappropriate. </p> </section> </section> </section> </section> <section class="results"> <div class="section-header section-collapse-header" id="CD005219-sec-0056" lang="en"> <h2 class="title section-collapse-title"> Results <i aria-hidden="true" class="fa fa-caret-up section-collapse-icon"></i> </h2> </div> <section class="results" lang="en"> <div class="section-header" id="CD005219-sec-0056"></div> <section id="CD005219-sec-0057"> <h3 class="title">Description of studies</h3> <section id="CD005219-sec-0058"> <h4 class="title">Results of the search</h4> <p>In the previous version of this review, nine trials met the inclusion criteria (<a href="./references#CD005219-bbs2-0080" title="BennettMH , FrenchC , SchnabelA , WasiakJ , KrankeP . Normobaric and hyperbaric oxygen therapy for migraine and cluster headache. Cochrane Database of Systematic Reviews2008, Issue 7. [DOI: 10.1002/14651858.CD005219.pub2] ">Bennett 2008</a>). For this review update we identified seven potential articles for inclusion after searching the literature up to 15 June 2015 (<a href="#CD005219-fig-0001">Figure 1</a>). Two of these articles were reviews of the treatment of cluster or migraine headache with no new data and a third was a third party report on an included trial. We excluded these three articles (see '<a href="./references#CD005219-sec-0184" title="">Characteristics of excluded studies</a>'). Of the remaining three reports, two dealt with a single trial (<a href="./references#CD005219-bbs2-0010" title="OzkurtB , CinarO , CevikE , AcarAY , ArslanD , EyiEY , et al. Efficacy of high‐flow oxygen therapy in all types of headache: A prospective, randomized, placebo‐controlled trial. Annals of Emergency Medicine. 2011; Vol. 1:S184. OzkurtB , CinarO , CevikE , AcarAY , ArslanD , EyiEY , et al. Efficacy of high‐flow oxygen therapy in all types of headache: a prospective, randomized, placebo‐controlled trial. American Journal of Emergency Medicine2012;30(9):1760‐4. ">Ozkurt 2012</a> (an abstract) and <a href="./references#CD005219-bbs2-0010" title="OzkurtB , CinarO , CevikE , AcarAY , ArslanD , EyiEY , et al. Efficacy of high‐flow oxygen therapy in all types of headache: A prospective, randomized, placebo‐controlled trial. Annals of Emergency Medicine. 2011; Vol. 1:S184. OzkurtB , CinarO , CevikE , AcarAY , ArslanD , EyiEY , et al. Efficacy of high‐flow oxygen therapy in all types of headache: a prospective, randomized, placebo‐controlled trial. American Journal of Emergency Medicine2012;30(9):1760‐4. ">Ozkurt 2012</a> (full report)). Therefore two new trials met the inclusion criteria (<a href="./references#CD005219-bbs2-0001" title="CohenAS , BurnsB , GoadsbyPJ . High‐flow oxygen for treatment of cluster headache: a randomized trial. JAMA2009;302(22):2451‐7. ">Cohen 2009</a>; <a href="./references#CD005219-bbs2-0010" title="OzkurtB , CinarO , CevikE , AcarAY , ArslanD , EyiEY , et al. Efficacy of high‐flow oxygen therapy in all types of headache: A prospective, randomized, placebo‐controlled trial. Annals of Emergency Medicine. 2011; Vol. 1:S184. OzkurtB , CinarO , CevikE , AcarAY , ArslanD , EyiEY , et al. Efficacy of high‐flow oxygen therapy in all types of headache: a prospective, randomized, placebo‐controlled trial. American Journal of Emergency Medicine2012;30(9):1760‐4. ">Ozkurt 2012</a>) and we pooled data where possible with the nine trials included in <a href="./references#CD005219-bbs2-0080" title="BennettMH , FrenchC , SchnabelA , WasiakJ , KrankeP . Normobaric and hyperbaric oxygen therapy for migraine and cluster headache. Cochrane Database of Systematic Reviews2008, Issue 7. [DOI: 10.1002/14651858.CD005219.pub2] ">Bennett 2008</a> (<a href="./references#CD005219-bbs2-0002" title="DiSabatoF , FuscoBM , PelaiaP , GiacovazzoM . Hyperbaric oxygen therapy in cluster headache. Pain1993;52(2):243‐5. ">Di Sabato 1993</a>; <a href="./references#CD005219-bbs2-0003" title="EftedalOS , LydersenS , HeldeG , WhiteL , BrubakkAO , StovnerLJ . A randomised, double blind study of the prophylactic effect of hyperbaric oxygen therapy on migraine. Cephalalgia2004;24(8):639‐44. ">Eftedal 2004</a>; <a href="./references#CD005219-bbs2-0004" title="FifeCE , MeyerJS , BerryJM , SuttonTE . Hyperbaric oxygen and acute migraine pain: preliminary results of a randomised blinded trial. Undersea Biomedical Research1992;19:106‐7. ">Fife 1992</a>; <a href="./references#CD005219-bbs2-0005" title="FoganL . Treatment of cluster headache. A double‐blind comparison of oxygen v air inhalation. Archives of Neurology1985;42(4):362‐3. ">Fogan 1985</a>; <a href="./references#CD005219-bbs2-0006" title="HillRK . A blinded, crossover controlled study of the use of hyperbaric oxygen in the treatment of migraine headache. Undersea Biomedical Research1992;19(S):106. ">Hill 1992</a>; <a href="./references#CD005219-bbs2-0007" title="KudrowL . Response of cluster headache attacks to oxygen inhalation. Headache1981;21(1):1‐4. ">Kudrow 1981</a>; <a href="./references#CD005219-bbs2-0008" title="MyersDE , MyersRA . A preliminary report on hyperbaric oxygen in the relief of migraine headache. Headache1995;35(4):197‐9. ">Myers 1995</a>; <a href="./references#CD005219-bbs2-0009" title="Nilsson RemahlAI , AnsjonR , LindF , WaldenlindE . Hyperbaric oxygen treatment of active cluster headache: a double‐blind placebo‐controlled cross‐over study. Cephalalgia2002;22(9):730‐9. ">Nilsson Remahl 2002</a>; <a href="./references#CD005219-bbs2-0011" title="WilsonJR , ForesmanGH , GamberRG , WrightT . Hyperbaric oxygen in the treatment of migraine with aura. Headache1998;38(2):112‐5. ">Wilson 1998</a>). <a href="./references#CD005219-bbs2-0001" title="CohenAS , BurnsB , GoadsbyPJ . High‐flow oxygen for treatment of cluster headache: a randomized trial. JAMA2009;302(22):2451‐7. ">Cohen 2009</a> was a crossover trial and four cluster headache attacks were treated in each individual. The trial authors reported the proportion of attacks that responded to normobaric oxygen rather than the proportion of participants. We requested further information but at this time this report is included in qualitative analysis of this review only. </p> <div class="figure" id="CD005219-fig-0001"> <div class="figure-caption-wrapper-top"> <nav class="inline-nav-list has-dividers"> <ul> <li><a class="open-in-figure-viewer" href="#0">Open in figure viewer</a></li> </ul> </nav> <div class="figure-label">Figure 1</div> </div> <hr class="top"/><img alt="Study flow diagram." data-id="CD005219-fig-0001" src="/cdsr/doi/10.1002/14651858.CD005219.pub3/media/CDSR/CD005219/image_n/nCD005219-AFig-FIG01.png"/><hr class="bottom"/> <div class="figure-caption-wrapper-bottom"> <div class="figure-caption"> <p>Study flow diagram.</p> </div> </div> </div> </section> <section id="CD005219-sec-0059"> <h4 class="title">Included studies</h4> <p>We included 11 trials in the quantitative analysis. Included trials were published between 1981 (<a href="./references#CD005219-bbs2-0007" title="KudrowL . Response of cluster headache attacks to oxygen inhalation. Headache1981;21(1):1‐4. ">Kudrow 1981</a>) and 2012 (<a href="./references#CD005219-bbs2-0010" title="OzkurtB , CinarO , CevikE , AcarAY , ArslanD , EyiEY , et al. Efficacy of high‐flow oxygen therapy in all types of headache: A prospective, randomized, placebo‐controlled trial. Annals of Emergency Medicine. 2011; Vol. 1:S184. OzkurtB , CinarO , CevikE , AcarAY , ArslanD , EyiEY , et al. Efficacy of high‐flow oxygen therapy in all types of headache: a prospective, randomized, placebo‐controlled trial. American Journal of Emergency Medicine2012;30(9):1760‐4. ">Ozkurt 2012</a>), and we are unaware of any ongoing RCTs in the area. One trial, <a href="./references#CD005219-bbs2-0010" title="OzkurtB , CinarO , CevikE , AcarAY , ArslanD , EyiEY , et al. Efficacy of high‐flow oxygen therapy in all types of headache: A prospective, randomized, placebo‐controlled trial. Annals of Emergency Medicine. 2011; Vol. 1:S184. OzkurtB , CinarO , CevikE , AcarAY , ArslanD , EyiEY , et al. Efficacy of high‐flow oxygen therapy in all types of headache: a prospective, randomized, placebo‐controlled trial. American Journal of Emergency Medicine2012;30(9):1760‐4. ">Ozkurt 2012</a>, enrolled all types of headache and evaluated one atmosphere oxygen breathing (NBOT). We included the results of those with migraine (56 participants) and cluster headache (two participants) in the relevant analyses in this review. Six trials enrolled a total of 159 patients experiencing acute migraine; all of which, except <a href="./references#CD005219-bbs2-0010" title="OzkurtB , CinarO , CevikE , AcarAY , ArslanD , EyiEY , et al. Efficacy of high‐flow oxygen therapy in all types of headache: A prospective, randomized, placebo‐controlled trial. Annals of Emergency Medicine. 2011; Vol. 1:S184. OzkurtB , CinarO , CevikE , AcarAY , ArslanD , EyiEY , et al. Efficacy of high‐flow oxygen therapy in all types of headache: a prospective, randomized, placebo‐controlled trial. American Journal of Emergency Medicine2012;30(9):1760‐4. ">Ozkurt 2012</a>, employed HBOT in one arm (<a href="./references#CD005219-bbs2-0003" title="EftedalOS , LydersenS , HeldeG , WhiteL , BrubakkAO , StovnerLJ . A randomised, double blind study of the prophylactic effect of hyperbaric oxygen therapy on migraine. Cephalalgia2004;24(8):639‐44. ">Eftedal 2004</a>; <a href="./references#CD005219-bbs2-0004" title="FifeCE , MeyerJS , BerryJM , SuttonTE . Hyperbaric oxygen and acute migraine pain: preliminary results of a randomised blinded trial. Undersea Biomedical Research1992;19:106‐7. ">Fife 1992</a>; <a href="./references#CD005219-bbs2-0006" title="HillRK . A blinded, crossover controlled study of the use of hyperbaric oxygen in the treatment of migraine headache. Undersea Biomedical Research1992;19(S):106. ">Hill 1992</a>; <a href="./references#CD005219-bbs2-0008" title="MyersDE , MyersRA . A preliminary report on hyperbaric oxygen in the relief of migraine headache. Headache1995;35(4):197‐9. ">Myers 1995</a>; <a href="./references#CD005219-bbs2-0011" title="WilsonJR , ForesmanGH , GamberRG , WrightT . Hyperbaric oxygen in the treatment of migraine with aura. Headache1998;38(2):112‐5. ">Wilson 1998</a>). Six trials enrolled a total of 209 patients with cluster headache. Four of these evaluated NBOT (<a href="./references#CD005219-bbs2-0001" title="CohenAS , BurnsB , GoadsbyPJ . High‐flow oxygen for treatment of cluster headache: a randomized trial. JAMA2009;302(22):2451‐7. ">Cohen 2009</a>; <a href="./references#CD005219-bbs2-0005" title="FoganL . Treatment of cluster headache. A double‐blind comparison of oxygen v air inhalation. Archives of Neurology1985;42(4):362‐3. ">Fogan 1985</a>; <a href="./references#CD005219-bbs2-0007" title="KudrowL . Response of cluster headache attacks to oxygen inhalation. Headache1981;21(1):1‐4. ">Kudrow 1981</a>; <a href="./references#CD005219-bbs2-0010" title="OzkurtB , CinarO , CevikE , AcarAY , ArslanD , EyiEY , et al. Efficacy of high‐flow oxygen therapy in all types of headache: A prospective, randomized, placebo‐controlled trial. Annals of Emergency Medicine. 2011; Vol. 1:S184. OzkurtB , CinarO , CevikE , AcarAY , ArslanD , EyiEY , et al. Efficacy of high‐flow oxygen therapy in all types of headache: a prospective, randomized, placebo‐controlled trial. American Journal of Emergency Medicine2012;30(9):1760‐4. ">Ozkurt 2012</a>), and the other two administered HBOT (<a href="./references#CD005219-bbs2-0002" title="DiSabatoF , FuscoBM , PelaiaP , GiacovazzoM . Hyperbaric oxygen therapy in cluster headache. Pain1993;52(2):243‐5. ">Di Sabato 1993</a>; <a href="./references#CD005219-bbs2-0009" title="Nilsson RemahlAI , AnsjonR , LindF , WaldenlindE . Hyperbaric oxygen treatment of active cluster headache: a double‐blind placebo‐controlled cross‐over study. Cephalalgia2002;22(9):730‐9. ">Nilsson Remahl 2002</a>). Several studies utilized a cross‐over design (<a href="./references#CD005219-bbs2-0001" title="CohenAS , BurnsB , GoadsbyPJ . High‐flow oxygen for treatment of cluster headache: a randomized trial. JAMA2009;302(22):2451‐7. ">Cohen 2009</a>; <a href="./references#CD005219-bbs2-0005" title="FoganL . Treatment of cluster headache. A double‐blind comparison of oxygen v air inhalation. Archives of Neurology1985;42(4):362‐3. ">Fogan 1985</a>; <a href="./references#CD005219-bbs2-0006" title="HillRK . A blinded, crossover controlled study of the use of hyperbaric oxygen in the treatment of migraine headache. Undersea Biomedical Research1992;19(S):106. ">Hill 1992</a>; <a href="./references#CD005219-bbs2-0007" title="KudrowL . Response of cluster headache attacks to oxygen inhalation. Headache1981;21(1):1‐4. ">Kudrow 1981</a>; <a href="./references#CD005219-bbs2-0009" title="Nilsson RemahlAI , AnsjonR , LindF , WaldenlindE . Hyperbaric oxygen treatment of active cluster headache: a double‐blind placebo‐controlled cross‐over study. Cephalalgia2002;22(9):730‐9. ">Nilsson Remahl 2002</a>; <a href="./references#CD005219-bbs2-0011" title="WilsonJR , ForesmanGH , GamberRG , WrightT . Hyperbaric oxygen in the treatment of migraine with aura. Headache1998;38(2):112‐5. ">Wilson 1998</a>). In total, these 11 trials included 363 participants. We have listed details of the methodology and interventions in the '<a href="./references#CD005219-sec-0183" title="">Characteristics of included studies</a>' table. </p> <p>The dose of oxygen per treatment session and for the total course of treatment varied somewhat between studies. Of the trials investigating the treatment of migraine with HBOT, all administered HBOT at 2.0 ATA except <a href="./references#CD005219-bbs2-0011" title="WilsonJR , ForesmanGH , GamberRG , WrightT . Hyperbaric oxygen in the treatment of migraine with aura. Headache1998;38(2):112‐5. ">Wilson 1998</a>, who utilized 2.4 ATA. The period of exposure to HBOT varied from 30 minutes on three consecutive days (<a href="./references#CD005219-bbs2-0003" title="EftedalOS , LydersenS , HeldeG , WhiteL , BrubakkAO , StovnerLJ . A randomised, double blind study of the prophylactic effect of hyperbaric oxygen therapy on migraine. Cephalalgia2004;24(8):639‐44. ">Eftedal 2004</a>) to a maximum of 60 minutes (<a href="./references#CD005219-bbs2-0011" title="WilsonJR , ForesmanGH , GamberRG , WrightT . Hyperbaric oxygen in the treatment of migraine with aura. Headache1998;38(2):112‐5. ">Wilson 1998</a>). All migraine trials except <a href="./references#CD005219-bbs2-0003" title="EftedalOS , LydersenS , HeldeG , WhiteL , BrubakkAO , StovnerLJ . A randomised, double blind study of the prophylactic effect of hyperbaric oxygen therapy on migraine. Cephalalgia2004;24(8):639‐44. ">Eftedal 2004</a> gave a single exposure only. The single trial using NBOT for migraine employed 15 litres of 100% oxygen versus air for 15 minutes (<a href="./references#CD005219-bbs2-0010" title="OzkurtB , CinarO , CevikE , AcarAY , ArslanD , EyiEY , et al. Efficacy of high‐flow oxygen therapy in all types of headache: A prospective, randomized, placebo‐controlled trial. Annals of Emergency Medicine. 2011; Vol. 1:S184. OzkurtB , CinarO , CevikE , AcarAY , ArslanD , EyiEY , et al. Efficacy of high‐flow oxygen therapy in all types of headache: a prospective, randomized, placebo‐controlled trial. American Journal of Emergency Medicine2012;30(9):1760‐4. ">Ozkurt 2012</a>). The three cluster headache trials investigating NBOT administered oxygen for 15 minutes. The two trials investigating HBOT both administered oxygen at 2.5 ATA; <a href="./references#CD005219-bbs2-0002" title="DiSabatoF , FuscoBM , PelaiaP , GiacovazzoM . Hyperbaric oxygen therapy in cluster headache. Pain1993;52(2):243‐5. ">Di Sabato 1993</a> for 30 minutes on a single occasion and <a href="./references#CD005219-bbs2-0009" title="Nilsson RemahlAI , AnsjonR , LindF , WaldenlindE . Hyperbaric oxygen treatment of active cluster headache: a double‐blind placebo‐controlled cross‐over study. Cephalalgia2002;22(9):730‐9. ">Nilsson Remahl 2002</a> for 70 minutes on two consecutive days. </p> <p>All trials, except <a href="./references#CD005219-bbs2-0007" title="KudrowL . Response of cluster headache attacks to oxygen inhalation. Headache1981;21(1):1‐4. ">Kudrow 1981</a>, provided a sham therapy and blinded participants and assessors to the treatment received. For the HBOT trials sham procedures varied, with the use of air at atmospheric pressure (<a href="./references#CD005219-bbs2-0002" title="DiSabatoF , FuscoBM , PelaiaP , GiacovazzoM . Hyperbaric oxygen therapy in cluster headache. Pain1993;52(2):243‐5. ">Di Sabato 1993</a>), air at 2.0 ATA (<a href="./references#CD005219-bbs2-0006" title="HillRK . A blinded, crossover controlled study of the use of hyperbaric oxygen in the treatment of migraine headache. Undersea Biomedical Research1992;19(S):106. ">Hill 1992</a>; <a href="./references#CD005219-bbs2-0003" title="EftedalOS , LydersenS , HeldeG , WhiteL , BrubakkAO , StovnerLJ . A randomised, double blind study of the prophylactic effect of hyperbaric oxygen therapy on migraine. Cephalalgia2004;24(8):639‐44. ">Eftedal 2004</a>), 10% oxygen at 2.0 to 2.5 ATA in order to maintain inspired oxygen tension near that of air at atmospheric pressure (<a href="./references#CD005219-bbs2-0004" title="FifeCE , MeyerJS , BerryJM , SuttonTE . Hyperbaric oxygen and acute migraine pain: preliminary results of a randomised blinded trial. Undersea Biomedical Research1992;19:106‐7. ">Fife 1992</a>; <a href="./references#CD005219-bbs2-0009" title="Nilsson RemahlAI , AnsjonR , LindF , WaldenlindE . Hyperbaric oxygen treatment of active cluster headache: a double‐blind placebo‐controlled cross‐over study. Cephalalgia2002;22(9):730‐9. ">Nilsson Remahl 2002</a>) and 100% oxygen administration at or near atmospheric pressure (<a href="./references#CD005219-bbs2-0008" title="MyersDE , MyersRA . A preliminary report on hyperbaric oxygen in the relief of migraine headache. Headache1995;35(4):197‐9. ">Myers 1995</a>; <a href="./references#CD005219-bbs2-0011" title="WilsonJR , ForesmanGH , GamberRG , WrightT . Hyperbaric oxygen in the treatment of migraine with aura. Headache1998;38(2):112‐5. ">Wilson 1998</a>). <a href="./references#CD005219-bbs2-0005" title="FoganL . Treatment of cluster headache. A double‐blind comparison of oxygen v air inhalation. Archives of Neurology1985;42(4):362‐3. ">Fogan 1985</a> had masked cylinders of air or oxygen to maintain blinding to participant and assessor. </p> <p>Inclusion and exclusion criteria varied widely across the trials. Of the migraine trials, three accepted patients with confirmed diagnoses by a neurologist or physician (<a href="./references#CD005219-bbs2-0004" title="FifeCE , MeyerJS , BerryJM , SuttonTE . Hyperbaric oxygen and acute migraine pain: preliminary results of a randomised blinded trial. Undersea Biomedical Research1992;19:106‐7. ">Fife 1992</a>; <a href="./references#CD005219-bbs2-0008" title="MyersDE , MyersRA . A preliminary report on hyperbaric oxygen in the relief of migraine headache. Headache1995;35(4):197‐9. ">Myers 1995</a>; <a href="./references#CD005219-bbs2-0011" title="WilsonJR , ForesmanGH , GamberRG , WrightT . Hyperbaric oxygen in the treatment of migraine with aura. Headache1998;38(2):112‐5. ">Wilson 1998</a>), while <a href="./references#CD005219-bbs2-0003" title="EftedalOS , LydersenS , HeldeG , WhiteL , BrubakkAO , StovnerLJ . A randomised, double blind study of the prophylactic effect of hyperbaric oxygen therapy on migraine. Cephalalgia2004;24(8):639‐44. ">Eftedal 2004</a> and <a href="./references#CD005219-bbs2-0010" title="OzkurtB , CinarO , CevikE , AcarAY , ArslanD , EyiEY , et al. Efficacy of high‐flow oxygen therapy in all types of headache: A prospective, randomized, placebo‐controlled trial. Annals of Emergency Medicine. 2011; Vol. 1:S184. OzkurtB , CinarO , CevikE , AcarAY , ArslanD , EyiEY , et al. Efficacy of high‐flow oxygen therapy in all types of headache: a prospective, randomized, placebo‐controlled trial. American Journal of Emergency Medicine2012;30(9):1760‐4. ">Ozkurt 2012</a> used the criteria of the International Headache Society (<a href="./references#CD005219-bbs2-0050" title="Headache Classification Committee of the International Headache Society. Classification and diagnostic criteria for headache disorders, cranial neuralgias and facial pain. Cephalalgia1988;8 Suppl 7:1‐96. ">IHS 1988</a>) and <a href="./references#CD005219-bbs2-0006" title="HillRK . A blinded, crossover controlled study of the use of hyperbaric oxygen in the treatment of migraine headache. Undersea Biomedical Research1992;19(S):106. ">Hill 1992</a> used the criteria of the Ad Hoc Committee of the National Institute of Neurological Diseases and Blindness (<a href="./references#CD005219-bbs2-0030" title="Ad Hoc Committee on the Classification of Headache of the National Institute of Neurological Diseases and Blindness. Classification of headache. JAMA1962;179(9):717‐8. ">AHC 1962</a>). Of the cluster headache trials, two RCTs used the <a href="./references#CD005219-bbs2-0030" title="Ad Hoc Committee on the Classification of Headache of the National Institute of Neurological Diseases and Blindness. Classification of headache. JAMA1962;179(9):717‐8. ">AHC 1962</a> criteria (<a href="./references#CD005219-bbs2-0002" title="DiSabatoF , FuscoBM , PelaiaP , GiacovazzoM . Hyperbaric oxygen therapy in cluster headache. Pain1993;52(2):243‐5. ">Di Sabato 1993</a>; <a href="./references#CD005219-bbs2-0005" title="FoganL . Treatment of cluster headache. A double‐blind comparison of oxygen v air inhalation. Archives of Neurology1985;42(4):362‐3. ">Fogan 1985</a>), three RCTs used the criteria of the <a href="./references#CD005219-bbs2-0050" title="Headache Classification Committee of the International Headache Society. Classification and diagnostic criteria for headache disorders, cranial neuralgias and facial pain. Cephalalgia1988;8 Suppl 7:1‐96. ">IHS 1988</a> (<a href="./references#CD005219-bbs2-0001" title="CohenAS , BurnsB , GoadsbyPJ . High‐flow oxygen for treatment of cluster headache: a randomized trial. JAMA2009;302(22):2451‐7. ">Cohen 2009</a>; <a href="./references#CD005219-bbs2-0009" title="Nilsson RemahlAI , AnsjonR , LindF , WaldenlindE . Hyperbaric oxygen treatment of active cluster headache: a double‐blind placebo‐controlled cross‐over study. Cephalalgia2002;22(9):730‐9. ">Nilsson Remahl 2002</a>; <a href="./references#CD005219-bbs2-0010" title="OzkurtB , CinarO , CevikE , AcarAY , ArslanD , EyiEY , et al. Efficacy of high‐flow oxygen therapy in all types of headache: A prospective, randomized, placebo‐controlled trial. Annals of Emergency Medicine. 2011; Vol. 1:S184. OzkurtB , CinarO , CevikE , AcarAY , ArslanD , EyiEY , et al. Efficacy of high‐flow oxygen therapy in all types of headache: a prospective, randomized, placebo‐controlled trial. American Journal of Emergency Medicine2012;30(9):1760‐4. ">Ozkurt 2012</a>), and <a href="./references#CD005219-bbs2-0007" title="KudrowL . Response of cluster headache attacks to oxygen inhalation. Headache1981;21(1):1‐4. ">Kudrow 1981</a> did not define the diagnosis. Most trials investigated the efficacy of oxygen for the termination of an acute headache attack, while <a href="./references#CD005219-bbs2-0009" title="Nilsson RemahlAI , AnsjonR , LindF , WaldenlindE . Hyperbaric oxygen treatment of active cluster headache: a double‐blind placebo‐controlled cross‐over study. Cephalalgia2002;22(9):730‐9. ">Nilsson Remahl 2002</a> and <a href="./references#CD005219-bbs2-0003" title="EftedalOS , LydersenS , HeldeG , WhiteL , BrubakkAO , StovnerLJ . A randomised, double blind study of the prophylactic effect of hyperbaric oxygen therapy on migraine. Cephalalgia2004;24(8):639‐44. ">Eftedal 2004</a> were primarily designed to investigate prophylaxis. We have given details of both inclusion and exclusion criteria, where recorded, in the '<a href="./references#CD005219-sec-0183" title="">Characteristics of included studies</a>' table. </p> <p>For most studies, control arms used no specific anti‐headache treatment (other than sham oxygen), except for <a href="./references#CD005219-bbs2-0007" title="KudrowL . Response of cluster headache attacks to oxygen inhalation. Headache1981;21(1):1‐4. ">Kudrow 1981</a> which used sublingual ergotamine tartrate in the control group, and <a href="./references#CD005219-bbs2-0008" title="MyersDE , MyersRA . A preliminary report on hyperbaric oxygen in the relief of migraine headache. Headache1995;35(4):197‐9. ">Myers 1995</a> which used NBOT in the control group. Most trials did not follow participants after the end of the therapy period with the exception of <a href="./references#CD005219-bbs2-0009" title="Nilsson RemahlAI , AnsjonR , LindF , WaldenlindE . Hyperbaric oxygen treatment of active cluster headache: a double‐blind placebo‐controlled cross‐over study. Cephalalgia2002;22(9):730‐9. ">Nilsson Remahl 2002</a> (one week), and both <a href="./references#CD005219-bbs2-0002" title="DiSabatoF , FuscoBM , PelaiaP , GiacovazzoM . Hyperbaric oxygen therapy in cluster headache. Pain1993;52(2):243‐5. ">Di Sabato 1993</a> and <a href="./references#CD005219-bbs2-0003" title="EftedalOS , LydersenS , HeldeG , WhiteL , BrubakkAO , StovnerLJ . A randomised, double blind study of the prophylactic effect of hyperbaric oxygen therapy on migraine. Cephalalgia2004;24(8):639‐44. ">Eftedal 2004</a> (two months). </p> <p>Other outcomes (including non‐clinical) reported included: number of doses of attack‐terminating medicine and plasma endothelin levels (<a href="./references#CD005219-bbs2-0003" title="EftedalOS , LydersenS , HeldeG , WhiteL , BrubakkAO , StovnerLJ . A randomised, double blind study of the prophylactic effect of hyperbaric oxygen therapy on migraine. Cephalalgia2004;24(8):639‐44. ">Eftedal 2004</a>); jugular venous plasma levels of calcitonin gene‐related peptide, vasoactive intestinal peptide, and neuropeptide Y (<a href="./references#CD005219-bbs2-0009" title="Nilsson RemahlAI , AnsjonR , LindF , WaldenlindE . Hyperbaric oxygen treatment of active cluster headache: a double‐blind placebo‐controlled cross‐over study. Cephalalgia2002;22(9):730‐9. ">Nilsson Remahl 2002</a>), length of stay in the emergency department (<a href="./references#CD005219-bbs2-0010" title="OzkurtB , CinarO , CevikE , AcarAY , ArslanD , EyiEY , et al. Efficacy of high‐flow oxygen therapy in all types of headache: A prospective, randomized, placebo‐controlled trial. Annals of Emergency Medicine. 2011; Vol. 1:S184. OzkurtB , CinarO , CevikE , AcarAY , ArslanD , EyiEY , et al. Efficacy of high‐flow oxygen therapy in all types of headache: a prospective, randomized, placebo‐controlled trial. American Journal of Emergency Medicine2012;30(9):1760‐4. ">Ozkurt 2012</a>); and pericranial tenderness with algometry (<a href="./references#CD005219-bbs2-0011" title="WilsonJR , ForesmanGH , GamberRG , WrightT . Hyperbaric oxygen in the treatment of migraine with aura. Headache1998;38(2):112‐5. ">Wilson 1998</a>). </p> </section> <section id="CD005219-sec-0060"> <h4 class="title">Excluded studies</h4> <p>We excluded 18 reports following examination of the full report. We have listed the details of these reports in the <a href="./references#CD005219-sec-0184" title="">Characteristics of excluded studies</a> table. Ten were reviews with no new data, four were non‐random comparative studies, three were case series, and one was a third party report of an included study. </p> </section> </section> <section id="CD005219-sec-0061"> <h3 class="title">Risk of bias in included studies</h3> <p>See the '<a href="./references#CD005219-sec-0183" title="">Characteristics of included studies</a>' table for further details. These trials varied in methodological quality and only eight were full reports of completed trials and available in a peer‐reviewed publication. Two of the included reports were presented as abstracts only (<a href="./references#CD005219-bbs2-0004" title="FifeCE , MeyerJS , BerryJM , SuttonTE . Hyperbaric oxygen and acute migraine pain: preliminary results of a randomised blinded trial. Undersea Biomedical Research1992;19:106‐7. ">Fife 1992</a>; <a href="./references#CD005219-bbs2-0006" title="HillRK . A blinded, crossover controlled study of the use of hyperbaric oxygen in the treatment of migraine headache. Undersea Biomedical Research1992;19(S):106. ">Hill 1992</a>). We have presented the 'Risk of bias' assessments for each included RCT in <a href="#CD005219-fig-0002">Figure 2</a> and <a href="#CD005219-fig-0003">Figure 3</a>. </p> <div class="figure" id="CD005219-fig-0002"> <div class="figure-caption-wrapper-top"> <nav class="inline-nav-list has-dividers"> <ul> <li><a class="open-in-figure-viewer" href="#0">Open in figure viewer</a></li> </ul> </nav> <div class="figure-label">Figure 2</div> </div> <hr class="top"/><img alt="'Risk of bias' graph: each 'Risk of bias' item presented as percentages across all included studies." data-id="CD005219-fig-0002" src="/cdsr/doi/10.1002/14651858.CD005219.pub3/media/CDSR/CD005219/image_n/nCD005219-AFig-FIG02.png"/><hr class="bottom"/> <div class="figure-caption-wrapper-bottom"> <div class="figure-caption"> <p>'Risk of bias' graph: each 'Risk of bias' item presented as percentages across all included studies. </p> </div> </div> </div> <div class="figure" id="CD005219-fig-0003"> <div class="figure-caption-wrapper-top"> <nav class="inline-nav-list has-dividers"> <ul> <li><a class="open-in-figure-viewer" href="#0">Open in figure viewer</a></li> </ul> </nav> <div class="figure-label">Figure 3</div> </div> <hr class="top"/><img alt="'Risk of bias' summary: review authors' judgements about each 'Risk of bias' item for each included study." data-id="CD005219-fig-0003" src="/cdsr/doi/10.1002/14651858.CD005219.pub3/media/CDSR/CD005219/image_n/nCD005219-AFig-FIG03.png"/><hr class="bottom"/> <div class="figure-caption-wrapper-bottom"> <div class="figure-caption"> <p>'Risk of bias' summary: review authors' judgements about each 'Risk of bias' item for each included study. </p> </div> </div> </div> <section id="CD005219-sec-0062"> <h4 class="title">Patient baseline characteristics</h4> <p>Most included trials poorly described patient baseline diagnosis.</p> <section id="CD005219-sec-0063"> <h5 class="title">Migraine</h5> <p>All trials used published diagnostic criteria (either <a href="./references#CD005219-bbs2-0030" title="Ad Hoc Committee on the Classification of Headache of the National Institute of Neurological Diseases and Blindness. Classification of headache. JAMA1962;179(9):717‐8. ">AHC 1962</a> or <a href="./references#CD005219-bbs2-0050" title="Headache Classification Committee of the International Headache Society. Classification and diagnostic criteria for headache disorders, cranial neuralgias and facial pain. Cephalalgia1988;8 Suppl 7:1‐96. ">IHS 1988</a>) or diagnosis by a specific neurologist or physician. <a href="./references#CD005219-bbs2-0011" title="WilsonJR , ForesmanGH , GamberRG , WrightT . Hyperbaric oxygen in the treatment of migraine with aura. Headache1998;38(2):112‐5. ">Wilson 1998</a> accepted only patients at least 18 months from first diagnosis of migraine with aura and <a href="./references#CD005219-bbs2-0003" title="EftedalOS , LydersenS , HeldeG , WhiteL , BrubakkAO , StovnerLJ . A randomised, double blind study of the prophylactic effect of hyperbaric oxygen therapy on migraine. Cephalalgia2004;24(8):639‐44. ">Eftedal 2004</a> required from two to eight attacks per month for the preceding three months. All trials entered patients during acute attacks except <a href="./references#CD005219-bbs2-0003" title="EftedalOS , LydersenS , HeldeG , WhiteL , BrubakkAO , StovnerLJ . A randomised, double blind study of the prophylactic effect of hyperbaric oxygen therapy on migraine. Cephalalgia2004;24(8):639‐44. ">Eftedal 2004</a> where the main outcome was prophylaxis rather than acute headache termination. </p> </section> <section id="CD005219-sec-0064"> <h5 class="title">Cluster</h5> <p>All trials used published diagnostic criteria (either <a href="./references#CD005219-bbs2-0030" title="Ad Hoc Committee on the Classification of Headache of the National Institute of Neurological Diseases and Blindness. Classification of headache. JAMA1962;179(9):717‐8. ">AHC 1962</a> or <a href="./references#CD005219-bbs2-0050" title="Headache Classification Committee of the International Headache Society. Classification and diagnostic criteria for headache disorders, cranial neuralgias and facial pain. Cephalalgia1988;8 Suppl 7:1‐96. ">IHS 1988</a>), except <a href="./references#CD005219-bbs2-0007" title="KudrowL . Response of cluster headache attacks to oxygen inhalation. Headache1981;21(1):1‐4. ">Kudrow 1981</a> who did not define diagnosis. <a href="./references#CD005219-bbs2-0009" title="Nilsson RemahlAI , AnsjonR , LindF , WaldenlindE . Hyperbaric oxygen treatment of active cluster headache: a double‐blind placebo‐controlled cross‐over study. Cephalalgia2002;22(9):730‐9. ">Nilsson Remahl 2002</a> enrolled both episodic and chronic cluster patients who had experienced at least six attacks in the previous week and in whom the cluster was expected to persist for at least four further weeks, <a href="./references#CD005219-bbs2-0002" title="DiSabatoF , FuscoBM , PelaiaP , GiacovazzoM . Hyperbaric oxygen therapy in cluster headache. Pain1993;52(2):243‐5. ">Di Sabato 1993</a> enrolled only episodic cluster patients in the 'florid phase' from day 10 to 15 of their cluster and <a href="./references#CD005219-bbs2-0001" title="CohenAS , BurnsB , GoadsbyPJ . High‐flow oxygen for treatment of cluster headache: a randomized trial. JAMA2009;302(22):2451‐7. ">Cohen 2009</a> enrolled both episodic and chronic cluster patients, while <a href="./references#CD005219-bbs2-0007" title="KudrowL . Response of cluster headache attacks to oxygen inhalation. Headache1981;21(1):1‐4. ">Kudrow 1981</a> and <a href="./references#CD005219-bbs2-0005" title="FoganL . Treatment of cluster headache. A double‐blind comparison of oxygen v air inhalation. Archives of Neurology1985;42(4):362‐3. ">Fogan 1985</a> did not report further baseline details. </p> </section> </section> <section id="CD005219-sec-0065"> <h4 class="title">Allocation</h4> <p>Allocation concealment was inadequate in one RCT (<a href="./references#CD005219-bbs2-0002" title="DiSabatoF , FuscoBM , PelaiaP , GiacovazzoM . Hyperbaric oxygen therapy in cluster headache. Pain1993;52(2):243‐5. ">Di Sabato 1993</a>), clearly indicated in three RCTs (<a href="./references#CD005219-bbs2-0005" title="FoganL . Treatment of cluster headache. A double‐blind comparison of oxygen v air inhalation. Archives of Neurology1985;42(4):362‐3. ">Fogan 1985</a>; <a href="./references#CD005219-bbs2-0010" title="OzkurtB , CinarO , CevikE , AcarAY , ArslanD , EyiEY , et al. Efficacy of high‐flow oxygen therapy in all types of headache: A prospective, randomized, placebo‐controlled trial. Annals of Emergency Medicine. 2011; Vol. 1:S184. OzkurtB , CinarO , CevikE , AcarAY , ArslanD , EyiEY , et al. Efficacy of high‐flow oxygen therapy in all types of headache: a prospective, randomized, placebo‐controlled trial. American Journal of Emergency Medicine2012;30(9):1760‐4. ">Ozkurt 2012</a>; <a href="./references#CD005219-bbs2-0011" title="WilsonJR , ForesmanGH , GamberRG , WrightT . Hyperbaric oxygen in the treatment of migraine with aura. Headache1998;38(2):112‐5. ">Wilson 1998</a>), and unclear in the remaining studies. <a href="./references#CD005219-bbs2-0001" title="CohenAS , BurnsB , GoadsbyPJ . High‐flow oxygen for treatment of cluster headache: a randomized trial. JAMA2009;302(22):2451‐7. ">Cohen 2009</a> and <a href="./references#CD005219-bbs2-0010" title="OzkurtB , CinarO , CevikE , AcarAY , ArslanD , EyiEY , et al. Efficacy of high‐flow oxygen therapy in all types of headache: A prospective, randomized, placebo‐controlled trial. Annals of Emergency Medicine. 2011; Vol. 1:S184. OzkurtB , CinarO , CevikE , AcarAY , ArslanD , EyiEY , et al. Efficacy of high‐flow oxygen therapy in all types of headache: a prospective, randomized, placebo‐controlled trial. American Journal of Emergency Medicine2012;30(9):1760‐4. ">Ozkurt 2012</a> described the randomisation procedure, but the remaining studies gave no details. <a href="./references#CD005219-bbs2-0002" title="DiSabatoF , FuscoBM , PelaiaP , GiacovazzoM . Hyperbaric oxygen therapy in cluster headache. Pain1993;52(2):243‐5. ">Di Sabato 1993</a> did not specifically use the term 'randomisation' and this trial may not have been truly randomised. Sensitivity analyses with and without this trial were considered during analysis. There is not a clear indication for any of the included trials that the trial authors were unable to predict the prospective group to which a participant would be allocated. </p> <p><a href="./references#CD005219-bbs2-0006" title="HillRK . A blinded, crossover controlled study of the use of hyperbaric oxygen in the treatment of migraine headache. Undersea Biomedical Research1992;19(S):106. ">Hill 1992</a> was a cross‐over design where the cross‐over occurred after a five‐minute period breathing air at 2.0 ATA. As any individual with relief from the first treatment period could not receive further relief during the second, we accepted only the response to the initial treatment period into this review. In general, the cross‐over trials were poorly reported and we could only extract data for <a href="./references#CD005219-bbs2-0005" title="FoganL . Treatment of cluster headache. A double‐blind comparison of oxygen v air inhalation. Archives of Neurology1985;42(4):362‐3. ">Fogan 1985</a> on the response of each individual to both study arms. </p> </section> <section id="CD005219-sec-0066"> <h4 class="title">Blinding</h4> <p>All trials blinded the outcome assessor to therapy except <a href="./references#CD005219-bbs2-0007" title="KudrowL . Response of cluster headache attacks to oxygen inhalation. Headache1981;21(1):1‐4. ">Kudrow 1981</a> (no blinding). <a href="./references#CD005219-bbs2-0002" title="DiSabatoF , FuscoBM , PelaiaP , GiacovazzoM . Hyperbaric oxygen therapy in cluster headache. Pain1993;52(2):243‐5. ">Di Sabato 1993</a> and <a href="./references#CD005219-bbs2-0008" title="MyersDE , MyersRA . A preliminary report on hyperbaric oxygen in the relief of migraine headache. Headache1995;35(4):197‐9. ">Myers 1995</a> blinded the assessor only, while all other trials blinded participants, investigators, and assessors. All trials provided a sham therapy except <a href="./references#CD005219-bbs2-0007" title="KudrowL . Response of cluster headache attacks to oxygen inhalation. Headache1981;21(1):1‐4. ">Kudrow 1981</a>, who provided a sublingual preparation as the comparator therapy. </p> </section> <section id="CD005219-sec-0067"> <h4 class="title">Incomplete outcome data</h4> <p>One participant was lost to final follow‐up in the control group of <a href="./references#CD005219-bbs2-0003" title="EftedalOS , LydersenS , HeldeG , WhiteL , BrubakkAO , StovnerLJ . A randomised, double blind study of the prophylactic effect of hyperbaric oxygen therapy on migraine. Cephalalgia2004;24(8):639‐44. ">Eftedal 2004</a>. Six participants were enrolled but did not complete therapy and were not analysed (one hyperbaric and five control): one suffered a technical problem with the chamber and could not be treated, two withdrew because of claustrophobia, one withdrew with a respiratory tract infection, one had a pathological chest X‐ray, and the final participant withdrew for unknown reasons. Some participants failed to cross for the second arm of therapy in five included trials (<a href="./references#CD005219-bbs2-0001" title="CohenAS , BurnsB , GoadsbyPJ . High‐flow oxygen for treatment of cluster headache: a randomized trial. JAMA2009;302(22):2451‐7. ">Cohen 2009</a>; <a href="./references#CD005219-bbs2-0004" title="FifeCE , MeyerJS , BerryJM , SuttonTE . Hyperbaric oxygen and acute migraine pain: preliminary results of a randomised blinded trial. Undersea Biomedical Research1992;19:106‐7. ">Fife 1992</a>; <a href="./references#CD005219-bbs2-0005" title="FoganL . Treatment of cluster headache. A double‐blind comparison of oxygen v air inhalation. Archives of Neurology1985;42(4):362‐3. ">Fogan 1985</a>; <a href="./references#CD005219-bbs2-0006" title="HillRK . A blinded, crossover controlled study of the use of hyperbaric oxygen in the treatment of migraine headache. Undersea Biomedical Research1992;19(S):106. ">Hill 1992</a>; <a href="./references#CD005219-bbs2-0007" title="KudrowL . Response of cluster headache attacks to oxygen inhalation. Headache1981;21(1):1‐4. ">Kudrow 1981</a>) and this accounts for the uneven numbers of participants in the different therapy arms of those trials. Cohen enrolled 109 participants but 33 dropped out (17 came out of the headache, nine were lost to follow‐up, six withdrew from the study, and one died). None of the remaining studies suffered any losses to follow‐up, or reported any violation of allocated treatment. </p> <p>Most trials delivered the intended therapy and analysed by ITT. No data were generated or analysed where participants withdrew from the study before therapy was delivered or where an individual failed to cross and receive the alternative therapy. <a href="./references#CD005219-bbs2-0003" title="EftedalOS , LydersenS , HeldeG , WhiteL , BrubakkAO , StovnerLJ . A randomised, double blind study of the prophylactic effect of hyperbaric oxygen therapy on migraine. Cephalalgia2004;24(8):639‐44. ">Eftedal 2004</a> supplied the raw data to allow ITT analysis for the missing participant in the control group. </p> </section> <section id="CD005219-sec-0068"> <h4 class="title">Selective reporting</h4> <p>There was little evidence of any selective reporting of pre‐determined outcomes, mainly because there was no evidence of trial registration for all included trials except <a href="./references#CD005219-bbs2-0001" title="CohenAS , BurnsB , GoadsbyPJ . High‐flow oxygen for treatment of cluster headache: a randomized trial. JAMA2009;302(22):2451‐7. ">Cohen 2009</a>. We included this trial in the qualitative review only. The trial authors indicated an intention to report the proportion of participants pain free after 15 minutes of treatment comparing oxygen and air, but actually reported the proportion of attacks treated that had responded. </p> </section> <section id="CD005219-sec-0069"> <h4 class="title">Other potential sources of bias</h4> <p>There was no indication of other potential sources of bias in the included trials.</p> </section> </section> <section id="CD005219-sec-0070"> <h3 class="title" id="CD005219-sec-0070">Effects of interventions</h3> <p>See: <a href="./full#CD005219-tbl-0001"><b>Summary of findings for the main comparison</b> Hyperbaric oxygen therapy for acute migraine</a> </p> <section id="CD005219-sec-0071"> <h4 class="title">Migraine</h4> <section id="CD005219-sec-0072"> <h5 class="title">HBOT for an acute attack</h5> <section id="CD005219-sec-0073"> <h6 class="title">Primary outcomes</h6> <section id="CD005219-sec-0074"> <p><b>1. Proportion of participant with pain‐free response (complete resolution of headache pain)</b></p> <p>No trials specifically reported on complete resolution of headache. Three trials reported the proportion of participants with resolution or significant relief of migraine with 40 to 45 minutes of HBOT (<a href="./references#CD005219-bbs2-0004" title="FifeCE , MeyerJS , BerryJM , SuttonTE . Hyperbaric oxygen and acute migraine pain: preliminary results of a randomised blinded trial. Undersea Biomedical Research1992;19:106‐7. ">Fife 1992</a>; <a href="./references#CD005219-bbs2-0006" title="HillRK . A blinded, crossover controlled study of the use of hyperbaric oxygen in the treatment of migraine headache. Undersea Biomedical Research1992;19(S):106. ">Hill 1992</a>; <a href="./references#CD005219-bbs2-0008" title="MyersDE , MyersRA . A preliminary report on hyperbaric oxygen in the relief of migraine headache. Headache1995;35(4):197‐9. ">Myers 1995</a>). These studies involved a total of 58 participants receiving 56 occasions of therapy (29 HBOT versus 27 sham). Two were of cross‐over design, and in these, following initial group assignment, cross‐over was undertaken at five minutes (<a href="./references#CD005219-bbs2-0006" title="HillRK . A blinded, crossover controlled study of the use of hyperbaric oxygen in the treatment of migraine headache. Undersea Biomedical Research1992;19(S):106. ">Hill 1992</a>) and 30 minutes (<a href="./references#CD005219-bbs2-0004" title="FifeCE , MeyerJS , BerryJM , SuttonTE . Hyperbaric oxygen and acute migraine pain: preliminary results of a randomised blinded trial. Undersea Biomedical Research1992;19:106‐7. ">Fife 1992</a>). Individual participant responses to each arm were not reported in <a href="./references#CD005219-bbs2-0006" title="HillRK . A blinded, crossover controlled study of the use of hyperbaric oxygen in the treatment of migraine headache. Undersea Biomedical Research1992;19(S):106. ">Hill 1992</a>, nor were any cross‐over effects reported in either trial. Our detailed approach to data extraction is indicated in <a href="./appendices#CD005219-sec-0167">Appendix 2</a>. There was a statistically significant increase in the proportion of participants with substantial relief of headache with HBOT (RR 6.21, 95% CI 2.41 to 16.00; I² statistic = 40%; <a href="./references#CD005219-fig-0005" title="">Analysis 1.1</a>; <a href="#CD005219-fig-0004">Figure 4</a>). We investigated the evidence of moderate heterogeneity by subgroup analysis by comparator therapy. There was no evidence of a substantially different effect when HBOT was compared to air or 100% normobaric oxygen (administered as an HBOT sham). The absolute risk difference of 0.72 between sham and HBOT suggests the number needed to treat for an additional beneficial outcome (NNTB) to achieve one extra case of relieved headache is two (95% CI 1 to 2). <a href="./references#CD005219-bbs2-0008" title="MyersDE , MyersRA . A preliminary report on hyperbaric oxygen in the relief of migraine headache. Headache1995;35(4):197‐9. ">Myers 1995</a> compared HBOT with NBOT (administered as an HBOT sham). With subgroup analysis by comparator therapy on the grounds of clinical heterogeneity, <a href="./references#CD005219-bbs2-0008" title="MyersDE , MyersRA . A preliminary report on hyperbaric oxygen in the relief of migraine headache. Headache1995;35(4):197‐9. ">Myers 1995</a> reported a similar magnitude of effect to the other two trials, and did not account for the heterogeneity between trials. There were no data reported for longer term outcomes. </p> <div class="figure" id="CD005219-fig-0004"> <div class="figure-caption-wrapper-top"> <nav class="inline-nav-list has-dividers"> <ul> <li><a class="open-in-figure-viewer" href="#0">Open in figure viewer</a></li> </ul> </nav> <div class="figure-label">Figure 4</div> </div> <hr class="top"/><img alt="Forest plot of comparison: 1 HBOT versus control for acute migraine attack, outcome: 1.1 Substantial acute relief of headache." data-id="CD005219-fig-0004" src="/cdsr/doi/10.1002/14651858.CD005219.pub3/media/CDSR/CD005219/image_n/nCD005219-AFig-FIG04.png"/><hr class="bottom"/> <div class="figure-caption-wrapper-bottom"> <div class="figure-caption"> <p>Forest plot of comparison: 1 HBOT versus control for acute migraine attack, outcome: 1.1 Substantial acute relief of headache. </p> </div> </div> </div> <p>The evidence for this outcome was of low quality (see <a href="./full#CD005219-tbl-0001">summary of findings Table for the main comparison</a>). </p> </section> <section id="CD005219-sec-0075"> <p><b>2. Proportion of participants with headache pain reduction from moderate/severe to mild or none</b></p> <p>No trials reported this outcome.</p> </section> <section id="CD005219-sec-0076"> <p><b>3. Proportion of participants with sustained relief for 24 hours</b></p> <p>No trials reported this outcome.</p> </section> </section> <section id="CD005219-sec-0077"> <h6 class="title">Secondary outcomes</h6> <section id="CD005219-sec-0078"> <p><b>1. Degree of headache relief or headache intensity</b></p> <p>Only <a href="./references#CD005219-bbs2-0011" title="WilsonJR , ForesmanGH , GamberRG , WrightT . Hyperbaric oxygen in the treatment of migraine with aura. Headache1998;38(2):112‐5. ">Wilson 1998</a> reported on this outcome (immediately following therapy), enrolling eight participants in a cross‐over study of NBOT versus HBOT. The cross‐over was made when the individual participant presented for treatment of a second headache. Pain intensity on a visual analogue scale of 0 (no pain) to 10 (worst pain) was significantly lower following HBOT (7.9 Standard Deviation (SD) 0.64 pre‐treatment versus 3.5 SD 1.34 after treatment, P = 0.03), but not when receiving NBOT (6.5 SD 0.87 pre‐treatment versus 6.3 SD 1.75, P = 0.99 after treatment). </p> </section> <section id="CD005219-sec-0079"> <p><b>2. Functional status or disability</b></p> <p>No trials reported this outcome.</p> </section> <section id="CD005219-sec-0080"> <p><b>3. Pain‐free response at four hours for migraine and two hours for cluster headache</b></p> <p>No trials reported this outcome.</p> </section> <section id="CD005219-sec-0081"> <p><b>4. Proportion of participants requiring rescue medication</b></p> <p>No trials reported this outcome.</p> </section> <section id="CD005219-sec-0082"> <p><b>5. Proportion of participants with sustained relief for 48 hours</b></p> <p>No trials reported this outcome.</p> </section> <section id="CD005219-sec-0083"> <p><b>6. Proportion of participants with photophobia or phonophobia</b></p> <p>No trials reported this outcome.</p> </section> <section id="CD005219-sec-0084"> <p><b>7. Proportion of participants with nausea and/or vomiting, after therapy</b></p> <p>No trials reported this outcome.</p> </section> </section> </section> <section id="CD005219-sec-0085"> <h5 class="title">HBOT for prevention of attacks</h5> <section id="CD005219-sec-0086"> <h6 class="title">Primary outcome</h6> <section id="CD005219-sec-0087"> <p><b>1. Frequency of attacks</b></p> <p>No trials reported this outcome.</p> </section> <section id="CD005219-sec-0088"> <p><b>2. Number of days with headache in the week after therapy</b></p> <p>Only <a href="./references#CD005219-bbs2-0003" title="EftedalOS , LydersenS , HeldeG , WhiteL , BrubakkAO , StovnerLJ . A randomised, double blind study of the prophylactic effect of hyperbaric oxygen therapy on migraine. Cephalalgia2004;24(8):639‐44. ">Eftedal 2004</a> reported on this outcome, enrolling 40 participants (20 HBOT, 20 sham). There was no statistically significant difference in the mean number of days with headaches for the first week after therapy (HBOT 3.0 SD 1.63 versus sham 2.87 SD 2.07), nor during the fourth week (HBOT 2.52 SD 1.78 versus sham 2.27 SD 1.94). P values were not given in the report. </p> </section> <section id="CD005219-sec-0089"> <p><b>3. Days lost to work</b></p> <p>No trials reported this outcome.</p> </section> </section> <section id="CD005219-sec-0090"> <h6 class="title">Secondary outcomes</h6> <section id="CD005219-sec-0091"> <p><b>1. Self‐reported assessment of success</b></p> <p>No trials reported this outcome.</p> </section> <section id="CD005219-sec-0092"> <p><b>2. Frequency of attacks rated by participant as 'severe'</b></p> <p>No trials reported this outcome.</p> </section> <section id="CD005219-sec-0093"> <p><b>3. Quality of life</b></p> <p>No trials reported this outcome.</p> </section> <section id="CD005219-sec-0094"> <p><b>4. Functional status or disability</b></p> <p>No trials reported this outcome.</p> </section> <section id="CD005219-sec-0095"> <p><b>5. Headache index</b></p> <p>No trials reported this outcome.</p> </section> <section id="CD005219-sec-0096"> <p><b>6. Proportion of participants requiring rescue medication</b></p> <p>Only <a href="./references#CD005219-bbs2-0003" title="EftedalOS , LydersenS , HeldeG , WhiteL , BrubakkAO , StovnerLJ . A randomised, double blind study of the prophylactic effect of hyperbaric oxygen therapy on migraine. Cephalalgia2004;24(8):639‐44. ">Eftedal 2004</a> reported on this outcome, enrolling 40 participants (20 HBOT, 20 sham). There was no statistically significant reduction in the proportion of participants requiring rescue medication after being given HBO as a prophylaxis. Most participants who were followed‐up required therapy at week 1, 4, and 8 after the intervention (e.g. at week 1: 18 of 19 for the HBOT group versus 12 of 15 for the sham therapy required some rescue medication; no P ‐values were given; RR 0.84, 95% CI 0.64 to 1.11; P = 0.23). The best case scenario for the allocation of withdrawals did not alter this finding (RR 0.94, 95% CI 0.75 to 1.19; P = 0.63); however, on a worst case scenario the risk of requiring rescue medication was significantly lower with sham (RR 0.63, 95% CI 0.44 to 0.92; P = 0.02). </p> </section> <section id="CD005219-sec-0097"> <p><b>7. Proportion of participants with nausea and vomiting after therapy</b></p> <p>Only <a href="./references#CD005219-bbs2-0003" title="EftedalOS , LydersenS , HeldeG , WhiteL , BrubakkAO , StovnerLJ . A randomised, double blind study of the prophylactic effect of hyperbaric oxygen therapy on migraine. Cephalalgia2004;24(8):639‐44. ">Eftedal 2004</a> reported on this outcome, enrolling 40 participants (20 HBOT, 20 sham). There was no statistically significant reduction in the proportion of participants suffering nausea with or without vomiting after being given HBO as a prophylaxis. Roughly half of the participants reported nausea with or without vomiting at week 1, 4, and 8 after the intervention (e.g. at week 1: 9 of 19 for the HBOT group versus 9 of 15 for the sham therapy. No P values were given). </p> </section> </section> </section> <section id="CD005219-sec-0098"> <h5 class="title">NBOT for an acute attack</h5> <section id="CD005219-sec-0099"> <h6 class="title">Primary outcomes</h6> <section id="CD005219-sec-0100"> <p><b>1. Proportion of participants with pain‐free response (complete resolution of headache pain)</b></p> <p>No trials reported this outcome</p> </section> <section id="CD005219-sec-0101"> <p><b>2. Proportion of participants with headache pain reduction from moderate/severe to mild or none</b></p> <p>No trials reported this outcome</p> </section> <section id="CD005219-sec-0102"> <p><b>3. Proportion of participants with sustained relief for 24 hours</b></p> <p>No trials reported this outcome</p> </section> </section> <section id="CD005219-sec-0103"> <h6 class="title">Secondary outcomes</h6> <section id="CD005219-sec-0104"> <p><b>1. Degree of headache relief or headache intensity</b></p> <p>Only <a href="./references#CD005219-bbs2-0010" title="OzkurtB , CinarO , CevikE , AcarAY , ArslanD , EyiEY , et al. Efficacy of high‐flow oxygen therapy in all types of headache: A prospective, randomized, placebo‐controlled trial. Annals of Emergency Medicine. 2011; Vol. 1:S184. OzkurtB , CinarO , CevikE , AcarAY , ArslanD , EyiEY , et al. Efficacy of high‐flow oxygen therapy in all types of headache: a prospective, randomized, placebo‐controlled trial. American Journal of Emergency Medicine2012;30(9):1760‐4. ">Ozkurt 2012</a> reported on this outcome, enrolling 56 participants (27 HBOT, 29 sham). There was a significant reduction in the intensity of pain recorded on a VAS (0 ‐ 100) at one hour after administration of 15 minutes of 100% oxygen at 15 litres per minute versus air on the same schedule. Mean pain intensity score in the sham group was 30 (SD 14) versus 17 (SD 14) in the NBOT group, 13 points lower in the NBOT group, 95% CI ‐5.5 to ‐20.5). </p> <p>(<a href="./references#CD005219-bbs2-0008" title="MyersDE , MyersRA . A preliminary report on hyperbaric oxygen in the relief of migraine headache. Headache1995;35(4):197‐9. ">Myers 1995</a> used NBOT (administered as an HBOT sham) as the comparator intervention for a trial of HBOT; see <a href="./references#CD005219-fig-0005" title="">Analysis 1.1</a>, above.) </p> </section> <section id="CD005219-sec-0105"> <p><b>2. Functional status or disability</b></p> <p>No trials reported this outcome.</p> </section> <section id="CD005219-sec-0106"> <p><b>3. Pain‐free response at four hours for migraine and two hours for cluster headache</b></p> <p>No trials reported this outcome.</p> </section> <section id="CD005219-sec-0107"> <p><b>4. Proportion of participants requiring rescue medication</b></p> <p>No trials reported this outcome.</p> </section> <section id="CD005219-sec-0108"> <p><b>5. Proportion of participants with sustained relief for 48 hours</b></p> <p>No trials reported this outcome.</p> </section> <section id="CD005219-sec-0109"> <p><b>6. Proportion of participants with photophobia or phonophobia</b></p> <p>No trials reported this outcome.</p> </section> <section id="CD005219-sec-0110"> <p><b>7. Proportion of participants with nausea and/or vomiting, after therapy</b></p> <p>No trials reported this outcome.</p> </section> </section> </section> <section id="CD005219-sec-0111"> <h5 class="title">NBOT for prevention of attacks</h5> <p>No trials studied the use of NBOT for prevention of attacks.</p> </section> <section id="CD005219-sec-0112"> <h5 class="title">Adverse events</h5> <p><a href="./references#CD005219-bbs2-0008" title="MyersDE , MyersRA . A preliminary report on hyperbaric oxygen in the relief of migraine headache. Headache1995;35(4):197‐9. ">Myers 1995</a> noted that "no untoward effects were reported". <a href="./references#CD005219-bbs2-0003" title="EftedalOS , LydersenS , HeldeG , WhiteL , BrubakkAO , StovnerLJ . A randomised, double blind study of the prophylactic effect of hyperbaric oxygen therapy on migraine. Cephalalgia2004;24(8):639‐44. ">Eftedal 2004</a> reported that following enrolment, two participants refused to complete therapy due to claustrophobia, one developed an upper respiratory chest infection and was withdrawn by the trial investigators and a further participant was withdrawn following a pathological chest X‐ray. No other trials made any reference to adverse events. </p> </section> </section> <section id="CD005219-sec-0113"> <h4 class="title">Cluster headache</h4> <section id="CD005219-sec-0114"> <h5 class="title">HBOT for an acute attack</h5> <section id="CD005219-sec-0115"> <h6 class="title">Primary outcomes</h6> <section id="CD005219-sec-0116"> <p><b>1. Proportion of participant with pain‐free response (complete resolution of headache pain)</b></p> <p>Only one small trial reported on the use of HBOT to relieve cluster headache (<a href="./references#CD005219-bbs2-0002" title="DiSabatoF , FuscoBM , PelaiaP , GiacovazzoM . Hyperbaric oxygen therapy in cluster headache. Pain1993;52(2):243‐5. ">Di Sabato 1993</a>). This trial enrolled 13 participants and reported the proportion achieving complete resolution within 20 minutes (six of seven (86%) with HBOT versus none of six with sham). No measure of statistical significance was given in the report. </p> </section> <section id="CD005219-sec-0117"> <p><b>2. Proportion of participants with headache pain reduction from moderate/severe to mild or none</b></p> <p>No trials reported this outcome</p> </section> <section id="CD005219-sec-0118"> <p><b>3. Proportion of participants with sustained relief for 24 hours</b></p> <p>No trials reported this outcome</p> </section> </section> <section id="CD005219-sec-0119"> <h6 class="title">Secondary outcomes</h6> <section id="CD005219-sec-0120"> <p><b>1. Degree of headache relief or headache intensity</b></p> <p>No trial reported this outcome.</p> </section> <section id="CD005219-sec-0121"> <p><b>2. Functional status or disability.</b></p> <p>No trials reported this outcome.</p> </section> <section id="CD005219-sec-0122"> <p><b>3. Pain‐free response at four hours for migraine and two hours for cluster headache</b></p> <p>No trials reported this outcome.</p> </section> <section id="CD005219-sec-0123"> <p><b>4. Proportion of participants requiring rescue medication</b></p> <p>No trials reported this outcome.</p> </section> <section id="CD005219-sec-0124"> <p><b>5. Proportion of participants with sustained relief for 48 hours</b></p> <p>Only one small trial reported on this outcome following HBOT (<a href="./references#CD005219-bbs2-0002" title="DiSabatoF , FuscoBM , PelaiaP , GiacovazzoM . Hyperbaric oxygen therapy in cluster headache. Pain1993;52(2):243‐5. ">Di Sabato 1993</a>). This trial enrolled 13 participants and reported the proportion achieving sustained resolution for at least 48 hours (six of seven (86%) with HBOT versus none of six with sham). No measure of statistical significance was given in the report. </p> </section> </section> </section> <section id="CD005219-sec-0125"> <h5 class="title">HBOT for prevention of attacks</h5> <section id="CD005219-sec-0126"> <h6 class="title">Primary outcomes</h6> <section id="CD005219-sec-0127"> <p><b>1. Frequency of attacks</b></p> <p>No trials reported this outcome.</p> </section> <section id="CD005219-sec-0128"> <p><b>2. Number of days with headache in the week after therapy</b></p> <p>No trials reported this outcome.</p> </section> <section id="CD005219-sec-0129"> <p><b>3. Days lost to work.</b></p> <p>No trials reported this outcome.</p> </section> </section> <section id="CD005219-sec-0130"> <h6 class="title">Secondary outcomes</h6> <section id="CD005219-sec-0131"> <p><b>1. Self‐reported assessment of treatment success</b></p> <p>No trials reported this outcome.</p> </section> <section id="CD005219-sec-0132"> <p><b>2. Frequency of attacks rated by participant as 'severe'</b></p> <p>No trials reported this outcome.</p> </section> <section id="CD005219-sec-0133"> <p><b>3. Quality of life</b></p> <p>No trials reported this outcome.</p> </section> <section id="CD005219-sec-0134"> <p><b>4. Functional status or disability</b></p> <p>No trials reported this outcome.</p> </section> <section id="CD005219-sec-0135"> <p><b>5. Headache index</b></p> <p>One trial reported on this outcome and enrolled 16 participants in a cross‐over design comparing HBOT with a sham therapy (<a href="./references#CD005219-bbs2-0009" title="Nilsson RemahlAI , AnsjonR , LindF , WaldenlindE . Hyperbaric oxygen treatment of active cluster headache: a double‐blind placebo‐controlled cross‐over study. Cephalalgia2002;22(9):730‐9. ">Nilsson Remahl 2002</a>). Twelve participants were defined as having episodic cluster headaches, while four were classified as having chronic cluster headache. Each headache was scored on a scale of 0 to 4 and the headache index (HI) was defined over a week as the sum of the number of headaches multiplied by severity on each occasion (for example, a week with two headaches scoring 3 and one headache scoring 4 would have a headache index of (2 x 3) + (1 x 4) = 10). Treatment was regarded as effective if the HI was reduced by 50% or more in the week following therapy compared to the week before therapy. Individual participant responses to each therapy were not reported. Overall, treatment was effective in five of 14 participants (36%) receiving HBOT versus six of 16 (38%) receiving sham. There was no advantage for sham or HBOT. </p> </section> <section id="CD005219-sec-0136"> <p><b>6. Proportion of participants requiring rescue medication</b></p> <p>No trials reported this outcome.</p> </section> </section> </section> <section id="CD005219-sec-0137"> <h5 class="title">NBOT for an acute attack</h5> <section id="CD005219-sec-0138"> <h6 class="title">Primary outcomes</h6> <section id="CD005219-sec-0139"> <p><b>1. Proportion of participant with pain‐free response (complete resolution of headache pain)</b></p> <p>Three cross‐over trials reported the proportion of participants responding to the administration of NBOT versus control (<a href="./references#CD005219-bbs2-0001" title="CohenAS , BurnsB , GoadsbyPJ . High‐flow oxygen for treatment of cluster headache: a randomized trial. JAMA2009;302(22):2451‐7. ">Cohen 2009</a>; <a href="./references#CD005219-bbs2-0005" title="FoganL . Treatment of cluster headache. A double‐blind comparison of oxygen v air inhalation. Archives of Neurology1985;42(4):362‐3. ">Fogan 1985</a>; <a href="./references#CD005219-bbs2-0007" title="KudrowL . Response of cluster headache attacks to oxygen inhalation. Headache1981;21(1):1‐4. ">Kudrow 1981</a>). <a href="./references#CD005219-bbs2-0007" title="KudrowL . Response of cluster headache attacks to oxygen inhalation. Headache1981;21(1):1‐4. ">Kudrow 1981</a> used a control of subcutaneous ergotamine tartrate and defined successful response to treatment as "complete or almost complete reduction of pain in seven of ten attacks, within 15 minutes", while <a href="./references#CD005219-bbs2-0005" title="FoganL . Treatment of cluster headache. A double‐blind comparison of oxygen v air inhalation. Archives of Neurology1985;42(4):362‐3. ">Fogan 1985</a> and <a href="./references#CD005219-bbs2-0001" title="CohenAS , BurnsB , GoadsbyPJ . High‐flow oxygen for treatment of cluster headache: a randomized trial. JAMA2009;302(22):2451‐7. ">Cohen 2009</a> compared NBOT to air. <a href="./references#CD005219-bbs2-0005" title="FoganL . Treatment of cluster headache. A double‐blind comparison of oxygen v air inhalation. Archives of Neurology1985;42(4):362‐3. ">Fogan 1985</a> reported the mean relief score (0 = no relief to 3 = complete relief) obtained from between one and 10 episodes of treatment with each of NBOT and air. <a href="./references#CD005219-bbs2-0001" title="CohenAS , BurnsB , GoadsbyPJ . High‐flow oxygen for treatment of cluster headache: a randomized trial. JAMA2009;302(22):2451‐7. ">Cohen 2009</a> reported the number of attacks that were successfully treated and enrolled 109 participants of whom 76 were analysed for a total of 298 cluster episodes. These trials together enrolled a total of 178 participants, with <a href="./references#CD005219-bbs2-0007" title="KudrowL . Response of cluster headache attacks to oxygen inhalation. Headache1981;21(1):1‐4. ">Kudrow 1981</a> enrolling 50 and <a href="./references#CD005219-bbs2-0005" title="FoganL . Treatment of cluster headache. A double‐blind comparison of oxygen v air inhalation. Archives of Neurology1985;42(4):362‐3. ">Fogan 1985</a> enrolling 19. <a href="./references#CD005219-bbs2-0005" title="FoganL . Treatment of cluster headache. A double‐blind comparison of oxygen v air inhalation. Archives of Neurology1985;42(4):362‐3. ">Fogan 1985</a> reported individual participant responses and an overall mean response, while <a href="./references#CD005219-bbs2-0007" title="KudrowL . Response of cluster headache attacks to oxygen inhalation. Headache1981;21(1):1‐4. ">Kudrow 1981</a> reported the proportion of participants and <a href="./references#CD005219-bbs2-0001" title="CohenAS , BurnsB , GoadsbyPJ . High‐flow oxygen for treatment of cluster headache: a randomized trial. JAMA2009;302(22):2451‐7. ">Cohen 2009</a> the proportion of attacks responding to treatment. Given the clear clinical and reporting heterogeneity we did not pool the results. </p> <p>The two trials using air as the comparator reported a better outcome following NBOT versus control. <a href="./references#CD005219-bbs2-0001" title="CohenAS , BurnsB , GoadsbyPJ . High‐flow oxygen for treatment of cluster headache: a randomized trial. JAMA2009;302(22):2451‐7. ">Cohen 2009</a> reported a statistically significant difference in the proportion of attacks successfully treated with oxygen. Of 150 attacks, 117 were successfully treated with NBOT (78%, 95% CI 71% to 85%) versus 30 of 148 attacks treated with NBOT (20%, 95% CI 17% to 24%). <a href="./references#CD005219-bbs2-0005" title="FoganL . Treatment of cluster headache. A double‐blind comparison of oxygen v air inhalation. Archives of Neurology1985;42(4):362‐3. ">Fogan 1985</a> reported a significantly increased chance of benefit from NBOT. Three participants did not have any headaches treated with NBOT, while five different individuals did not have any headaches treated with air. Nine of 16 participants (56%) versus one of 14 (7%) reported complete relief or significant reduction in headache intensity (defined as a mean relief score of ≥ 2, that is, where the mean score was at least rated as 'significant relief') and this result suggests an NNT of 2 (95% CI 1 to 5) to obtain this outcome with NBOT. <a href="./references#CD005219-bbs2-0007" title="KudrowL . Response of cluster headache attacks to oxygen inhalation. Headache1981;21(1):1‐4. ">Kudrow 1981</a> reported a successful response in 41 of 50 participants with NBOT (82%) versus 35 of 50 participants with ergotamine (70%), but this difference was not statistically significant. </p> </section> <section id="CD005219-sec-0140"> <p><b>2. Proportion of participants with headache pain reduction from moderate/severe to mild or none</b></p> <p>No trials reported this outcome.</p> </section> <section id="CD005219-sec-0141"> <p><b>3. Proportion of participants with sustained relief for 24 hours</b></p> <p>No trials reported this outcome.</p> </section> </section> <section id="CD005219-sec-0142"> <h6 class="title">Secondary outcomes</h6> <section id="CD005219-sec-0143"> <p><b>1. Degree of headache relief or headache intensity</b></p> <p>One trial reported the pain intensity score following treatment with NBOT versus sham (air) and enrolled 19 participants in a cross‐over design where 16 received NBOT and 14 sham (<a href="./references#CD005219-bbs2-0005" title="FoganL . Treatment of cluster headache. A double‐blind comparison of oxygen v air inhalation. Archives of Neurology1985;42(4):362‐3. ">Fogan 1985</a>). Relief was measured on a scale of 0 (no relief) to 3 (complete relief). After NBOT administration, participants rated their degree of relief at 1.93 Standard Error (SE) 0.22 and after air at 0.77, SE 0.23, and this was reported as statistically significant (P &lt; 0.01). </p> </section> <section id="CD005219-sec-0144"> <p><b>2. Functional status or disability</b></p> <p>No trials reported this outcome.</p> </section> <section id="CD005219-sec-0145"> <p><b>3. Pain‐free response at four hours for migraine and two hours for cluster headache</b></p> <p>No trials reported this outcome.</p> </section> <section id="CD005219-sec-0146"> <p><b>4. Proportion of participants requiring rescue medication</b></p> <p>No trials reported this outcome.</p> </section> <section id="CD005219-sec-0147"> <p><b>5. Proportion of participants with sustained relief for 48 hours</b></p> <p>No trials reported this outcome.</p> </section> </section> </section> <section id="CD005219-sec-0148"> <h5 class="title">NBOT for prevention of attacks</h5> <p>No trials studied the use of NBOT for prevention of attacks.</p> </section> <section id="CD005219-sec-0149"> <h5 class="title">Adverse events</h5> <p><a href="./references#CD005219-bbs2-0002" title="DiSabatoF , FuscoBM , PelaiaP , GiacovazzoM . Hyperbaric oxygen therapy in cluster headache. Pain1993;52(2):243‐5. ">Di Sabato 1993</a> reported that no adverse reactions were noted in any participant while <a href="./references#CD005219-bbs2-0001" title="CohenAS , BurnsB , GoadsbyPJ . High‐flow oxygen for treatment of cluster headache: a randomized trial. JAMA2009;302(22):2451‐7. ">Cohen 2009</a> reported there were no serious adverse events related to the treatments. Two participants reported an empty cylinder before completing the trial gas administration. No other trial made any reference to adverse events. </p> </section> </section> </section> </section> </section> <section class="discussion"> <div class="section-header section-collapse-header" id="CD005219-sec-0150" lang="en"> <h2 class="title section-collapse-title"> Discussion <i aria-hidden="true" class="fa fa-caret-up section-collapse-icon"></i> </h2> </div> <section class="discussion" lang="en"> <div class="section-header" id="CD005219-sec-0150"></div> <section id="CD005219-sec-0151"> <h3 class="title" id="CD005219-sec-0151">Summary of main results</h3> <p>Since the last version of this review, <a href="./references#CD005219-bbs2-0080" title="BennettMH , FrenchC , SchnabelA , WasiakJ , KrankeP . Normobaric and hyperbaric oxygen therapy for migraine and cluster headache. Cochrane Database of Systematic Reviews2008, Issue 7. [DOI: 10.1002/14651858.CD005219.pub2] ">Bennett 2008</a>, two new included studies have provided additional information to change the conclusions of this review. In this review update we included data from 11 trials in total and believe these represent all RCTs in this area, both published and unpublished. We found some evidence using pooled data from three trials that the administration of HBOT can substantially relieve an acute migraine attack (<a href="./references#CD005219-bbs2-0004" title="FifeCE , MeyerJS , BerryJM , SuttonTE . Hyperbaric oxygen and acute migraine pain: preliminary results of a randomised blinded trial. Undersea Biomedical Research1992;19:106‐7. ">Fife 1992</a>; <a href="./references#CD005219-bbs2-0006" title="HillRK . A blinded, crossover controlled study of the use of hyperbaric oxygen in the treatment of migraine headache. Undersea Biomedical Research1992;19(S):106. ">Hill 1992</a>; <a href="./references#CD005219-bbs2-0008" title="MyersDE , MyersRA . A preliminary report on hyperbaric oxygen in the relief of migraine headache. Headache1995;35(4):197‐9. ">Myers 1995</a>). This analysis suggests more than 70% of participants obtained relief within about 40 minutes, with a NNT = 2 (95% CI 1 to 2) compared to a sham therapy. We have presented our pooled estimate in <a href="./full#CD005219-tbl-0001">summary of findings Table for the main comparison</a>. One trial showed no evidence to suggest that HBOT could prevent migraine episodes, reduce the incidence of nausea and vomiting, or reduce the requirement for rescue medication (<a href="./references#CD005219-bbs2-0003" title="EftedalOS , LydersenS , HeldeG , WhiteL , BrubakkAO , StovnerLJ . A randomised, double blind study of the prophylactic effect of hyperbaric oxygen therapy on migraine. Cephalalgia2004;24(8):639‐44. ">Eftedal 2004</a>). Only one very small cross‐over trial reported pain intensity following HBOT (<a href="./references#CD005219-bbs2-0011" title="WilsonJR , ForesmanGH , GamberRG , WrightT . Hyperbaric oxygen in the treatment of migraine with aura. Headache1998;38(2):112‐5. ">Wilson 1998</a>). While this trial reported a significant reduction in pain intensity in the HBOT group but not in the NBOT group, there was no statistically significant reduction in intensity when directly comparing HBOT and NBOT. </p> <p>Only a single trial investigated HBOT use for the termination of cluster headache, and this very small trial (13 participants) was underpowered to reliably demonstrate even a large difference between groups (<a href="./references#CD005219-bbs2-0002" title="DiSabatoF , FuscoBM , PelaiaP , GiacovazzoM . Hyperbaric oxygen therapy in cluster headache. Pain1993;52(2):243‐5. ">Di Sabato 1993</a>). Eleven of 13 participants in the HBOT group obtained relief versus none of the same 13 when they received sham therapy; all of these participants were reported as remaining free of headache for at least 48 hours. There was some evidence that NBOT may also terminate acute cluster headache. <a href="./references#CD005219-bbs2-0001" title="CohenAS , BurnsB , GoadsbyPJ . High‐flow oxygen for treatment of cluster headache: a randomized trial. JAMA2009;302(22):2451‐7. ">Cohen 2009</a> reported 78% of cluster headaches were terminated with HBOT versus 20% with air, and this supported the findings of <a href="./references#CD005219-bbs2-0005" title="FoganL . Treatment of cluster headache. A double‐blind comparison of oxygen v air inhalation. Archives of Neurology1985;42(4):362‐3. ">Fogan 1985</a> (more than 50% of participants achieved relief from headache within 15 minutes). <a href="./references#CD005219-bbs2-0007" title="KudrowL . Response of cluster headache attacks to oxygen inhalation. Headache1981;21(1):1‐4. ">Kudrow 1981</a> demonstrated no benefit from NBOT when compared to the administration of ergotamine tartrate. However, combining the NBOT arms of each of these studies suggests that a high proportion of cluster headaches will respond to NBOT (50 of 66 participants). We could not pool these trials because of clinical heterogeneity, specifically because comparators and outcomes measured differed between trials. There was no evidence from a single trial that HBOT can prevent cluster headaches (<a href="./references#CD005219-bbs2-0009" title="Nilsson RemahlAI , AnsjonR , LindF , WaldenlindE . Hyperbaric oxygen treatment of active cluster headache: a double‐blind placebo‐controlled cross‐over study. Cephalalgia2002;22(9):730‐9. ">Nilsson Remahl 2002</a>). </p> </section> <section id="CD005219-sec-0152"> <h3 class="title" id="CD005219-sec-0152">Overall completeness and applicability of evidence</h3> <p>While we can have some confidence that HBOT will terminate a migraine headache in many people, and similarly that NBOT can terminate a cluster headache, there is little evidence in answer to our other clinical questions. In particular, there is no indication based on the sparse evidence available that either HBOT or NBOT can prevent headaches of either type, and very little evidence that HBOT has any added value over NBOT for cluster headache. </p> <p>Data from the included trials suggest both potential treatments are relatively safe. Only two trials specifically mentioned adverse events (<a href="./references#CD005219-bbs2-0001" title="CohenAS , BurnsB , GoadsbyPJ . High‐flow oxygen for treatment of cluster headache: a randomized trial. JAMA2009;302(22):2451‐7. ">Cohen 2009</a>; <a href="./references#CD005219-bbs2-0003" title="EftedalOS , LydersenS , HeldeG , WhiteL , BrubakkAO , StovnerLJ . A randomised, double blind study of the prophylactic effect of hyperbaric oxygen therapy on migraine. Cephalalgia2004;24(8):639‐44. ">Eftedal 2004</a>). There were two reported cases of claustrophobia in the former, while two participants ran out of trial gas in the other. Otherwise no complications directly related to HBOT or NBOT were noted. </p> <p>HBOT is regarded as a relatively benign intervention. There are few major adverse events (pulmonary barotrauma, drug reactions, injuries, or death related to chamber fire). There are a number of more minor complications that may commonly occur. Visual disturbance, usually a reversible reduction in visual acuity secondary to conformational changes in the lens, is very commonly reported; perhaps as many as 50% of those having a course of 30 treatments (<a href="./references#CD005219-bbs2-0054" title="KhanB , EvansAW , EasterbrookM . Refractive changes in patients undergoing hyperbaric oxygen therapy: a prospective study. Undersea &amp; Hyperbaric Medicine2003;24 Suppl:9. ">Khan 2003</a>). This is unlikely to be a problem after the single exposures used in most of these included trials. The second most common adverse effect associated with HBOT is barotrauma. Barotrauma can affect any air‐filled cavity in the body (including the middle ear, lungs, and respiratory sinuses) and occurs as a direct result of compression. Aural barotrauma is by far the most common as the middle ear air space is small, largely surrounded by bone and the sensitive tympanic membrane, and usually requires active effort by the patient in order to inflate the middle ear through the eustachian tube on each side. Barotrauma is thus not a consequence of HBOT directly, but rather of the physical conditions required to administer it. Most episodes of barotrauma are mild, easily treated, or recover spontaneously and do not require the therapy to be abandoned. While HBOT administration may be an effective means for terminating migraine, there are problems of both cost and availability in applying this therapy in routine clinical practice. For safe administration, HBOT requires relatively sophisticated equipment, and for this reason is generally available only in specialist units whether free‐standing or hospital based. Many migraineurs would not have easy access to such facilities. While the cost of hyperbaric therapy varies greatly around the world, one facility in Australia has recently estimated the cost of a single session of treatment for an uncomplicated patient at AUD 304.00 (<a href="./references#CD005219-bbs2-0043" title="Gomez‐CastilloJD , BennettMH . The cost of hyperbaric therapy at the Prince of Wales Hospital, Sydney. South Pacific Underwater Medicine Journal2005;35(4):194‐8. ">Gomez‐Castillo 2005</a>). This is unlikely to be cost‐effective compared to established therapeutic options. HBOT may be a useful option for patients who are refractory to other medications; however, this subgroup of patients has not been selected for study and the efficacy of HBOT in these patients is unknown. </p> <p>NBOT has been widely recommended for the treatment of cluster headache since <a href="./references#CD005219-bbs2-0048" title="HortonBT . Histaminic cephalgia: differential diagnosis and treatment. Proceedings of the Staff Meetings. Mayo Clinic1956;31(11):325‐33. ">Horton 1956</a>. It is generally accepted that about 70% of patients will receive significant relief, based on the small studies of <a href="./references#CD005219-bbs2-0005" title="FoganL . Treatment of cluster headache. A double‐blind comparison of oxygen v air inhalation. Archives of Neurology1985;42(4):362‐3. ">Fogan 1985</a>, <a href="./references#CD005219-bbs2-0007" title="KudrowL . Response of cluster headache attacks to oxygen inhalation. Headache1981;21(1):1‐4. ">Kudrow 1981</a>, and the larger study from <a href="./references#CD005219-bbs2-0001" title="CohenAS , BurnsB , GoadsbyPJ . High‐flow oxygen for treatment of cluster headache: a randomized trial. JAMA2009;302(22):2451‐7. ">Cohen 2009</a>. </p> <p>We planned to perform subgroup analyses with respect to the dose of oxygen received (HBOT versus NBOT), session time, and length of treatment course. This was only appropriate with respect to oxygen dose in the relief of migraine. In that analysis, HBOT appeared equally effective when compared to either air or NBOT. </p> </section> <section id="CD005219-sec-0153"> <h3 class="title" id="CD005219-sec-0153">Quality of the evidence</h3> <p>We rated the quality of the evidence as low for HBOT for the relief of acute migraine (<a href="./references#CD005219-bbs2-0044" title="McMaster University, 2015 (developed by Evidence Prime, Inc.). GRADEpro Guideline Development Tool [Software]. McMaster University, 2015 (developed by Evidence Prime, Inc.), 2015. ">GRADEPro GDT 2015</a>). Generally we assessed the methodological quality of the 11 included trials as moderate to low. Randomisation was poorly described in all but three included trials and none appear to have been based on sound sample size calculations for expected differences. One trial did not attempt to blind participants to therapy (<a href="./references#CD005219-bbs2-0007" title="KudrowL . Response of cluster headache attacks to oxygen inhalation. Headache1981;21(1):1‐4. ">Kudrow 1981</a>). Other problems were the failure to clearly report on primary outcomes in many of the trials, poor reporting of means and standard deviations, and the variable methods used to report similar outcomes. The results of this review must therefore be interpreted with great caution. </p> </section> <section id="CD005219-sec-0154"> <h3 class="title" id="CD005219-sec-0154">Potential biases in the review process</h3> <p>Six trials evaluated HBOT for the termination of an acute migraine attack (161 migraine participants), two trials evaluated HBOT for cluster headache, and three evaluated NBOT for cluster headache (202 cluster headache patients). While we have made every effort to locate further unpublished data, it remains possible this review is subject to a positive publication bias, with generally favourable trials more likely to achieve publication. </p> </section> <section id="CD005219-sec-0155"> <h3 class="title" id="CD005219-sec-0155">Agreements and disagreements with other studies or reviews</h3> <p>There are few recent reviews of oxygen therapy for migraine headache. In a review concentrating on potential mechanisms of action, <a href="./references#CD005219-bbs2-0074" title="TaylorFR . Nutraceuticals and headache: the biological basis. Headache: The Journal of Head and Face Pain 2011;51(3):484‐501. ">Taylor 2011</a> discussed the use of HBOT for both migraine and cluster headaches, but did not make therapeutic recommendations. In agreement with our review, <a href="./references#CD005219-bbs2-0047" title="HollandS , SilbersteinSD , FreitagF , DodickDW , ArgoffC , AshmanE . Evidence‐based guideline update: NSAIDs and other complementary treatments for episodic migraine prevention in adults. Report of the Quality Standards Subcommittee of the American Academy of Neurology and the American Headache Society. Neurology 2012;78(17):1346‐53. ">Holland 2012</a> considered the prevention of migraine and concluded there was insufficient evidence to justify the use of HBOT for this purpose. For cluster headache, a recent review recommends both sumatriptan and oxygen to abort ongoing headaches and suggest the evidence available to support their use is good (Class I) (<a href="./references#CD005219-bbs2-0023" title="LeoneM ,   Franzini A , Proietti CecchiniA , MeaE , BroggiG , BussoneG . Management of chronic cluster headache. Current Treatment Options in Neurology2011;13(1):56‐70. ">Leone 2010</a>).  </p> </section> </section> </section> <div class="figures-list"> <div class="figure" id="CD005219-fig-0001"> <div> <p><a class="external" href="/cdsr/doi/10.1002/14651858.CD005219.pub3/media/CDSR/CD005219/urn:x-wiley:14651858:media:CD005219:CD005219-AFig-FIG01" target="_blank"><b></b></a></p> </div> <div> <p><a class="external" href="/cdsr/doi/10.1002/14651858.CD005219.pub3/media/CDSR/CD005219/image_t/tCD005219-AFig-FIG01.png" target="_blank"><b></b></a></p> </div><img alt="Study flow diagram." data-id="CD005219-fig-0001" src="/cdsr/doi/10.1002/14651858.CD005219.pub3/media/CDSR/CD005219/image_n/nCD005219-AFig-FIG01.png"/> <div class="scolaris-modal-title">Figures and Tables - </div> <div class="figure-viewer-caption"> <div class="figure-label">Figure 1</div> <div class="figure-caption"> <p>Study flow diagram.</p> </div> </div> <div class="tools"><a class="scolaris-systematic-reviews" href="https://training.cochrane.org/essentials/module-4-understanding-using-systematic-reviews" target="_blank">Using systematic reviews (free)</a><a class="figureList" href="/cdsr/doi/10.1002/14651858.CD005219.pub3/full#CD005219-fig-0001">Navigate to figure in review</a><button class="print-figure" href="#">Print figure</button><a class="figure-viewer-isolate" href="/cdsr/doi/10.1002/14651858.CD005219.pub3/media/CDSR/CD005219/image_n/nCD005219-AFig-FIG01.png" target="_blank">Open in new tab</a></div> </div> <div class="figure" id="CD005219-fig-0002"> <div> <p><a class="external" href="/cdsr/doi/10.1002/14651858.CD005219.pub3/media/CDSR/CD005219/urn:x-wiley:14651858:media:CD005219:CD005219-AFig-FIG02" target="_blank"><b></b></a></p> </div> <div> <p><a class="external" href="/cdsr/doi/10.1002/14651858.CD005219.pub3/media/CDSR/CD005219/image_t/tCD005219-AFig-FIG02.png" target="_blank"><b></b></a></p> </div><img alt="'Risk of bias' graph: each 'Risk of bias' item presented as percentages across all included studies." data-id="CD005219-fig-0002" src="/cdsr/doi/10.1002/14651858.CD005219.pub3/media/CDSR/CD005219/image_n/nCD005219-AFig-FIG02.png"/> <div class="scolaris-modal-title">Figures and Tables - </div> <div class="figure-viewer-caption"> <div class="figure-label">Figure 2</div> <div class="figure-caption"> <p>'Risk of bias' graph: each 'Risk of bias' item presented as percentages across all included studies. </p> </div> </div> <div class="tools"><a class="scolaris-systematic-reviews" href="https://training.cochrane.org/essentials/module-4-understanding-using-systematic-reviews" target="_blank">Using systematic reviews (free)</a><a class="figureList" href="/cdsr/doi/10.1002/14651858.CD005219.pub3/full#CD005219-fig-0002">Navigate to figure in review</a><button class="print-figure" href="#">Print figure</button><a class="figure-viewer-isolate" href="/cdsr/doi/10.1002/14651858.CD005219.pub3/media/CDSR/CD005219/image_n/nCD005219-AFig-FIG02.png" target="_blank">Open in new tab</a></div> </div> <div class="figure" id="CD005219-fig-0003"> <div> <p><a class="external" href="/cdsr/doi/10.1002/14651858.CD005219.pub3/media/CDSR/CD005219/urn:x-wiley:14651858:media:CD005219:CD005219-AFig-FIG03" target="_blank"><b></b></a></p> </div> <div> <p><a class="external" href="/cdsr/doi/10.1002/14651858.CD005219.pub3/media/CDSR/CD005219/image_t/tCD005219-AFig-FIG03.png" target="_blank"><b></b></a></p> </div><img alt="'Risk of bias' summary: review authors' judgements about each 'Risk of bias' item for each included study." data-id="CD005219-fig-0003" src="/cdsr/doi/10.1002/14651858.CD005219.pub3/media/CDSR/CD005219/image_n/nCD005219-AFig-FIG03.png"/> <div class="scolaris-modal-title">Figures and Tables - </div> <div class="figure-viewer-caption"> <div class="figure-label">Figure 3</div> <div class="figure-caption"> <p>'Risk of bias' summary: review authors' judgements about each 'Risk of bias' item for each included study. </p> </div> </div> <div class="tools"><a class="scolaris-systematic-reviews" href="https://training.cochrane.org/essentials/module-4-understanding-using-systematic-reviews" target="_blank">Using systematic reviews (free)</a><a class="figureList" href="/cdsr/doi/10.1002/14651858.CD005219.pub3/full#CD005219-fig-0003">Navigate to figure in review</a><button class="print-figure" href="#">Print figure</button><a class="figure-viewer-isolate" href="/cdsr/doi/10.1002/14651858.CD005219.pub3/media/CDSR/CD005219/image_n/nCD005219-AFig-FIG03.png" target="_blank">Open in new tab</a></div> </div> <div class="figure" id="CD005219-fig-0004"> <div> <p><a class="external" href="/cdsr/doi/10.1002/14651858.CD005219.pub3/media/CDSR/CD005219/urn:x-wiley:14651858:media:CD005219:CD005219-AFig-FIG04" target="_blank"><b></b></a></p> </div> <div> <p><a class="external" href="/cdsr/doi/10.1002/14651858.CD005219.pub3/media/CDSR/CD005219/image_t/tCD005219-AFig-FIG04.png" target="_blank"><b></b></a></p> </div><img alt="Forest plot of comparison: 1 HBOT versus control for acute migraine attack, outcome: 1.1 Substantial acute relief of headache." data-id="CD005219-fig-0004" src="/cdsr/doi/10.1002/14651858.CD005219.pub3/media/CDSR/CD005219/image_n/nCD005219-AFig-FIG04.png"/> <div class="scolaris-modal-title">Figures and Tables - </div> <div class="figure-viewer-caption"> <div class="figure-label">Figure 4</div> <div class="figure-caption"> <p>Forest plot of comparison: 1 HBOT versus control for acute migraine attack, outcome: 1.1 Substantial acute relief of headache. </p> </div> </div> <div class="tools"><a class="scolaris-systematic-reviews" href="https://training.cochrane.org/essentials/module-4-understanding-using-systematic-reviews" target="_blank">Using systematic reviews (free)</a><a class="figureList" href="/cdsr/doi/10.1002/14651858.CD005219.pub3/full#CD005219-fig-0004">Navigate to figure in review</a><button class="print-figure" href="#">Print figure</button><a class="figure-viewer-isolate" href="/cdsr/doi/10.1002/14651858.CD005219.pub3/media/CDSR/CD005219/image_n/nCD005219-AFig-FIG04.png" target="_blank">Open in new tab</a></div> </div> <div class="figure" id="CD005219-fig-0005"> <div> <p><a class="external" href="/cdsr/doi/10.1002/14651858.CD005219.pub3/media/CDSR/CD005219/urn:x-wiley:14651858:media:CD005219:CD005219-CMP-001-01" target="_blank"><b></b></a></p> </div> <div> <p><a class="external" href="/cdsr/doi/10.1002/14651858.CD005219.pub3/media/CDSR/CD005219/image_t/tCD005219-CMP-001-01.png" target="_blank"><b></b></a></p> </div><img alt="Comparison 1 HBOT versus control for acute migraine attack, Outcome 1 Substantial acute relief of headache." data-id="CD005219-fig-0005" src="/cdsr/doi/10.1002/14651858.CD005219.pub3/media/CDSR/CD005219/image_n/nCD005219-CMP-001-01.png"/> <div class="scolaris-modal-title">Figures and Tables - </div> <div class="figure-viewer-caption"> <div class="figure-label">Analysis 1.1</div> <div class="figure-caption"> <p>Comparison 1 HBOT versus control for acute migraine attack, Outcome 1 Substantial acute relief of headache. </p> </div> </div> <div class="tools"><a class="scolaris-systematic-reviews" href="https://training.cochrane.org/essentials/module-4-understanding-using-systematic-reviews" target="_blank">Using systematic reviews (free)</a><a class="figureList" href="/cdsr/doi/10.1002/14651858.CD005219.pub3/references#CD005219-fig-0005">Navigate to figure in review</a><button class="print-figure" href="#">Print figure</button><a class="figure-viewer-isolate" href="/cdsr/doi/10.1002/14651858.CD005219.pub3/media/CDSR/CD005219/image_n/nCD005219-CMP-001-01.png" target="_blank">Open in new tab</a></div> </div> </div> <div class="tables-list"> <div class="table"> <table class="summary-of-findings framed" data-id="CD005219-tbl-0001"> <div class="table-heading"><span class="table-label">Summary of findings for the main comparison.</span> <span class="table-title">Hyperbaric oxygen therapy for acute migraine</span></div> <tbody> <tr class="separated"> <td align="left" bgcolor="#ffffff" colspan="7" rowspan="1" valign="top"> <p><b>Hyperbaric oxygen therapy for the relief of acute migraine</b> </p> </td> </tr> <tr class="separated"> <td align="left" bgcolor="#ffffff" colspan="7" rowspan="1" valign="top"> <p><b>Patient or population:</b> Acute migraine<br/> <b>Setting:</b> Hospital care<br/> <b>Intervention:</b> HBOT (2.0 to 2.4 ATA for 40 to 45 minutes)<br/> <b>Comparison:</b> Sham therapy (air at pressure or 100% oxygen at 1 ATA) </p> </td> </tr> <tr class="table-header separated"> <td align="left" class="table-header" colspan="1" rowspan="2" valign="top"> <p><b>Outcomes</b> </p> </td> <td align="left" class="table-tint table-highlight" colspan="2" rowspan="1" valign="top"> <p><b>Anticipated absolute effects<sup>*</sup> (95% CI)</b> </p> </td> <td align="left" class="table-header" colspan="1" rowspan="2" valign="top"> <p><b>Relative effect<br/> (95% CI)</b> </p> </td> <td align="left" class="table-header" colspan="1" rowspan="2" valign="top"> <p><b>Number of participants<br/> (trials)</b> </p> </td> <td align="left" class="table-header" colspan="1" rowspan="2" valign="top"> <p><b>Quality of the evidence<br/> (GRADE)</b> </p> </td> <td align="left" class="table-header" colspan="1" rowspan="2" valign="top"> <p><b>Comments</b> </p> </td> </tr> <tr class="table-header separated"> <td align="left" class="table-tint table-highlight" colspan="1" rowspan="1" valign="top"> <p><b>Risk with sham therapy</b> </p> </td> <td align="left" class="table-tint table-highlight" colspan="1" rowspan="1" valign="top"> <p><b>Risk with HBOT</b> </p> </td> </tr> <tr class="separated"> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="2" valign="top"> <p>Chance of obtaining substantial headache relief (Relief).<br/> Assessed with: Patient self‐assessment </p> </td> <td align="left" class="table-tint table-highlight" colspan="2" rowspan="1" valign="top"> <p>Study population</p> </td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="2" valign="top"> <p>RR 6.21<br/> (2.41 to 16.00) </p> </td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="2" valign="top"> <p>58<br/> (3 RCTs) </p> </td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="2" valign="top"> <p>Low¹</p> </td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="2" valign="top"> <p>We included 3 small RCTs but all showed large effect size with HBOT compared to either air or 100% oxygen sham. </p> </td> </tr> <tr class="separated"> <td align="left" class="table-tint table-highlight" colspan="1" rowspan="1" valign="top"> <p>111 per 1000</p> </td> <td align="left" class="table-tint table-highlight" colspan="1" rowspan="1" valign="top"> <p>663 per 1000<br/> (162 to 1000) </p> </td> </tr> <tr class="separated"> <td align="" bgcolor="#ffffff" colspan="7" rowspan="1" valign=""> <p>*<b>The risk in the intervention group</b> (and its 95% CI) is based on the assumed risk in the comparison group and the <b>relative effect</b> of the intervention (and its 95% CI).<br/> <b>Abbreviations: CI:</b> confidence interval; <b>RR:</b> risk ratio; <b>OR:</b> odds ratio; <b>ATA:</b> atmospheres absolute; <b>HBOT:</b> hyperbaric oxygen therapy. </p> </td> </tr> <tr class="separated"> <td align="" bgcolor="#ffffff" colspan="7" rowspan="1" valign=""> <p><b>GRADE Working Group grades of evidence</b> <br/> <b>High quality:</b> We are very confident that the true effect lies close to that of the estimate of the effect.<br/> <b>Moderate quality:</b> We are moderately confident in the effect estimate: The true effect is likely to be close to the estimate of the effect, but there is a possibility that it is substantially different.<br/> <b>Low quality:</b> Our confidence in the effect estimate is limited: The true effect may be substantially different from the estimate of the effect.<br/> <b>Very low quality:</b> We have very little confidence in the effect estimate: The true effect is likely to be substantially different from the estimate of effect. </p> </td> </tr> </tbody> <tfoot> <tr> <td colspan="7"> <div class="table-footnote"> <p>¹The evidence has been downgraded from moderate to low due to two of these trials being incompletely reported crossover trials reported only in abstract. [Two of the three included studies were planned as crossover trials. In those two, many patients obtained relief during the first treatment period and were not crossed to the second period. For <a href="./references#CD005219-bbs2-0006" title="HillRK . A blinded, crossover controlled study of the use of hyperbaric oxygen in the treatment of migraine headache. Undersea Biomedical Research1992;19(S):106. ">Hill 1992</a>, where all patients are not clearly accounted for we have included the results only from the first treatment period.] </p> </div> </td> </tr> </tfoot> </table> <div class="scolaris-modal-title">Figures and Tables - </div> <div class="table-viewer-caption"> <div class="table-heading"><span class="table-label">Summary of findings for the main comparison.</span> <span class="table-title">Hyperbaric oxygen therapy for acute migraine</span></div> </div> <div class="tools"><a class="tableList" href="/cdsr/doi/10.1002/14651858.CD005219.pub3/full#CD005219-tbl-0001">Navigate to table in review</a></div> </div> <div class="table"> <table class="comparison" data-id="CD005219-tbl-0002"> <div class="table-heading"><span class="table-label">Comparison 1.</span> <span class="table-title">HBOT versus control for acute migraine attack</span></div> <thead> <tr> <td align="" bgcolor="#ffffff" colspan="1" data-title="Outcome or subgroup title" rowspan="1" valign=""> <p>Outcome or subgroup title</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of studies" rowspan="1" valign=""> <p>No. of studies</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of participants" rowspan="1" valign=""> <p>No. of participants</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Statistical method" rowspan="1" valign=""> <p>Statistical method</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Effect size" rowspan="1" valign=""> <p>Effect size</p> </td> </tr> </thead> <tbody> <tr> <td align="" bgcolor="#ffffff" colspan="1" data-title="Outcome or subgroup title" rowspan="1" valign=""> <p class="subgroupTitle">1 Substantial acute relief of headache <span class="subgroupLink"><b class="text-toggle-control">Show forest plot</b><i aria-hidden="true" class="fa fa-caret-down"></i></span></p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of studies" rowspan="1" valign=""> <p>3</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of participants" rowspan="1" valign=""> <p>58</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Statistical method" rowspan="1" valign=""> <p>Risk Ratio (M‐H, Fixed, 95% CI)</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Effect size" rowspan="1" valign=""> <p>6.21 [2.41, 16.00]</p> </td> </tr> <tr class="figure-image"> <td colspan="5"></td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" data-title="Outcome or subgroup title" rowspan="1" valign=""> <p>1.1 HBOT versus air sham therapy</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of studies" rowspan="1" valign=""> <p>2</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of participants" rowspan="1" valign=""> <p>38</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Statistical method" rowspan="1" valign=""> <p>Risk Ratio (M‐H, Fixed, 95% CI)</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Effect size" rowspan="1" valign=""> <p>5.28 [1.76, 15.87]</p> </td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" data-title="Outcome or subgroup title" rowspan="1" valign=""> <p>1.2 HBOT versus 100% oxygen at 1 ATA</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of studies" rowspan="1" valign=""> <p>1</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of participants" rowspan="1" valign=""> <p>20</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Statistical method" rowspan="1" valign=""> <p>Risk Ratio (M‐H, Fixed, 95% CI)</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Effect size" rowspan="1" valign=""> <p>9.0 [1.39, 58.44]</p> </td> </tr> </tbody> </table> <div class="scolaris-modal-title">Figures and Tables - </div> <div class="table-viewer-caption"> <div class="table-heading"><span class="table-label">Comparison 1.</span> <span class="table-title">HBOT versus control for acute migraine attack</span></div> </div> <div class="tools"><a class="tableList" href="/cdsr/doi/10.1002/14651858.CD005219.pub3/references#CD005219-tbl-0002">Navigate to table in review</a></div> </div> </div> <noscript> <img height="1" src="/scolaris-auth/report/nonjs/fulltexthtmlreg?doi=10.1002%2F14651858.CD005219.pub3&amp;rf=&amp;articleType=CDSR" style="display:none" width="1"> </img></noscript> <section class="translation-notes-modal" data-modal-class="translation-notes" data-modal-title="Translation notes" data-ok-btn-selector=".ok-btn" style="display: none"> <div class="translation-notes"> <div class="section-language-toggles"> <nav class="section-languages"> <ul> <li class="section-languages-legend">Available in</li> <li class="section-language"> <a class="" href="de#CD005219-note-0001">Deutsch</a> </li> <li class="section-language"> <a class="" href="es#CD005219-note-0009">Español</a> </li> <li class="section-language"> <a class="" href="fa#CD005219-note-0006">فارسی</a> </li> <li class="section-language"> <a class="" href="hr#CD005219-note-0005">Hrvatski</a> </li> <li class="section-language"> <a class="" href="ja#CD005219-note-0004">日本語</a> </li> <li class="section-language"> <a class="" href="ko#CD005219-note-0003">한국어</a> </li> <li class="section-language"> <a class="" href="ru#CD005219-note-0002">Русский</a> </li> </ul> </nav> </div> <section class="translation-notes-content"> </section> <button class="btn primary ok-btn pull-right" type="button">Close</button> </div> </section></article> </div> <div class="citation-modal" style="display: none"> <div class="export-citation-header"> <p class="inset-message" data-load-error="Unable to load citation data" id="citeProcText"></p> </div> <div class="export-citation-body row-fluid"> <div class="span12"> <div class="addthis_toolbox addthis_default_style addthis_16x16_style"> <nav class="inline-nav-list is-bordered"> <li> <h4 class="heading">Save citation to:</h4> </li> <li><a class="citation-btn-refworks at300b btn btn-link" href="#" id="refWorksCitationBtn"><span class="citation-icon refworks"></span>RefWorks</a></li> <li><a class="citation-btn-sciwheel at300b btn btn-link disabled" href="#" id="sciWheelCitationBtn" target="_blank"><span class="citation-icon sciwheel"></span>SciWheel</a></li> </nav> </div> </div> </div> <div class="row-fluid"> <div class="span12"> <div class="citation-format"> <h4>Copy or download citation</h4> <a href="/en/help/exporting-search-results" rel="noopener noreferrer" target="_blank">Export help</a> </div> <nav class="inline-nav-list has-dividers"> <li class="citation-option" data-option="plain"><button class="btn btn-link" type="button">Plain text</button></li> <li class="citation-option" data-option="endnote"><button class="btn btn-link" type="button">EndNote</button></li> <li class="citation-option" data-option="refmanager"><button class="btn btn-link" type="button">Reference Manager</button></li> <li class="citation-option" data-option="procite"><button class="btn btn-link" type="button">ProCite</button></li> <li class="citation-option" data-option="bibtex"><button class="btn btn-link" type="button">BibteX</button></li> <li class="citation-option" data-option="csv"><button class="btn btn-link" type="button">CSV (Excel)</button></li> </nav> <div class="citation-content"> <pre data-load-error="Unable to load citation data" id="citationContent" tabindex="0"></pre> </div> <div class="clearfix"> <form class="download-citation-form" data-citation-citeproc-url="https://www.cochranelibrary.com/en/content?p_p_id=scolariscontentdisplay_WAR_scolariscontentdisplay&amp;p_p_lifecycle=2&amp;p_p_state=normal&amp;p_p_mode=view&amp;p_p_resource_id=citation-citeproc&amp;p_p_cacheability=cacheLevelPage&amp;p_p_col_id=column-1&amp;p_p_col_count=1" method="GET" target="citation-download-iframe"> <input id="siteId" name="siteId" type="hidden" value=""> <input id="downloadType" name="downloadType" type="hidden" value=""> <input id="style" name="style" type="hidden" value=""> <input id="articleId" name="articleId" type="hidden" value=""> <input name="p_p_id" type="hidden" value="scolariscontentdisplay_WAR_scolariscontentdisplay"><input name="p_p_lifecycle" type="hidden" value="2"><input name="p_p_state" type="hidden" value="normal"><input name="p_p_mode" type="hidden" value="view"/><input name="p_p_resource_id" type="hidden" value="citation-download"/><input name="p_p_cacheability" type="hidden" value="cacheLevelPage"/><input name="p_p_col_id" type="hidden" value="column-1"/><input name="p_p_col_count" type="hidden" value="1"/> <button class="btn primary wide pull-right" type="submit">Download</button> <div class="inline-checkbox pull-right"> <label title=" for=" withabstract"=""> <input checked="" class="checkbox" name="withAbstract" type="checkbox"/> <span class="checkbox-label">Include abstract</span> </label> </div> </input></input></input></input></input></input></input></form> <iframe aria-hidden="true" name="citation-download-iframe" src="" style="display: none; visibility: hidden" title="Citation download frame"></iframe> </div> </div> </div> </div> <div class="print-modal" data-modal-title="Print this review" style="display: none;"> <div class="print-options-wrapper"> <p><strong>All sections are selected by default</strong>, please select the sections you do not wish to print or use the select or deselect all button to add or remove sections.</p> <div class="print-options-controls"> <input checked="checked" class="print-options-select-all" title="Select/deselect all" type="checkbox"/> <span class="checkbox-label">Select/deselect all</span> </div> <ul class="print-options checkbox-list"> </ul> <button class="btn primary print-article pull-right"><i aria-hidden="true" class="fa fa-print"></i> Print</button> </div> </div> <div class="download-stats-data-modal" data-modal-title="Download data package" style="display: none;"> <div> <p> The data available are protected by copyright and may only be used in accordance with the <a class="external" href="/about/data-download" target="_blank">Terms and Conditions.</a> </p> <div class="hide-for-zip"> <p> <a class="external" href="https://revman.cochrane.org/#/rm5Converter" target="_blank">RevMan 5 files</a> can be converted to a <a class="external" href="https://links.cochrane.org/review-datapack-userguide" target="_blank">data package.</a> </p> </div> <p> Files in the data package can be imported to <a class="external" href="https://revman.cochrane.org/info" target="_blank">Review Manager software</a> or opened in other tools that support CSV and RIS. </p> <form class="download-stats-data-form" method="GET" target="_blank"> <input name="content-disposition" type="hidden" value="attachment"/> <input name="mime-type" type="hidden" value="application/octet-stream"/> <p class="print-options-controls"> <input aria-label="I agree to these terms and conditions" class="download-stats-data-toc-check-box" type="checkbox"/> <span aria-hidden="true" class="checkbox-label">I agree to these terms and conditions</span> <button class="btn primary download-stats-data pull-right" disabled=""><i aria-hidden="true" class="fa fa-download"></i> Download data</button> </p> </form> </div> </div> <div class="share-modal" data-modal-title="Share this review" style="display:none;"> </div> <div class="viewer-thumbnail-pane-html" style="display:none;"> <div class="figure-viewer-options"> <nav class="inline-nav-list"> <li class="figure-options-btn-container"><button class="btn btn-link" id="figureOptionBtn" type="button">Figures</button></li> <li class="table-options-btn-container"><button class="btn btn-link" id="tableOptionBtn" type="button">Tables</button></li> </nav> </div> <div class="figure-viewer-thumbnails"> <div class="figure-thumbnails is-visible" id="figureThumbnails"></div> <div class="table-thumbnails" id="tableThumbnails"></div> </div> </div> <div class="utilities-html" style="display:none;"> <div class="figure-viewer-utilities"> <a class="figure-viewer-menu-toggle" href="#"> <i class="fa fa-chevron-left"></i><span class="toggle-label" data-figure-hide-text="Hide thumbnails" data-figure-show-text="Show thumbnails" data-table-hide-text="Hide table list" data-table-show-text="Show table list">Hide thumbnails</span> </a> <a class="figure-viewer-navigateback" href="#"> <i class="fa fa-chevron-left"></i> </a> <a class="figure-viewer-rotate" href="#"> <i class="fa fa-undo"></i> </a> <a class="figure-viewer-download" href="#"> <i class="fa fa-download"></i> </a> <a class="figure-viewer-share" href="#"> <i class="fa fa-share-alt"></i> </a> <a class="figure-viewer-zoomin" href="#"> <i class="fa fa-plus"></i><span>zoom in</span> </a> <a class="figure-viewer-zoomout" href="#"> <i class="fa fa-minus"></i><span>zoom out</span> </a> </div> </div> <div class="controls-html" style="display:none;"> <div class="figure-viewer-navigation"> <a class="figure-viewer-nav previous" href="#"> <i class="fa fa-chevron-left"></i><span>left</span> </a> <a class="figure-viewer-nav next" href="#"> <i class="fa fa-chevron-right"></i><span>right</span> </a> </div> </div> <div class="mobile-thumbnail-selector-html" style="display:none;"> <div class="figure-viewer-mobile-thumbnails"> <select class="figure-selection"> <option>Figures</option> </select> <select class="table-selection"> <option>Tables</option> </select> </div> </div> </div> </div> </div> <div style="display:none"> <input id="freelabel" name="freelabel" type="hidden" value="Free access"/>
<input id="openlabel" name="openlabel" type="hidden" value="Open access"/>
</div>
</section>
</div>
</div>
</div>
</div>
</div>
<div class="portlet-boundary portlet-boundary_1_WAR_kaleodesignerportlet_ portlet-static portlet-static-end kaleo-designer-portlet" id="p_p_id_1_WAR_kaleodesignerportlet_">
<span id="p_1_WAR_kaleodesignerportlet"></span>
</div>
<form action="#" id="hrefFm" method="post" name="hrefFm">
<span></span>
</form>
</div>
<footer class="footer">
<div class="main-footer">
<div class="main-footer-wrapper container">
<div class="brand">
<p class="brand-name">Cochrane</p>
<a href="http://www.cochrane.org/" title="Cochrane logo">
<img alt="Cochrane logo" class="footer-logo logo-part-1" src="https://www.cochranelibrary.com/cochrane-theme/images/footer-logo-part-1.png"> <img alt="" class="footer-logo logo-part-2" src="https://www.cochranelibrary.com/cochrane-theme/images/footer-logo-part-2.png"> </img></img></a> </div> </div> </div> <div class="aux-footer"> <div class="aux-footer-nav-container container"> <nav class="aux-footer-nav"> <ul class="aux-footer-nav-list"> <li><a class="aux-footer-nav-link" href="https://onlinelibrary.wiley.com/">Browse Publications</a></li> <li><a class="aux-footer-nav-link" href="https://onlinelibrary.wiley.com/">Browse by Subject</a></li> </ul> <ul class="aux-footer-nav-list"> <li><a class="aux-footer-nav-link" href="https://onlinelibrary.wiley.com/advertisers">Advertisers &amp; Agents</a></li> <li><a class="aux-footer-nav-link" href="https://hub.wiley.com/community/support/cochrane-library">Contact Us</a></li> </ul> <ul class="aux-footer-nav-list"> <li><a class="aux-footer-nav-link" href="https://hub.wiley.com/community/support/cochrane-library">Help &amp; Support</a></li> <li><a class="aux-footer-nav-link" href="https://onlinelibrary.wiley.com/terms-and-conditions">Terms &amp; Conditions</a></li> </ul> </nav> </div> <div class="brand"> <div class="brand-container container"> <p class="copyright"> Copyright © 2000 - 2025 by <a class="" href="http://www.wiley.com">John Wiley &amp; Sons, Inc.</a> All Rights Reserved <br> Review our <a href="https://www.wiley.com/privacy"><strong>Privacy Policy</strong></a> <a href="https://www.wiley.com/cookies"><strong>Cookie Policy</strong></a> <a href="#" onclick="Osano.cm.showDrawer('osano-cm-dom-info-dialog-open')"><strong>Cookie Preferences</strong></a> </br></p> <a href="http://eu.wiley.com/"><img alt="Wiley logo" class="logo" src="https://www.cochranelibrary.com/cochrane-theme/images/en-US_wiley-footer-logo.png"/></a> </div> </div> <span class="wiley-semi-circle"></span> </div> <!--BEGIN QUALTRICS WEBSITE FEEDBACK SNIPPET--> <script type="text/javascript"> (function(){var g=function(e,h,f,g){ this.get=function(a){for(var a=a+"=",c=document.cookie.split(";"),b=0,e=c.length;b<e;b++){for(var d=c[b];" "==d.charAt(0);)d=d.substring(1,d.length);if(0==d.indexOf(a))return d.substring(a.length,d.length)}return null}; this.set=function(a,c){var b="",b=new Date;b.setTime(b.getTime()+6048E5);b="; expires="+b.toGMTString();document.cookie=a+"="+c+b+"; path=/; "}; this.check=function(){var a=this.get(f);if(a)a=a.split(":");else if(100!=e)"v"==h&&(e=Math.random()>=e/100?0:100),a=[h,e,0],this.set(f,a.join(":"));else return!0;var c=a[1];if(100==c)return!0;switch(a[0]){case "v":return!1;case "r":return c=a[2]%Math.floor(100/c),a[2]++,this.set(f,a.join(":")),!c}return!0}; this.go=function(){if(this.check()){var a=document.createElement("script");a.type="text/javascript";a.src=g;document.body&&document.body.appendChild(a)}}; this.start=function(){var t=this;"complete"!==document.readyState?window.addEventListener?window.addEventListener("load",function(){t.go()},!1):window.attachEvent&&window.attachEvent("onload",function(){t.go()}):t.go()};}; try{(new g(100,"r","QSI_S_ZN_cGCHHvWNpnJb1zf","https://zncgchhvwnpnjb1zf-wiley.siteintercept.qualtrics.com/SIE/?Q_ZID=ZN_cGCHHvWNpnJb1zf")).start()}catch(i){}})(); </script><div id="ZN_cGCHHvWNpnJb1zf"><!--DO NOT REMOVE-CONTENTS PLACED HERE--></div> <!--END WEBSITE FEEDBACK SNIPPET--> </footer> <div class="scolaris-modal-overlay"></div> <div class="scolaris-modal"> <div class="scolaris-modal-titlebar clearfix"> <p class="scolaris-modal-title"></p> <a class="scolaris-modal-close" href="#"><span>close</span><span class="icon fa fa-times"></span></a> <div class="scolaris-modal-ui"></div> </div> <!-- Static injection of addtoAny as dynamic injection not working properly--> <div class="scolaris-share-modal-content clearfix"> <div class="scolaris-modal-ui clearfix"> <div class="a2a_kit a2a_kit_size_32 a2a_default_style"> <a class="a2a_button_facebook share-button">  Facebook</a> <a class="a2a_button_x share-button">  X(Twitter)</a> <a class="a2a_button_whatsapp share-button">  WhatsApp</a> <a class="a2a_dd share-button">  View more</a> </div> </div> </div> <div class="scolaris-modal-content clearfix"> <div class="scolaris-modal-ui clearfix"></div> </div> <div class="scolaris-modal-ui clearfix"></div> </div> <div class="english-only-modal-wrapper" data-modal-class="english-only-modal" data-modal-title="Feature in English only" style="display: none"> <div class="english-only-modal"> <p class="message"></p> <button class="btn primary ok-btn pull-right" type="button">OK</button> <button class="btn primary border-only cancel-btn pull-right" type="button">Cancel</button> </div> </div> <!--[if gte IE 9]><!--> <script src="/cochrane-theme/vendor/ie9.js?t=1738735355000" type="text/javascript"></script> <!--<![endif]--> <script src="https://www.cochranelibrary.com/cochrane-theme/js/theme.js?t=1738735355000" type="text/javascript"></script> <script src="https://content.readcube.com/cochrane/checkout.js"></script> <script src="https://content.readcube.com/cochrane/epdf_linker.js" type="text/javascript"></script> <script src="https://crossmark-cdn.crossref.org/widget/v2.0/widget.js" type="text/javascript"></script> <script src="https://d1bxh8uas1mnw7.cloudfront.net/assets/embed.js" type="text/javascript"></script> <script src="https://www.cochranelibrary.com/scolaris-content-display/js/hit-highlighting.js?browserId=other&amp;minifierType=js&amp;languageId=en_US&amp;b=6210&amp;t=1739773978000" type="text/javascript"></script> <script src="https://www.cochranelibrary.com/scolaris-content-display/js/topics-lookup.js?browserId=other&amp;minifierType=js&amp;languageId=en_US&amp;b=6210&amp;t=1739773978000" type="text/javascript"></script> <script src="https://www.cochranelibrary.com/scolaris-content-display/js/institution.js?browserId=other&amp;minifierType=js&amp;languageId=en_US&amp;b=6210&amp;t=1739773978000" type="text/javascript"></script> <script src="https://www.cochranelibrary.com/scolaris-content-display/js/api-manager.js?browserId=other&amp;minifierType=js&amp;languageId=en_US&amp;b=6210&amp;t=1739773978000" type="text/javascript"></script> <script src="https://www.cochranelibrary.com/scolaris-content-display/js/pico.js?browserId=other&amp;minifierType=js&amp;languageId=en_US&amp;b=6210&amp;t=1739773978000" type="text/javascript"></script> <script src="https://www.cochranelibrary.com/scolaris-content-display/js/reference-linking.js?browserId=other&amp;minifierType=js&amp;languageId=en_US&amp;b=6210&amp;t=1739773978000" type="text/javascript"></script> <script src="https://www.cochranelibrary.com/scolaris-content-display/js/rightsLink.js?browserId=other&amp;minifierType=js&amp;languageId=en_US&amp;b=6210&amp;t=1739773978000" type="text/javascript"></script> <script src="https://www.cochranelibrary.com/scolaris-content-display/js/ui.submit.failed.js?browserId=other&amp;minifierType=js&amp;languageId=en_US&amp;b=6210&amp;t=1739773978000" type="text/javascript"></script> <script src="https://www.cochranelibrary.com/scolaris-content-display/js/ui.comment.form.js?browserId=other&amp;minifierType=js&amp;languageId=en_US&amp;b=6210&amp;t=1739773978000" type="text/javascript"></script> <script src="https://www.cochranelibrary.com/scolaris-content-display/js/safety-alerts.js?browserId=other&amp;minifierType=js&amp;languageId=en_US&amp;b=6210&amp;t=1739773978000" type="text/javascript"></script> <script src="https://www.cochranelibrary.com/scolaris-content-display/js/ui.translation-notes-modal.js?browserId=other&amp;minifierType=js&amp;languageId=en_US&amp;b=6210&amp;t=1739773978000" type="text/javascript"></script> <script src="https://www.cochranelibrary.com/scolaris-content-display/js/main.js?browserId=other&amp;minifierType=js&amp;languageId=en_US&amp;b=6210&amp;t=1739773978000" type="text/javascript"></script> <script src="https://www.cochranelibrary.com/notifications-portlet/notifications/js/main.js?browserId=other&amp;minifierType=js&amp;languageId=en_US&amp;b=6210&amp;t=1739774000000" type="text/javascript"></script> <script src="https://www.cochranelibrary.com/scolaris-search/js/main.js?browserId=other&amp;minifierType=js&amp;languageId=en_US&amp;b=6210&amp;t=1739774074000" type="text/javascript"></script> <script src="https://www.cochranelibrary.com/scolaris-topics/js/main.js?browserId=other&amp;minifierType=js&amp;languageId=en_US&amp;b=6210&amp;t=1739774074000" type="text/javascript"></script> <script src="https://www.cochranelibrary.com/scolaris-language-portlet/js/main.js?browserId=other&amp;minifierType=js&amp;languageId=en_US&amp;b=6210&amp;t=1739774000000" type="text/javascript"></script> <script type="text/javascript">Liferay.Util.addInputFocus();</script> <script type="text/javascript">Liferay.Portlet.register("scolarislanguageselector_WAR_scolarislanguageportlet_INSTANCE_header");Liferay.Portlet.onLoad({canEditTitle:false,columnPos:0,isStatic:"end",namespacedId:"p_p_id_scolarislanguageselector_WAR_scolarislanguageportlet_INSTANCE_header_",portletId:"scolarislanguageselector_WAR_scolarislanguageportlet_INSTANCE_header",refreshURL:"\x2fen\x2fc\x2fportal\x2frender_portlet\x3fp_l_id\x3d20757\x26p_p_id\x3dscolarislanguageselector_WAR_scolarislanguageportlet_INSTANCE_header\x26p_p_lifecycle\x3d0\x26p_t_lifecycle\x3d0\x26p_p_state\x3dnormal\x26p_p_mode\x3dview\x26p_p_col_id\x3dnull\x26p_p_col_pos\x3dnull\x26p_p_col_count\x3dnull\x26p_p_static\x3d1\x26p_p_isolated\x3d1\x26currentURL\x3d\x252Fweb\x252Fcochrane\x252Fcontent\x253FtemplateType\x253Dfull\x2526urlTitle\x253D\x252Fcdsr\x252Fdoi\x252F10\x2e1002\x252F14651858\x2eCD005219\x2epub3\x2526doi\x253D10\x2e1002\x252F14651858\x2eCD005219\x2epub3\x2526type\x253Dcdsr\x2526contentLanguage\x253D\x26templateType\x3dfull\x26urlTitle\x3d\x252Fcdsr\x252Fdoi\x252F10\x2e1002\x252F14651858\x2eCD005219\x2epub3\x26contentLanguage\x3d\x26type\x3dcdsr\x26doi\x3d10\x2e1002\x252F14651858\x2eCD005219\x2epub3"});Liferay.Portlet.register("scolariscontentdisplay_WAR_scolariscontentdisplay");Liferay.Portlet.onLoad({canEditTitle:false,columnPos:0,isStatic:"end",namespacedId:"p_p_id_scolariscontentdisplay_WAR_scolariscontentdisplay_",portletId:"scolariscontentdisplay_WAR_scolariscontentdisplay",refreshURL:"\x2fen\x2fc\x2fportal\x2frender_portlet\x3fp_l_id\x3d20757\x26p_p_id\x3dscolariscontentdisplay_WAR_scolariscontentdisplay\x26p_p_lifecycle\x3d0\x26p_t_lifecycle\x3d0\x26p_p_state\x3dnormal\x26p_p_mode\x3dview\x26p_p_col_id\x3dcolumn-1\x26p_p_col_pos\x3d0\x26p_p_col_count\x3d1\x26p_p_isolated\x3d1\x26currentURL\x3d\x252Fweb\x252Fcochrane\x252Fcontent\x253FtemplateType\x253Dfull\x2526urlTitle\x253D\x252Fcdsr\x252Fdoi\x252F10\x2e1002\x252F14651858\x2eCD005219\x2epub3\x2526doi\x253D10\x2e1002\x252F14651858\x2eCD005219\x2epub3\x2526type\x253Dcdsr\x2526contentLanguage\x253D"});Liferay.provide(Liferay.Util,"openKaleoDesignerPortlet",function(c){var b=AUI();var e=Liferay.PortletURL.createURL("https://www.cochranelibrary.com/en/content?p_p_id=2_WAR_kaleodesignerportlet&p_p_lifecycle=0");e.setParameter("mvcPath","/designer/edit_kaleo_draft_definition.jsp");e.setParameter("availableFields",c.availableFields);e.setParameter("availablePropertyModels",c.availablePropertyModels);e.setParameter("ddmStructureId",c.ddmStructureId);e.setParameter("draftVersion",c.draftVersion);e.setParameter("kaleoProcessId",c.kaleoProcessId);e.setParameter("name",c.name);e.setParameter("openerWindowName",c.openerWindowName);e.setParameter("portletResourceNamespace",c.portletResourceNamespace);e.setParameter("propertiesSaveCallback",c.propertiesSaveCallback);e.setParameter("refreshOpenerOnClose",c.refreshOpenerOnClose);e.setParameter("saveCallback",c.saveCallback);e.setParameter("version",c.version);e.setWindowState("pop_up");c.uri=e.toString();var d=c.dialog;if(!d){var f=b.one(Liferay.Util.getOpener()).get("region");d={destroyOnHide:true};c.dialog=d}if(!("align" in d)){d.align=Liferay.Util.Window.ALIGN_CENTER}var a=c.dialogIframe;if(!a){a={closeOnEscape:false};c.dialogIframe=a}Liferay.Util.openWindow(c)},["liferay-portlet-url"]);Liferay.Portlet.register("1_WAR_kaleodesignerportlet");Liferay.Portlet.onLoad({canEditTitle:false,columnPos:0,isStatic:"end",namespacedId:"p_p_id_1_WAR_kaleodesignerportlet_",portletId:"1_WAR_kaleodesignerportlet",refreshURL:"\x2fen\x2fc\x2fportal\x2frender_portlet\x3fp_l_id\x3d20757\x26p_p_id\x3d1_WAR_kaleodesignerportlet\x26p_p_lifecycle\x3d0\x26p_t_lifecycle\x3d0\x26p_p_state\x3dnormal\x26p_p_mode\x3dview\x26p_p_col_id\x3dnull\x26p_p_col_pos\x3dnull\x26p_p_col_count\x3dnull\x26p_p_static\x3d1\x26p_p_isolated\x3d1\x26currentURL\x3d\x252Fweb\x252Fcochrane\x252Fcontent\x253FtemplateType\x253Dfull\x2526urlTitle\x253D\x252Fcdsr\x252Fdoi\x252F10\x2e1002\x252F14651858\x2eCD005219\x2epub3\x2526doi\x253D10\x2e1002\x252F14651858\x2eCD005219\x2epub3\x2526type\x253Dcdsr\x2526contentLanguage\x253D\x26templateType\x3dfull\x26urlTitle\x3d\x252Fcdsr\x252Fdoi\x252F10\x2e1002\x252F14651858\x2eCD005219\x2epub3\x26contentLanguage\x3d\x26type\x3dcdsr\x26doi\x3d10\x2e1002\x252F14651858\x2eCD005219\x2epub3"});Liferay.Portlet.register("scolarissearchportlet_WAR_scolarissearch");Liferay.Portlet.onLoad({canEditTitle:false,columnPos:0,isStatic:"end",namespacedId:"p_p_id_scolarissearchportlet_WAR_scolarissearch_",portletId:"scolarissearchportlet_WAR_scolarissearch",refreshURL:"\x2fen\x2fc\x2fportal\x2frender_portlet\x3fp_l_id\x3d20757\x26p_p_id\x3dscolarissearchportlet_WAR_scolarissearch\x26p_p_lifecycle\x3d0\x26p_t_lifecycle\x3d0\x26p_p_state\x3dnormal\x26p_p_mode\x3dview\x26p_p_col_id\x3dnull\x26p_p_col_pos\x3dnull\x26p_p_col_count\x3dnull\x26p_p_static\x3d1\x26p_p_isolated\x3d1\x26currentURL\x3d\x252Fweb\x252Fcochrane\x252Fcontent\x253FtemplateType\x253Dfull\x2526urlTitle\x253D\x252Fcdsr\x252Fdoi\x252F10\x2e1002\x252F14651858\x2eCD005219\x2epub3\x2526doi\x253D10\x2e1002\x252F14651858\x2eCD005219\x2epub3\x2526type\x253Dcdsr\x2526contentLanguage\x253D\x26templateType\x3dfull\x26urlTitle\x3d\x252Fcdsr\x252Fdoi\x252F10\x2e1002\x252F14651858\x2eCD005219\x2epub3\x26contentLanguage\x3d\x26type\x3dcdsr\x26doi\x3d10\x2e1002\x252F14651858\x2eCD005219\x2epub3"});Liferay.Portlet.register("scolariscontentlanguagebanner_WAR_scolarislanguageportlet");Liferay.Portlet.onLoad({canEditTitle:false,columnPos:0,isStatic:"end",namespacedId:"p_p_id_scolariscontentlanguagebanner_WAR_scolarislanguageportlet_",portletId:"scolariscontentlanguagebanner_WAR_scolarislanguageportlet",refreshURL:"\x2fen\x2fc\x2fportal\x2frender_portlet\x3fp_l_id\x3d20757\x26p_p_id\x3dscolariscontentlanguagebanner_WAR_scolarislanguageportlet\x26p_p_lifecycle\x3d0\x26p_t_lifecycle\x3d0\x26p_p_state\x3dnormal\x26p_p_mode\x3dview\x26p_p_col_id\x3dnull\x26p_p_col_pos\x3dnull\x26p_p_col_count\x3dnull\x26p_p_static\x3d1\x26p_p_isolated\x3d1\x26currentURL\x3d\x252Fweb\x252Fcochrane\x252Fcontent\x253FtemplateType\x253Dfull\x2526urlTitle\x253D\x252Fcdsr\x252Fdoi\x252F10\x2e1002\x252F14651858\x2eCD005219\x2epub3\x2526doi\x253D10\x2e1002\x252F14651858\x2eCD005219\x2epub3\x2526type\x253Dcdsr\x2526contentLanguage\x253D\x26templateType\x3dfull\x26urlTitle\x3d\x252Fcdsr\x252Fdoi\x252F10\x2e1002\x252F14651858\x2eCD005219\x2epub3\x26contentLanguage\x3d\x26type\x3dcdsr\x26doi\x3d10\x2e1002\x252F14651858\x2eCD005219\x2epub3"});AUI().use("aui-base","liferay-menu","liferay-notice","liferay-poller","liferay-session",function(a){(function(){Liferay.Util.addInputType();Liferay.Portlet.ready(function(b,c){Liferay.Util.addInputType(c)});if(a.UA.mobile){Liferay.Util.addInputCancel()}})();(function(){new Liferay.Menu();var b=Liferay.Data.notices;for(var c=1;c<b.length;c++){new Liferay.Notice(b[c])}})();(function(){Liferay.Session=new Liferay.SessionBase({autoExtend:true,sessionLength:1800,redirectOnExpire:false,redirectUrl:"https\x3a\x2f\x2fwww\x2ecochranelibrary\x2ecom\x2fweb\x2fcochrane",warningLength:0})})()});</script> <script src="https://www.cochranelibrary.com/cochrane-theme/js/main.js?browserId=other&amp;minifierType=js&amp;languageId=en_US&amp;b=6210&amp;t=1738735355000" type="text/javascript"></script> <script type="text/javascript"></script> <div class="mobile-righthand-nav"> <a class="rh-nav-close-btn" href="#"> <span>Close</span> <span class="fa fa-chevron-down"></span> </a> <div class="wrapper"> </div> <a class="rh-nav-open-btn" href="#"> <span>Review tools &amp; navigation</span> </a> </div> <iframe aria-hidden="true" id="printframe" name="printframe" style="position: absolute; left: -2000px; top: 0;" title="Print frame"></iframe> <iframe aria-hidden="true" id="citationExportFrame" name="citationExportFrame" style="position: absolute; left: -2000px; top: 0;" title="scolaris.citation.export.frame"></iframe> <nav> <div class="mobile-navigation"> <div class="close-container"> <a aria-label="Navigate back" class="main-nav-back-btn" href="#"><i class="fa fa-chevron-left"></i></a> <a class="main-nav-close-btn" href="#" title="Close menu">Close menu <i class="fa fa-times"></i></a> </div> <div class="mobile-search basic-search-container"> <div class="portlet-boundary portlet-boundary_scolarissearchportlet_WAR_scolarissearch_ portlet-static portlet-static-end" id="p_p_id_scolarissearchportlet_WAR_scolarissearch_"> <span id="p_scolarissearchportlet_WAR_scolarissearch"></span> <section class="portlet" id="portlet_scolarissearchportlet_WAR_scolarissearch"> <header class="portlet-topper"> <h1 class="portlet-title"> <span class="" onmouseover="Liferay.Portal.ToolTip.show(this, 'Scolaris\x20Search\x20Portlet')"> <img alt="" id="ymag__null__null" src="/scolaris-search/icon.png"> <span class="taglib-text hide-accessible">Scolaris Search Portlet</span> </img></span> <span class="portlet-title-text">Scolaris Search Portlet</span> </h1> <menu class="portlet-topper-toolbar" id="portlet-topper-toolbar_scolarissearchportlet_WAR_scolarissearch" type="toolbar"> </menu> </header> <div class="portlet-content"> <div class="portlet-content-container"> <div class="portlet-body"> <div class="header-search"> <form action="https://www.cochranelibrary.com/en/content?p_auth=jU9oKp1Y&amp;p_p_id=scolarissearchportlet_WAR_scolarissearch&amp;p_p_lifecycle=1&amp;p_p_state=normal&amp;p_p_mode=view&amp;_scolarissearchportlet_WAR_scolarissearch_scolarisAction=redirectSearchResult" method="post"> <input name="searchType" type="hidden" value="basic"> <input name="facetDisplayName" type="hidden" value=""> <input name="facetQueryTerm" type="hidden" value=""/> <input name="facetQueryField" type="hidden" value=""/> <input name="facetCategory" type="hidden" value=""/> <fieldset class="fieldset"> <legend class="sr-only">Basic Search</legend> <div class="select search-by"> <select aria-label="Search by options" class="custom-select-enabled search-type" name="searchBy" title="Search by options"> <option value="1">Title Abstract Keyword</option> <option value="2">Record Title</option> <option value="3">Abstract</option> <option value="4">Author</option> <option value="5">Keyword</option> <option value="6">All Text</option> <option value="7">Publication Type</option> <option value="8">Source</option> <option value="9">DOI</option> <option value="14">Language</option> <option value="10">Accession Number</option> <option value="11">Trial Registry Number</option> <option value="12">Cochrane Group</option> <option value="13">Cochrane Topic</option> </select> </div> <div class="search-select-crg-container select" style="display: none;"> <select class="search-select-crg-list"></select> </div> <div class="search-select-topic-container select" data-topic-list-url="https://www.cochranelibrary.com/en/content?p_p_id=scolaristopics_WAR_scolaristopics&amp;p_p_lifecycle=2&amp;p_p_state=normal&amp;p_p_mode=view&amp;p_p_resource_id=topics-list&amp;p_p_cacheability=cacheLevelPage" style="display: none;"> <select class="search-select-topic-list"></select> </div> <div class="search-select-cl-container select" style="display: none;"> <select class="search-select-cl-list"></select> </div> <div class="search-text-container"> <div class="control-group control-group-inline search-input-wrapper"> <input aria-label="Enter search term" class="field browser-search search-text ui-autocomplete-input" id="searchText" name="searchText" placeholder="Search" size="30" type="text" value=""/>
<div id="autocomplete-results"></div>
</div>
<div class="control-group control-group-inline search-button-wrapper">
<button aria-label="Search" class="searchByBtn" type="submit">
<i aria-hidden="true" class="fa fa-search"></i>
</button>
</div>
</div>
</fieldset>
</input></input></form>
</div>
<script>
    window.displayResultURL = 'https://www.cochranelibrary.com/en/content?p_p_id=scolarissearchportlet_WAR_scolarissearch&p_p_lifecycle=2&p_p_state=normal&p_p_mode=view&p_p_resource_id=getSuggestions&p_p_cacheability=cacheLevelPage&_scolarissearchportlet_WAR_scolarissearch_templateType=full&_scolarissearchportlet_WAR_scolarissearch_urlTitle=%2Fcdsr%2Fdoi%2F10.1002%2F14651858.CD005219.pub3&_scolarissearchportlet_WAR_scolarissearch_contentLanguage=&_scolarissearchportlet_WAR_scolarissearch_type=cdsr&_scolarissearchportlet_WAR_scolarissearch_doi=10.1002%2F14651858.CD005219.pub3';
    window.searchByOption = '';
</script>
</div>
</div>
</div>
<div style="display:none">
<input id="freelabel" name="freelabel" type="hidden" value="Free access"/>
<input id="openlabel" name="openlabel" type="hidden" value="Open access"/>
</div>
</section>
</div>
<a class="btn secondary" href="/en/browse-by-topic">Browse </a>
<a class="btn secondary advanced-search-button" href="/en/advanced-search">Advanced search</a>
</div>
<div class="menu-items parent">
<div>
<div class="nav-root-item parent">
<a class="language-selection-title-link" href="#" title="Select language">
<span class="mobile-nav-language-title">Select your preferred language </span></a> <span class="icon fa fa-caret-down"></span>
<div class="mob-child">
<div class="portlet-boundary portlet-boundary_scolarislanguageselector_WAR_scolarislanguageportlet_ portlet-static portlet-static-end" id="p_p_id_scolarislanguageselector_WAR_scolarislanguageportlet_INSTANCE_mobilenav_">
<span id="p_scolarislanguageselector_WAR_scolarislanguageportlet_INSTANCE_mobilenav"></span>
<section class="portlet" id="portlet_scolarislanguageselector_WAR_scolarislanguageportlet_INSTANCE_mobilenav">
<header class="portlet-topper">
<h1 class="portlet-title">
<span class="" onmouseover="Liferay.Portal.ToolTip.show(this, 'Scolaris\x20Language\x20Selector')">
<img alt="" id="fdkn__null__null" src="/scolaris-language-portlet/icon.png"> <span class="taglib-text hide-accessible">Scolaris Language Selector</span> </img></span> <span class="portlet-title-text">Scolaris Language Selector</span> </h1> <menu class="portlet-topper-toolbar" id="portlet-topper-toolbar_scolarislanguageselector_WAR_scolarislanguageportlet_INSTANCE_mobilenav" type="toolbar"> </menu> </header> <div class="portlet-content"> <div class="portlet-content-container"> <div class="portlet-body"> <div class="language-display" data-content-languages="[de, en, es, fa, fr, hi, hr, id, ja, ko, hu, ms, nl, pl, pt, ru, ro, ta, th, zh_HANT, zh_HANS]"> <a class="language-select-mobile" href="#" title="Select your preferred language"> <i class="fa fa-file-text"></i> English </a> <a class="language-select-mobile" href="#" title="Select your preferred language"> <i class="fa fa-globe"></i> English </a> </div> <div class="form-content language-selector-modal child"> <div class="row-fluid"> <h3><i class="fa fa-file-text"></i> Cochrane review language</h3> <p>Select your preferred language for Cochrane reviews and other content. Sections without translation will be in English.</p> <div class="dropdown-trigger" id="active-content-language"> <span>English</span> <i aria-hidden="true" class="fa fa-caret-down"></i> </div> <div class="language-selector-dropdown"> <a class="content-language-selector" data-languagecode="de" href="https://www.cochranelibrary.com/en/content?p_p_id=scolariscontentlanguagebanner_WAR_scolarislanguageportlet&amp;p_p_lifecycle=2&amp;p_p_state=normal&amp;p_p_mode=view&amp;p_p_resource_id=set-content-language&amp;p_p_cacheability=cacheLevelPage&amp;_scolariscontentlanguagebanner_WAR_scolarislanguageportlet_contentLanguage=de">Deutsch</a> <a class="content-language-selector is-active" data-languagecode="en" href="https://www.cochranelibrary.com/en/content?p_p_id=scolariscontentlanguagebanner_WAR_scolarislanguageportlet&amp;p_p_lifecycle=2&amp;p_p_state=normal&amp;p_p_mode=view&amp;p_p_resource_id=set-content-language&amp;p_p_cacheability=cacheLevelPage&amp;_scolariscontentlanguagebanner_WAR_scolarislanguageportlet_contentLanguage=en">English</a> <a class="content-language-selector" data-languagecode="es" href="https://www.cochranelibrary.com/en/content?p_p_id=scolariscontentlanguagebanner_WAR_scolarislanguageportlet&amp;p_p_lifecycle=2&amp;p_p_state=normal&amp;p_p_mode=view&amp;p_p_resource_id=set-content-language&amp;p_p_cacheability=cacheLevelPage&amp;_scolariscontentlanguagebanner_WAR_scolarislanguageportlet_contentLanguage=es">Español</a> <a class="content-language-selector" data-languagecode="fa" href="https://www.cochranelibrary.com/en/content?p_p_id=scolariscontentlanguagebanner_WAR_scolarislanguageportlet&amp;p_p_lifecycle=2&amp;p_p_state=normal&amp;p_p_mode=view&amp;p_p_resource_id=set-content-language&amp;p_p_cacheability=cacheLevelPage&amp;_scolariscontentlanguagebanner_WAR_scolarislanguageportlet_contentLanguage=fa">فارسی</a> <a class="content-language-selector" data-languagecode="fr" href="https://www.cochranelibrary.com/en/content?p_p_id=scolariscontentlanguagebanner_WAR_scolarislanguageportlet&amp;p_p_lifecycle=2&amp;p_p_state=normal&amp;p_p_mode=view&amp;p_p_resource_id=set-content-language&amp;p_p_cacheability=cacheLevelPage&amp;_scolariscontentlanguagebanner_WAR_scolarislanguageportlet_contentLanguage=fr">Français</a> <a class="content-language-selector" data-languagecode="hi" href="https://www.cochranelibrary.com/en/content?p_p_id=scolariscontentlanguagebanner_WAR_scolarislanguageportlet&amp;p_p_lifecycle=2&amp;p_p_state=normal&amp;p_p_mode=view&amp;p_p_resource_id=set-content-language&amp;p_p_cacheability=cacheLevelPage&amp;_scolariscontentlanguagebanner_WAR_scolarislanguageportlet_contentLanguage=hi">हिन्दी</a> <a class="content-language-selector" data-languagecode="hr" href="https://www.cochranelibrary.com/en/content?p_p_id=scolariscontentlanguagebanner_WAR_scolarislanguageportlet&amp;p_p_lifecycle=2&amp;p_p_state=normal&amp;p_p_mode=view&amp;p_p_resource_id=set-content-language&amp;p_p_cacheability=cacheLevelPage&amp;_scolariscontentlanguagebanner_WAR_scolarislanguageportlet_contentLanguage=hr">Hrvatski</a> <a class="content-language-selector" data-languagecode="id" href="https://www.cochranelibrary.com/en/content?p_p_id=scolariscontentlanguagebanner_WAR_scolarislanguageportlet&amp;p_p_lifecycle=2&amp;p_p_state=normal&amp;p_p_mode=view&amp;p_p_resource_id=set-content-language&amp;p_p_cacheability=cacheLevelPage&amp;_scolariscontentlanguagebanner_WAR_scolarislanguageportlet_contentLanguage=id">Bahasa Indonesia</a> <a class="content-language-selector" data-languagecode="ja" href="https://www.cochranelibrary.com/en/content?p_p_id=scolariscontentlanguagebanner_WAR_scolarislanguageportlet&amp;p_p_lifecycle=2&amp;p_p_state=normal&amp;p_p_mode=view&amp;p_p_resource_id=set-content-language&amp;p_p_cacheability=cacheLevelPage&amp;_scolariscontentlanguagebanner_WAR_scolarislanguageportlet_contentLanguage=ja">日本語</a> <a class="content-language-selector" data-languagecode="ko" href="https://www.cochranelibrary.com/en/content?p_p_id=scolariscontentlanguagebanner_WAR_scolarislanguageportlet&amp;p_p_lifecycle=2&amp;p_p_state=normal&amp;p_p_mode=view&amp;p_p_resource_id=set-content-language&amp;p_p_cacheability=cacheLevelPage&amp;_scolariscontentlanguagebanner_WAR_scolarislanguageportlet_contentLanguage=ko">한국어</a> <a class="content-language-selector" data-languagecode="hu" href="https://www.cochranelibrary.com/en/content?p_p_id=scolariscontentlanguagebanner_WAR_scolarislanguageportlet&amp;p_p_lifecycle=2&amp;p_p_state=normal&amp;p_p_mode=view&amp;p_p_resource_id=set-content-language&amp;p_p_cacheability=cacheLevelPage&amp;_scolariscontentlanguagebanner_WAR_scolarislanguageportlet_contentLanguage=hu">Magyar</a> <a class="content-language-selector" data-languagecode="ms" href="https://www.cochranelibrary.com/en/content?p_p_id=scolariscontentlanguagebanner_WAR_scolarislanguageportlet&amp;p_p_lifecycle=2&amp;p_p_state=normal&amp;p_p_mode=view&amp;p_p_resource_id=set-content-language&amp;p_p_cacheability=cacheLevelPage&amp;_scolariscontentlanguagebanner_WAR_scolarislanguageportlet_contentLanguage=ms">Bahasa Malaysia</a> <a class="content-language-selector" data-languagecode="nl" href="https://www.cochranelibrary.com/en/content?p_p_id=scolariscontentlanguagebanner_WAR_scolarislanguageportlet&amp;p_p_lifecycle=2&amp;p_p_state=normal&amp;p_p_mode=view&amp;p_p_resource_id=set-content-language&amp;p_p_cacheability=cacheLevelPage&amp;_scolariscontentlanguagebanner_WAR_scolarislanguageportlet_contentLanguage=nl">Nederlands</a> <a class="content-language-selector" data-languagecode="pl" href="https://www.cochranelibrary.com/en/content?p_p_id=scolariscontentlanguagebanner_WAR_scolarislanguageportlet&amp;p_p_lifecycle=2&amp;p_p_state=normal&amp;p_p_mode=view&amp;p_p_resource_id=set-content-language&amp;p_p_cacheability=cacheLevelPage&amp;_scolariscontentlanguagebanner_WAR_scolarislanguageportlet_contentLanguage=pl">Polski</a> <a class="content-language-selector" data-languagecode="pt" href="https://www.cochranelibrary.com/en/content?p_p_id=scolariscontentlanguagebanner_WAR_scolarislanguageportlet&amp;p_p_lifecycle=2&amp;p_p_state=normal&amp;p_p_mode=view&amp;p_p_resource_id=set-content-language&amp;p_p_cacheability=cacheLevelPage&amp;_scolariscontentlanguagebanner_WAR_scolarislanguageportlet_contentLanguage=pt">Português</a> <a class="content-language-selector" data-languagecode="ru" href="https://www.cochranelibrary.com/en/content?p_p_id=scolariscontentlanguagebanner_WAR_scolarislanguageportlet&amp;p_p_lifecycle=2&amp;p_p_state=normal&amp;p_p_mode=view&amp;p_p_resource_id=set-content-language&amp;p_p_cacheability=cacheLevelPage&amp;_scolariscontentlanguagebanner_WAR_scolarislanguageportlet_contentLanguage=ru">Русский</a> <a class="content-language-selector" data-languagecode="ro" href="https://www.cochranelibrary.com/en/content?p_p_id=scolariscontentlanguagebanner_WAR_scolarislanguageportlet&amp;p_p_lifecycle=2&amp;p_p_state=normal&amp;p_p_mode=view&amp;p_p_resource_id=set-content-language&amp;p_p_cacheability=cacheLevelPage&amp;_scolariscontentlanguagebanner_WAR_scolarislanguageportlet_contentLanguage=ro">Română</a> <a class="content-language-selector" data-languagecode="ta" href="https://www.cochranelibrary.com/en/content?p_p_id=scolariscontentlanguagebanner_WAR_scolarislanguageportlet&amp;p_p_lifecycle=2&amp;p_p_state=normal&amp;p_p_mode=view&amp;p_p_resource_id=set-content-language&amp;p_p_cacheability=cacheLevelPage&amp;_scolariscontentlanguagebanner_WAR_scolarislanguageportlet_contentLanguage=ta">தமிழ்</a> <a class="content-language-selector" data-languagecode="th" href="https://www.cochranelibrary.com/en/content?p_p_id=scolariscontentlanguagebanner_WAR_scolarislanguageportlet&amp;p_p_lifecycle=2&amp;p_p_state=normal&amp;p_p_mode=view&amp;p_p_resource_id=set-content-language&amp;p_p_cacheability=cacheLevelPage&amp;_scolariscontentlanguagebanner_WAR_scolarislanguageportlet_contentLanguage=th">ภาษาไทย</a> <a class="content-language-selector" data-languagecode="zh_HANT" href="https://www.cochranelibrary.com/en/content?p_p_id=scolariscontentlanguagebanner_WAR_scolarislanguageportlet&amp;p_p_lifecycle=2&amp;p_p_state=normal&amp;p_p_mode=view&amp;p_p_resource_id=set-content-language&amp;p_p_cacheability=cacheLevelPage&amp;_scolariscontentlanguagebanner_WAR_scolarislanguageportlet_contentLanguage=zh_HANT">繁體中文</a> <a class="content-language-selector" data-languagecode="zh_HANS" href="https://www.cochranelibrary.com/en/content?p_p_id=scolariscontentlanguagebanner_WAR_scolarislanguageportlet&amp;p_p_lifecycle=2&amp;p_p_state=normal&amp;p_p_mode=view&amp;p_p_resource_id=set-content-language&amp;p_p_cacheability=cacheLevelPage&amp;_scolariscontentlanguagebanner_WAR_scolarislanguageportlet_contentLanguage=zh_HANS">简体中文</a> </div> </div> <div class="row-fluid"> <h3 class="portal-language-header"><i class="fa fa-globe"></i> Website language</h3> <p>Select your preferred language for the Cochrane Library website.</p> <div class="dropdown-trigger" id="active-portal-language"> <span>English</span> <i aria-hidden="true" class="fa fa-caret-down"></i> </div> <div class="language-selector-dropdown"> <a class="portal-language-selector is-active" data-portallanguage="en" href="/en/cdsr/doi/10.1002/14651858.CD005219.pub3/full/en">English</a> <a class="portal-language-selector" data-portallanguage="es" href="/es/cdsr/doi/10.1002/14651858.CD005219.pub3/full/es">Español</a> </div> </div> <a class="btn secondary ok-btn pull-right" href="https://www.cochranelibrary.com/en/content?p_p_id=scolariscontentlanguagebanner_WAR_scolarislanguageportlet&amp;p_p_lifecycle=2&amp;p_p_state=normal&amp;p_p_mode=view&amp;p_p_resource_id=set-content-language&amp;p_p_cacheability=cacheLevelPage">Save</a> </div> </div> </div> </div> <div style="display:none"> <input id="freelabel" name="freelabel" type="hidden" value="Free access"/>
<input id="openlabel" name="openlabel" type="hidden" value="Open access"/>
</div>
</section>
</div>
</div>
</div>
<div class="parent">
<a class="mobile-link signin" data-redirect="false" href="https://www.cochranelibrary.com/c/portal/login?p_l_id=20757&amp;redirect=%2Fcdsr%2Fdoi%2F10.1002%2F14651858.CD005219.pub3%2Ffull" rel="nofollow">
                        Sign In
                    </a>
</div>
</div>
<div class="menu-items-footer">
<div class="utility-links">
<a class="cochrane-link" href="http://www.cochrane.org/" target="_blank">Visit Cochrane.org</a>
</div>
</div>
</div>
<div class="menu-items child"></div>
</div>
</nav><div class="basic-login-form-content" data-modal-title="Sign in" style="display: none;">
<div class="form-content">
<div class="row-fluid">
<div class="span12">
<div class="portlet-boundary portlet-boundary_58_ portlet-static portlet-static-end portlet-login" id="p_p_id_58_INSTANCE_MODAL_">
<span id="p_58_INSTANCE_MODAL"></span>
<section class="portlet" id="portlet_58_INSTANCE_MODAL">
<header class="portlet-topper">
<h1 class="portlet-title">
<span class="" onmouseover="Liferay.Portal.ToolTip.show(this, 'Sign\x20In')">
<img alt="" id="dbam__null__null" src="https://www.cochranelibrary.com/cochrane-theme/images/spacer.png" style="background-image: url('https://www.cochranelibrary.com/sprite/html/icons/_sprite.png'); background-position: 50% -592px; background-repeat: no-repeat; height: 16px; width: 16px;"> <span class="taglib-text hide-accessible">Sign In</span> </img></span> <span class="portlet-title-text">Sign In</span> </h1> <menu class="portlet-topper-toolbar" id="portlet-topper-toolbar_58_INSTANCE_MODAL" type="toolbar"> </menu> </header> <div class="portlet-content"> <div class="portlet-content-container"> <div class="portlet-body"> <form action="https://www.cochranelibrary.com/en/content?p_p_id=58_INSTANCE_MODAL&amp;p_p_lifecycle=1&amp;p_p_state=normal&amp;p_p_mode=view&amp;_58_INSTANCE_MODAL_struts_action=%2Flogin%2Flogin" autocomplete="on" class="form sign-in-form" id="_58_INSTANCE_MODAL_fm" method="post" name="_58_INSTANCE_MODAL_fm"> <fieldset class="input-container" disabled="disabled"> <legend class="sr-only">Cochrane Login</legend> <input name="_58_INSTANCE_MODAL_formDate" type="hidden" value="1740714374780"> <input class="field" id="_58_INSTANCE_MODAL_saveLastPath" name="_58_INSTANCE_MODAL_saveLastPath" type="hidden" value="false"> <input class="field" id="_58_INSTANCE_MODAL_redirect" name="_58_INSTANCE_MODAL_redirect" type="hidden" value="/cdsr/doi/10.1002/14651858.CD005219.pub3/full"> <input class="field" id="_58_INSTANCE_MODAL_doActionAfterLogin" name="_58_INSTANCE_MODAL_doActionAfterLogin" type="hidden" value="false"> <div class="control-group input-text-wrapper"> <label class="control-label" for="_58_INSTANCE_MODAL_login"> Email Address </label> <input class="field clearable" id="_58_INSTANCE_MODAL_login" name="_58_INSTANCE_MODAL_login" type="text" value=""> </input></div> <div class="control-group input-text-wrapper"> <label class="control-label" for="_58_INSTANCE_MODAL_password"> Password </label> <input class="field" id="_58_INSTANCE_MODAL_password" name="_58_INSTANCE_MODAL_password" type="password" value=""/> </div> <span id="_58_INSTANCE_MODAL_passwordCapsLockSpan" style="display: none;"> Caps Lock is on. </span> <div class="clearfix"> <div class="checkbox-list pull-left"> <div class="checkbox-list-item"> <div class="control-group form-inline input-checkbox-wrapper"> <label for="_58_INSTANCE_MODAL_rememberMeCheckbox"> <input id="_58_INSTANCE_MODAL_rememberMe" name="_58_INSTANCE_MODAL_rememberMe" type="hidden" value="true"/> <input checked="" class="field" id="_58_INSTANCE_MODAL_rememberMeCheckbox" name="_58_INSTANCE_MODAL_rememberMeCheckbox" onclick="Liferay.Util.updateCheckboxValue(this); " type="checkbox" value="true"/> Remember Me </label> </div> </div> </div> <div class="pull-right"> <a href="https://onlinelibrary.wiley.com/user/forgottenpassword" target="_blank">Forgotten password?</a> </div> </div> <div class="login-form-footer clearfix"> <div class="pull-left"> <button class="btn primary" type="submit">Sign in</button> <a class="btn secondary" href="https://onlinelibrary.wiley.com/user-registration" target="_blank">Register</a> </div> <div class="pull-right"> <a class="institutional-login-form-button" href="https://www.cochranelibrary.com/en/content?p_p_id=scolariscontentdisplay_WAR_scolariscontentdisplay&amp;p_p_lifecycle=0&amp;p_p_state=normal&amp;p_p_mode=view&amp;_scolariscontentdisplay_WAR_scolariscontentdisplay_action=institution-access">Institutional login</a> </div> </div> </input></input></input></input></fieldset> </form> </div> </div> </div> <div style="display:none"> <input id="freelabel" name="freelabel" type="hidden" value="Free access"/>
<input id="openlabel" name="openlabel" type="hidden" value="Open access"/>
</div>
</section>
</div>
</div>
</div>
</div></div>
<div class="institution-login-form-content" data-modal-title="Institutional login" style="display: none;">
<div class="form-content">
<div class="row-fluid access-content-wrapper">
<div class="span12">
<div class="section">
<div class="portlet-boundary portlet-boundary_scolariscontentdisplay_WAR_scolariscontentdisplay_ portlet-static portlet-static-end scolaris-content-display-portlet" id="p_p_id_scolariscontentdisplay_WAR_scolariscontentdisplay_INSTANCE_combinedloginform_">
<span id="p_scolariscontentdisplay_WAR_scolariscontentdisplay_INSTANCE_combinedloginform"></span>
<section class="portlet" id="portlet_scolariscontentdisplay_WAR_scolariscontentdisplay_INSTANCE_combinedloginform">
<header class="portlet-topper">
<h1 class="portlet-title">
<span class="" onmouseover="Liferay.Portal.ToolTip.show(this, 'Scolaris\x20Content\x20Display')">
<img alt="" id="obft__null__null" src="/scolaris-content-display/icon.png"> <span class="taglib-text hide-accessible">Scolaris Content Display</span> </img></span> <span class="portlet-title-text">Scolaris Content Display</span> </h1> <menu class="portlet-topper-toolbar" id="portlet-topper-toolbar_scolariscontentdisplay_WAR_scolariscontentdisplay_INSTANCE_combinedloginform" type="toolbar"> </menu> </header> <div class="portlet-content"> <div class="portlet-content-container"> <div class="portlet-body"> <div class="access-content-section"> <div class="section-content"> <p>Search for your institution's name below to login via Shibboleth</p> <form action="/shibboleth" id="institutionLoginForm" method="post"> <div class="fieldset"> <div class="form-group access-input-wrapper"> <div class="ui-widget ui-front"> <label class="sr-only" for="institutionName">Institution name</label> <input class="field" id="institutionName" name="institutionName" type="text" value=""/>
</div>
<button class="btn primary" name="button" type="submit">Go</button>
</div>
<div class="message error" id="institutionLookupErrorDiv" style="display:none">
                        '<span id="enteredInstitionNameSpan"></span>' is not set up for this type of access on Wiley Online Library. Please contact your institution's administrator to ask about access.
                    </div>
</div>
<input id="entityId" name="entityId" type="hidden" value=""/>
</form>
<h4>Previously accessed institutions</h4>
<ul class="plain" id="previousInstitutions">
<li>(none)</li>
</ul>
</div>
<div class="section-content">
<div class="open-athens-login">
                Login using <a href="/openathens">OpenAthens</a>
</div>
</div>
</div>
</div>
</div>
</div>
<div style="display:none">
<input id="freelabel" name="freelabel" type="hidden" value="Free access"/>
<input id="openlabel" name="openlabel" type="hidden" value="Open access"/>
</div>
</section>
</div>
<div class="portlet-boundary portlet-boundary_58_ portlet-static portlet-static-end portlet-login" id="p_p_id_58_INSTANCE_4_">
<span id="p_58_INSTANCE_4"></span>
<section class="portlet" id="portlet_58_INSTANCE_4">
<header class="portlet-topper">
<h1 class="portlet-title">
<span class="" onmouseover="Liferay.Portal.ToolTip.show(this, 'Sign\x20In')">
<img alt="" id="joiu__null__null" src="https://www.cochranelibrary.com/cochrane-theme/images/spacer.png" style="background-image: url('https://www.cochranelibrary.com/sprite/html/icons/_sprite.png'); background-position: 50% -592px; background-repeat: no-repeat; height: 16px; width: 16px;"> <span class="taglib-text hide-accessible">Sign In</span> </img></span> <span class="portlet-title-text">Sign In</span> </h1> <menu class="portlet-topper-toolbar" id="portlet-topper-toolbar_58_INSTANCE_4" type="toolbar"> </menu> </header> <div class="portlet-content"> <div class="portlet-content-container"> <div class="portlet-body"> <p>If you have a <strong>Wiley Online Library</strong> institutional username and password, enter them here.</p> <form action="https://www.cochranelibrary.com/en/content?p_p_id=58_INSTANCE_4&amp;p_p_lifecycle=1&amp;p_p_state=normal&amp;p_p_mode=view&amp;_58_INSTANCE_4_struts_action=%2Flogin%2Flogin" autocomplete="on" class="form sign-in-form" id="_58_INSTANCE_4_fm" method="post" name="_58_INSTANCE_4_fm"> <fieldset class="input-container" disabled="disabled"> <legend class="sr-only">Cochrane Login</legend> <input name="_58_INSTANCE_4_formDate" type="hidden" value="1740714374784"> <input class="field" id="_58_INSTANCE_4_saveLastPath" name="_58_INSTANCE_4_saveLastPath" type="hidden" value="false"> <input class="field" id="_58_INSTANCE_4_redirect" name="_58_INSTANCE_4_redirect" type="hidden" value="/cdsr/doi/10.1002/14651858.CD005219.pub3/full"> <input class="field" id="_58_INSTANCE_4_doActionAfterLogin" name="_58_INSTANCE_4_doActionAfterLogin" type="hidden" value="false"> <div class="control-group input-text-wrapper"> <label class="control-label" for="_58_INSTANCE_4_login"> Username </label> <input class="field clearable" id="_58_INSTANCE_4_login" name="_58_INSTANCE_4_login" type="text" value=""> </input></div> <div class="control-group input-text-wrapper"> <label class="control-label" for="_58_INSTANCE_4_password"> Password </label> <input class="field" id="_58_INSTANCE_4_password" name="_58_INSTANCE_4_password" type="password" value=""> </input></div> <input class="field" id="_58_INSTANCE_4_institutionalLogin" name="_58_INSTANCE_4_institutionalLogin" type="hidden" value="true"/> <span id="_58_INSTANCE_4_passwordCapsLockSpan" style="display: none;"> Caps Lock is on. </span> <div class="login-form-footer clearfix"> <div class="pull-left"> <button class="btn primary" type="submit">Sign in</button> </div> </div> </input></input></input></input></fieldset> </form> </div> </div> </div> <div style="display:none"> <input id="freelabel" name="freelabel" type="hidden" value="Free access"/>
<input id="openlabel" name="openlabel" type="hidden" value="Open access"/>
</div>
</section>
</div>
</div>
</div>
</div>
</div></div>
<div class="get-access-form-content" data-modal-title="Unlock gold-standard Cochrane evidence" style="display: none;">
<div class="portlet-boundary portlet-boundary_scolariscontentdisplay_WAR_scolariscontentdisplay_ portlet-static portlet-static-end scolaris-content-display-portlet" id="p_p_id_scolariscontentdisplay_WAR_scolariscontentdisplay_INSTANCE_getaccessform_">
<span id="p_scolariscontentdisplay_WAR_scolariscontentdisplay_INSTANCE_getaccessform"></span>
<section class="portlet" id="portlet_scolariscontentdisplay_WAR_scolariscontentdisplay_INSTANCE_getaccessform">
<header class="portlet-topper">
<h1 class="portlet-title">
<span class="" onmouseover="Liferay.Portal.ToolTip.show(this, 'Scolaris\x20Content\x20Display')">
<img alt="" id="wpdq__null__null" src="/scolaris-content-display/icon.png"/> <span class="taglib-text hide-accessible">Scolaris Content Display</span> </span> <span class="portlet-title-text">Scolaris Content Display</span> </h1> <menu class="portlet-topper-toolbar" id="portlet-topper-toolbar_scolariscontentdisplay_WAR_scolariscontentdisplay_INSTANCE_getaccessform" type="toolbar"> </menu> </header> <div class="portlet-content"> <div class="portlet-content-container"> <div class="portlet-body"> <div class="readcube-checkout-container-outer"> <div class="row-fluid access-content-wrapper"> <div class="span6 access-left-content"> <div class="section"> <div class="section-content"> <p>Improve your health decisions with access to trusted, independent evidence from the Cochrane Library. Unlock this review for uninterrupted access.</p> <p>Still deciding? <a href="https://m.info.wiley.com/webApp/cochranenewsletter"> Sign up to our newsletter to learn more </a> </p> </div> </div> <div class="section"> <div class="access-content-section"> <h3 class="title">Institutional users</h3> <div class="section-content"> <p>Search for your institution's name below to login via Shibboleth</p> <form action="/shibboleth" id="institutionLoginForm" method="post"> <div class="fieldset"> <div class="form-group access-input-wrapper"> <div class="ui-widget ui-front"> <label class="sr-only" for="institutionName">Institution name</label> <input class="field" id="institutionName" name="institutionName" type="text" value=""/> </div> <button class="btn primary" name="button" type="submit">Go</button> </div> <div class="message error" id="institutionLookupErrorDiv" style="display:none"> '<span id="enteredInstitionNameSpan"></span>' is not set up for this type of access on Wiley Online Library. Please contact your institution's administrator to ask about access. </div> </div> <input id="entityId" name="entityId" type="hidden" value=""/> </form> <h4>Previously accessed institutions</h4> <ul class="plain" id="previousInstitutions"> <li>(none)</li> </ul> </div> <div class="section-content"> <div class="open-athens-login"> Login using <a href="/openathens">OpenAthens</a> </div> </div> </div> </div> <div class="section"> <div class="access-content-section"> <h3 class="title"> Other access options </h3> <div class="section-content"> <ul class="plain"> <li> <a class="get-access-individual-login-button" href="/c/portal/login"> Individual access - via Wiley Online Library </a> </li> </ul> </div> </div> </div> </div> <div class="span6 access-right-content readcube-checkout-container"> <div class="section"> </div> </div> </div> </div> </div> </div> </div> <div style="display:none"> <input id="freelabel" name="freelabel" type="hidden" value="Free access"/> <input id="openlabel" name="openlabel" type="hidden" value="Open access"/> </div> </section> </div> </div> <!-- Scolaris Version: --> <script type="text/javascript">if(window._satellite){_satellite.pageBottom()};</script> </div> <script>(function(){function c(){var b=a.contentDocument||a.contentWindow.document;if(b){var d=b.createElement('script');d.innerHTML="window.__CF$cv$params={r:'918d6d24cca39377',t:'MTc0MDcxNDM3NS4wMDAwMDA='};var a=document.createElement('script');a.nonce='';a.src='/cdn-cgi/challenge-platform/scripts/jsd/main.js';document.getElementsByTagName('head')[0].appendChild(a);";b.getElementsByTagName('head')[0].appendChild(d)}}if(document.body){var a=document.createElement('iframe');a.height=1;a.width=1;a.style.position='absolute';a.style.top=0;a.style.left=0;a.style.border='none';a.style.visibility='hidden';document.body.appendChild(a);if('loading'!==document.readyState)c();else if(window.addEventListener)document.addEventListener('DOMContentLoaded',c);else{var e=document.onreadystatechange||function(){};document.onreadystatechange=function(b){e(b);'loading'!==document.readyState&&(document.onreadystatechange=e,c())}}}})();</script></body> </html> 